The Effects of In-utero Thyroxine Exposure On Mandibular Shape in Mice by Kesterke, Matthew J.
THE EFFECTS OF IN UTERO THYROXINE EXPOSURE ON MANDIBULAR 
SHAPE IN MICE 
by 
Matthew J. Kesterke 
B.A., Anthropology, University of Wyoming, 2003
M.A., Anthropology, University of Wyoming 2008
Submitted to the Graduate Faculty of the 
Kenneth P. Dietrich School of Arts and Sciences in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy in Anthropology 
University of Pittsburgh 
2016 
ii 
UNIVERSITY OF PITTSBURGH 
DIETRICH SCHOOL OF ARTS AND SCIENCES 
This dissertation was presented 
by 
Matthew J. Kesterke 
It was defended on 
October 21st, 2016 
and approved by 
James M. Cray, PhD, Assistant Professor 
Mark P. Mooney, PhD, Professor 
Michael I. Siegel, PhD, Professor 
Co-Chair: Seth M. Weinberg, PhD, Associate Professor 
Dissertation Advisor: Margaret M. Judd, PhD, Associate Professor 
iii 
Copyright © by Matthew J. Kesterke 
2016 
iv 
An estimated 3% of U.S. pregnancies are affected by maternal thyroid dysfunction, with between 
one and three of every 1,000 pregnancies being complicated by overactive maternal thyroid levels. 
Overactive maternal thyroid hormones have been linked to neurological impairment and 
craniofacial development dysmorphogenesis, affecting both endochondral and intramembranous 
bone. Using both Euclidean Distance Matrix Analysis (EDMA) and geometric morphometric 
approach, this study evaluates the role of in utero thyroxine overexposure on the growth of 
offspring mandibles in a sample of 241 mice. Principle component analysis (PCA) and canonical 
variate analysis (CVA) utilized 16 unilateral mandibular landmarks obtained from 3D microCT to 
assess shape changes between unexposed controls (n=63) and exposed mice (n=178). By 
evaluating shape changes in the mandible between different age groups (15, 20, and 25 days 
postnatal) and different dosage levels (low, medium, and high), this study found that maternal 
thyroxine alters offspring mandibular shape in both age- and dosage-dependent manners, 
particularly within the high dosage individuals in the oldest age group. The EDMA results 
demonstrate marked shape changes throughout the mandible, with the gonial angle and alveolus 
undergoing significant (p <0.10) changes. Geometric morphometric analysis revealed that group 
differences in overall shape were significant (p <0.001 for both PCA and CVA) and showed major 
changes in regions of the mandible associated with muscle attachment (coronoid process, gonial 
angle) and regions of growth largely governed by articulation with the cranial base (condyle) and 
occlusion (alveolus). These results compliment recent studies demonstrating that maternal 
thyroxine levels can alter the cranial base and cranial vault of offspring, contributing to a better 
understanding of both normal and abnormal mandibular development and facilitating a fuller 
understanding of evolutionary and medical implications of craniofacial growth and development. 
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1.0  INTRODUCTION 
An estimated 3% of U.S. pregnancies are affected by maternal thyroid dysfunction, with 
between one and three of every 1,000 pregnancies being complicated by overactive maternal 
thyroid levels (Casey and Leveno 2006; Negro and Mestman 2011; Mestman 2009). Overactive 
maternal thyroid hormones have been linked to neurological impairment, bowel and urogenital 
malformation, and craniofacial development and dysmorphogenesis, particularly in regards to the 
development of both endochondral and intramembranous bone (Casey and Leveno 2006; 
Hershman 2009). These issues of human skeletal growth have long been an interest of human 
biologists and clinicians, and forays in to the field from anthropologists are increasingly more 
common. Biological anthropology provides a unique lens with which to review existing and new 
data regarding developmental skeletal biology, providing much needed population and cultural 
perspectives regarding human growth anomalies. Much of the existing research delves in to the 
role of genetic and physiological influences on developmental anomalies; contributing maternal 
factors are often overlooked in clinical and academic scholarship, especially in regards to the role 
of maternal endocrine factors during embryological and early human growth and development. In 
particular, the role of maternal thyroid levels and their influence on growth and development has 
yet to be linked from clinical settings and animal models to the anthropological literature.  
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1.1 RESEARCH RATIONALE 
This dissertation aims to understand the role of aberrant maternal thyroid levels in offspring 
craniofacial development. By focusing on the mandible, a region that develops and grows largely 
in response to extrinsic factors such as cranial base growth and occlusal properties, this research 
will aid in understanding the role of maternal environment on the craniofacial growth and 
development of offspring. Characterizing the role of maternal thyroid on offspring mandibular 
shape has far-reaching implications for anthropology, clinical medicine, and corrective and 
aesthetic practitioners. This dissertation fills a substantial gap in research regarding the role of 
maternal environment on craniofacial growth and development.  
1.2 LITERATURE REVIEW 
1.2.1 Normal Bone Growth 
The musculoskeletal system originates early in embryonic development as the mesoderm 
gives rise to two rows, called the paraxial mesoderm, on either side of the neural tube, which then 
give rise to segmented blocks called somites (Moore, Persaud, and Torchia 2013). Bones in 
different parts of the body form from different regions. Many of the craniofacial bones form from 
the mesenchymal cells of neural crest origins: the other bones in the body arise from mesenchyme 
of somite origin or mesenchyme in the head mesoderm or lateral plate mesoderm during the third 
through fifth weeks of embryonic development (Resnick et al. 2002; Moore, Persaud, and Torchia 
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2013). The majority of the musculoskeletal system is formed by week seven in utero, though the 
biomechanical and habitual forces exerted on the individual play a large role in the further 
development of the skeleton (Carter, van der Meulen, and Beaupré 1996). At the cellular level, 
osteoblasts arise from pluripotent mesenchymal cells, whereas osteoclasts are derived from 
hematopoietic cells; the interaction between such cells and the other organic and inorganic aspects 
of bone result in overall skeletal growth seen at a macroscopic level (Donahue, Siedlecki, and 
Vogler 2005).  
An understanding of bone embryogenesis is essential to the study of bone development, as 
the process of embryogenesis is very similar to the processes of bone remodeling and bone repair 
(Bruder, Fink, and Caplan 1994; Gerstenfeld et al. 2003). This is not to say that the process is 
simple or well studied. The process of bone embryogenesis illustrates that the role of mesenchymal 
cells is remarkably similar between these apparently disparate processes. Mesenchymal cells give 
rise to new bone during development, but also to osteogenic cells present during bone remodeling 
and repair after trauma and during illness affecting the bone (Bruder, Fink, and Caplan 1994). 
These mesenchymal cells can proliferate and differentiate in to various tissues, including 
osteoblasts, chondrocytes, myoblasts, stromal cells, fibroblasts, and various other cells responsible 
for the growth and development of connective tissues (Bruder, Fink, and Caplan 1994; Moore, 
Persaud, and Torchia 2013; Adler 2000). This proliferation results in the cartilaginous precursors 
of long bones that provide the models for the future ossification of long bones and the membranous 
boundaries found in intramembranous ossification (described below). 
The transition of these mesenchymal cells into osteoprogenitor cells (sometimes called pre-
osteoblasts), then in to osteoblasts, and finally in some cases in to osteocytes, is a complex process 
involving multiple cytokines and growth factors. This transition also differs slightly depending on 
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both the method of ossification and local epigenetic influences (Caplan and Boyan 1994; Ballock 
and O’Keefe 2003). In fact, this sequence is almost the same seen in fracture repair. The initial 
phase, be it embryological or the inflammatory period directly after a fracture, begins with the 
accumulation of mesenchymal stem cells; these cells then differentiate in to cartilage and/or bone 
cells that begin forming stabilizing structure around the fracture, or a growth collar in the case of 
embryological growth (Linkhart, Mohan, and Baylink 1996). The cartilage begins to atrophy as 
the bone cells begin more extensive osteogenesis, and the now woven bone undergoes remodeling 
and further ossification until healthy bone is achieved (Bruder, Fink, and Caplan 1994; Caplan and 
Boyan 1994; White, Black, and Folkens 2012). Both chemical signaling and biomechanical 
influences affect the processes of bone growth and remodeling, and these influences can be seen 
in a review of the two forms of bone formation. 
Growth factors play key roles in the development of both endochondral and 
intramembranous bones, namely insulin-like growth factors, transforming growth factors, and 
fibroblast growth factors, but biomechanical stressors and forces also play a crucial role (Croucher 
and Russel 1999; Doll 2005). For example, the growth of the fetal brain dictates much of the 
growth patterns of the cranial intramembranous bones, but Fgf and Twist receptors play an 
important role in the development of the flat bones of the skull, specifically in the sutural regions 
of the parietal and frontal bones (Doll 2005). Bone morphogenic proteins (BMP’s) and fibroblastic 
growth factors (FGF’s) also play a key role in the development of the bones of the midface and 
cranial vault as they help regulate tissue induction and the proliferation of osteogenic cells (Sperber 
2002; Leboy 2006). The bones of the cranial vault are not uniform in their origins, or in the timing 
of their development, suggesting multiple genetic pathways are responsible for their development. 
Bone growth in the cranial vault, midface, and mandible is of primary interest to craniofacial 
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researchers, and the complex growth process has been debated for well over 40 years (see Enlow 
1982; Moss and Salentijn 1969a; Latham 1970; Siegel et al. 1990). The timing and completion of 
osteogenesis of intramembranous bone is of utmost importance to clinicians, specifically those 
manipulating the growth and development of the face for medical or aesthetic purposes. Once the 
bones have fused and completed their growth, they are no longer as pliable as developing bones 
and must be altered surgically.  
The various genes coding for proteins during the normal development of bone result in a 
complex interaction of cell differentiation and migration. While certain genes affect the 
differentiation of bone cells in localized areas, other genes are responsible for the regulation of the 
positional orientation of the embryo in all vertebrates (Argiropoulos and Humphries 2007). These 
genes, called Hox genes, are an (estimated) 39 genes located on various chromosomes in humans 
that regulate the segmental differentiation and growth of the embryo (Krumlauf 1994). Simply put, 
Hox genes organize the developing body of all vertebrates along the axis, conferring the axial 
identity of the body from head to tail without actually forming the limbs themselves (McGinnis 
and Krumlauf 1992). Hox genes alone do not affect the formation of bone tissue; rather they affect 
body plan and organization, thereby affecting the pattern of body and limb development (Sperber 
2002). Just as mutations in various genes responsible for the normal growth of bone can cause 
abnormalities (FGFR-3 mutations and achondroplasia and endochondral dysplasia, for example), 
mutations in Hox genes can result in changes ranging  from relatively minor abnormalities (e.g., 
polydactyly, synpolydactly) to much more serious developmental abnormalities (e.g., dysgenesis 
disorders), cancers, and intrauterine death (Goodman and Scrambler 2001; Quinonez and Innis 
2014; Horton, Hall, and Hecht 2007; Deng et al. 1996). Furthermore, investigations in to the role 
of Hox genes in the regulation of hematopoietic stem cell, and possibly even leukemogenic stem 
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cell production suggests that the pathways involved with Hox genes play a significant role in bone 
osteogenesis and development (see Argiropoulos and Humphries 2007).  
The complex interaction between patterning Hox genes and the aforementioned regulatory 
genes result in the development of human bone, and are thus key to the understanding of normal 
skeletal growth (Argiropoulos and Humphries 2007). However, bone is not a static tissue once it 
has completed development, as it changes throughout an individual’s life. Once bone has attained 
adult size and orientation, it still undergoes the complex process of bone remodeling. Broadly 
defined, remodeling refers to the alteration of existing bone. This process occurs throughout an 
individual’s life, and is integral in an organism’s ability to adapt to mechanical and environmental 
stresses exhibited on the body (Boskey 1999). The process of bone remodeling was poorly 
understood until the late 19th century, when researchers sought to better understand the process of 
mechanical loading on the skeleton and the body’s subsequent response (Aldersey-Williams 2013; 
Grob 2014). Bone remodeling involves the same basic histological structures as growth and 
development, though it is regulated by different factors and results in a myriad of outcomes.  
The remodeling process relies heavily on the interaction of osteoblasts and osteoclasts. As 
mentioned above, osteoclasts continually resorb longitudinal cavities in cortical bone that will 
become osteons, the basic unit of healthy bone facilitating communication and repair between 
disparate areas of the bone. As osteoblasts migrate to the area and deposit osteoid that will later 
become ossified. As the osteoid is deposited in the developing osteon, it becomes calcified and the 
osteon becomes progressively narrower (White, Black, and Folkens 2012). The central canal 
remains open, and a series of enlargements by osteoclasts followed by deposition of new osteoid 
by osteoblasts follows, leaving telltale markers (reversal lines) between the new osseous material 
and the material deposited earlier in the process (Doll and Koch 2005). Osteoblasts may also 
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deposit osteoid in trabecular bone, and the deposited fibular matrix is structurally similar despite 
not being laid down in the same layered manner as in lamellar bone (Marotti 1990). This ever-
present process of new osteon formation is vital for the healthy turnover of bone and the tissue’s 
ability to respond to biomechanical stress, the environment, and the metabolic demands of the 
body. As the primary store of the body’s calcium, necessary for normal cell function, muscle 
contraction, and healthy nerve function, the mammalian skeleton provides a reservoir of calcium 
essential to the organism’s survival (Costanzo 2014). The main hormone responsible for the 
resorption of bone, which initiates a release of free calcium ions in to the body, is parathyroid 
hormone (Vogl et al. 1993). The release of parathyroid hormone initiates formation of 
hematopoietic stem cells that differentiate in to osteoclasts, which in turn resorb bone; this process 
is typically followed by osteoblastic activity at the site, which deposits new bone at the areas of 
resorption (Doll and Koch 2005). In times of metabolic stress, however, this balance may not be 
maintained and can result in an imbalance of osteoblastic and osteoclastic activity and an overall 
deformation of bone (Ooi and Fraser 1997; Resnick et al. 2002; Roberts et al. 2006).  
Osteoblastic activity in healthy individuals is regulated by the hormone calcitonin, released 
by the thyroid, during times of calcium excess in the body (Murphy and Williams 2004). As 
stressed above, the balance between osteoblasts and osteoclasts is integral in the healthy 
maintenance of the human skeleton, and numerous diseases can cause issues with the chemical 
signaling of either type of bone cell (Cole and Cohen 1990; Resnick et al. 2002). These cellular 
imbalances can cause overactivity of the osteoclasts, such as Paget’s disease of bone, which in turn 
causes the body to signal for the production of osteoblasts. This imbalance causes a rapid increase 
of poorly formed bone as the osteoblasts and osteoclasts both increase in activity (Delmas and 
Meunier 1997). While Paget’s disease of bone is a relative rare disease linked to a genetic mutation 
8 
 
in SQSTM1, a gene involved in the binding of ubiquitin, it demonstrates the body’s attempts to 
continually balance the activity of bone cells (Ooi and Fraser 1997; Ortner 2003). There are 
numerous diseases that affect the activity of these bone cells, any of which can lead to a cascade 
of cellular activity that leads to a cellular imbalance and ultimately affects the skeletal system. 
Other pathogenic processes can affect the substances necessary for the production and 
maintenance of bone, such as calcium (e.g., osteoporosis), vitamin C (e.g., scurvy), vitamin D 
(e.g., rickets), or numerous less common diseases affecting problems with collagen production, 
such as osteopetrosis, osteogenesis imperfecta (Ortner 2003; Grob 2014). The recognition of the 
balance between the deposition and resorption of bone is essential in an understanding of how 
bone responds to biomechanical stress and environment. The exact stimulus initiating bone 
resorption is not fully understood, though it is likely a combination of paracrine factors of 
osteocytes, piezoelectric response, and mechanical stimuli (Murphy and Williams 2004).  
Bone response to biomechanical loads and stress was poorly understood well in to the 19th 
century. A comprehensive explanation for the role of biomechanical loads on bone was finally 
postulated in 1892 by Julius Wolff (Wolff 1892; Murray 1936). Now called Wolff’s Law, Wolff’s 
hypothesis was indispensable in the overall understanding of how bones gain and maintain their 
shape as a result of biomechanical stress. Multiple translations of Wolff’s original manuscript 
exist, but the core argument of his argument is: 
“Every change in the form and function of bone or of their function alone is followed 
by certain definite changes in their internal architecture and equally definite 
secondary alteration in their external conformation, in accordance with 
mathematical laws.” (Ethier and Simmons 2007: 11) 
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Simply put, Wolff’s law states that biomechanical forces exerted on bone, such as habitual 
movement through locomotion, can change that bone’s shape. Wolff’s law was the first definitive 
argument that external forces can alter and affect bone, but does not provide evidence as to how 
these changes may occur (Frost 1990). Wolff’s original proposition that bone remodels 
interstitially by deposition bone between existing layers was novel in its time, opposing existing 
viewpoints that bone only remodeled by resorbing old bone and depositing new bone in its place 
(Prendergast and Huiskes 1995). Wolff correctly hypothesized that bone responded to some sort 
of external signal, be it chemical or electrical, and responded to these stimuli by depositing or 
resorbing bone until the stress was reduced and the signaling ceased. It has since been shown that 
stress response in bone is largely due to the activity of osteocytes and their associated lacunae and 
trabeculae (Frost 1994). Building upon the principles of Wolff’s work, more recent studies have 
shown that it is indeed stress that plays the integral role in the shaping of bones, and that human 
bones can almost be described as self-designing structures (Carter, van der Meulen, and Beaupré 
1996). As stress is applied or removed to bone, biochemical responses within the structure respond 
to the stimuli, either depositing new bone or resorbing existing bone to adapt to the external 
environment (Figure 6; Frost 1994). The relatively recent development of human genome mapping 
and better methods for identifying the nuanced roles of the endocrine system have furthered the 
understanding of Wolff’s Law in recent years, and allowed researchers to apply these concepts 
beyond cortical bone to trabecular bone and other regions of the body, such as the mandible 
(Roberts et al. 2006a; Roberts et al. 2006b). 
 Trabecular bone still remodels at similar rates as cortical bone, though the basic 
multicellular unit (BMU) of the remodeling system involves surface resorptive cavities and 
subsequent bone deposition rather than the cutting methods with subsequent lamellae observed in 
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cortical bone (Roberts et al. 2006). The pioneers in this development utilized bone research at the 
molecular level, a realm that was not well understood by early researchers. Recent histological 
research has shown that this remodeling process takes similar amounts of time for both cortical 
and trabecular bone. In humans, it takes roughly one month to create a resorptive cavity one quarter 
of a millimeter in diameter, and nearly four times as long to fill the cavity (Vanderoost and van 
Lenthe 2014; Roberts, Epker, et al. 2006). Using this model, microdamage as a result of stress is 
the driving factor behind bone remodeling. Microdamage causes the release of inflammatory 
cytokines, which causes T cells to migrate to the area and release RANK ligand (RANKL), 
inducing osteoclast production (Boyle, Simonet, and Lacey 2003). As bone is resorbed, growth 
factors are released that deactivate the osteoclasts and new osteogenic cells move in to the 
resorption cavity is eventually filled with new bone (Boyle, Simonet, and Lacey 2003; Roberts, 
Epker, et al. 2006). Biomechanical stress is not the only factor regulating bone resorption, 
however, as the endocrine system regulates the body’s calcium levels primarily through the 
resorption of trabecular bone (Roberts, Epker, et al. 2006). It is through this complex interaction 
that bone is not only remodeled, but calcium levels remain in homeostasis.  
The overarching process of bone remodeling can best be envisioned using a model, first 
proposed in the 1980’s by Harold M. Frost (Stout and Crowder 2012; Frost 1983). Called the 
‘mechanostat’, this system takes in to account longitudinal bone growth, microstructural bone 
remodeling, and biomechanical stress to predict BMU remodeling in human bone (Figure 1). Using 
a household thermostat as a model, the mechanostat model argues that bone that is strained at a 
level below the minimum effective strain level is kept in a sort of ‘conservative’ mode, much like 
a furnace that only turns on once a minimum temperature is met; if this threshold is not met, 
however, bone will not remodel and will instead go in to a ‘disuse’ mode (resulting in osteopenia 
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and/or osteoporosis; Frost 1983; Stout and Crowder 2012; Webster 2005). Loading during the 
conserve mode leads to overall bone remodeling. Conversely, overloading the bone during the 
conserve mode, or that above the minimum level of effective strain, can lead to microfractures; if 
these levels of strain continue and the bone cannot remodel at a sufficient rate to repair the 
microfractures, the bone will fail (Stout and Crowder 2012; Frost 1983). Simply put, the 
mechanostat model argues that levels of strain necessary for stress are lower than those for 
remodeling, which are in turn lower than those for pathology, which are in turn lower than those 
leading to fracture (Figure 1; Frost 1983; Webster 2005). The mechanostat model does a fine job 
of evaluating bone remodeling, though it does little to effectively describe the process of bone 
remodeling from a cellular level.  
 
Figure 1. Frost's 'mechanostat' feedback loop explaining BMU remodeling of human bone. Modified 
from Webster (2005): 7. 
 
A new paradigm, stemming from multiple theorists and workshops seeking to integrate 
various fields of skeletal research, arose in the 1990’s in an attempt to incorporate Frost’s model 
and that of other fields (Stout and Crowder 2012; Webster 2005). This new model, dubbed the 
‘Utah Paradigm’, is an extensive feedback loop that builds upon the mechanostat model (Figure 2; 
Webster 2005). Incorporating the fact that continual strain from natural biomechanical loading 
leads to microfractures in bone, which leads to bone repair under pathological and non-fracturing 
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levels of strain, the Utah paradigm is being continually modified to incorporate contemporary 
studies in the molecular and genetic factors of bone remodeling (osteocyte apoptosis and 
subsequent osteoblastic activity). In this updated model, biomechanical forces and strain are still 
the main cause of skeletal remodeling, though hormones, diet, sexual dimorphism, and other 
nonmechanical factors play an important role in the process (Figure 2; Stout and Crowder 2012; 
Webster 2005). As described above, it should be readily apparent that hormones, especially growth 
factors, play an important role in both growth and development (Table 1). Key among these 
hormones are calcitonin and parathyroid hormone, which regulate osteoblasts and osteoclasts, but 
there are numerous other hormones that affect the growth and development of bone; estrogen and 
testosterone play crucial roles in osteogenic and chondrogenic processes, especially later in life, 
while vitamin D and even insulin (both produced by the body in conjunction with dietary intake) 
play a role in bone remodeling (Lieberman 2011; Moore, Persaud, and Torchia 2013). It then 
stands to reason that hormones and other factors gained from diet (minerals, vitamins, dietary 
hormones) affect other aspects of the body that are also regulated by the same inputs, and that 
skeletal physiology and biology will be altered disparately depending on environmental factors. 
This loop is not a replacement of Frost’s mechanostat model, though it has shaped Frost’s approach 
to the factors affecting bone growth (Roberts et al. 2006; Frost 1998; Frost 2000).This feedback 
model allows for all perceivable contributing factors to bone remodeling, and provides the 
foundation for most contemporary theories regarding bone remodeling and biomechanical loading 
of bone (Stout and Crowder 2012; Webster 2005).  
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Table 1. Major hormones/growth factors affecting skeletal growth throughout life 
(from Lieberman 2011). 
Hormone Major Effects on Skeletal Growth 
Estrogen 
Up-regulates osteoblasts 
Up-regulates chondrocytes at moderate levels 
Down-regulates chondrocytes at high levels 
Down-regulates osteoclasts 
Testosterone Up-regulates chondrocytes and osteoblasts at moderate levels 
Vitamin D Up-regulates osteoblast and chondrocytes  
Thyroid Hormone 
Up-regulates osteoblasts and chondrocytes at normal levels 
Up-regulates osteoclasts at high levels 
Parathyroid Hormone Up-regulates osteoclasts 
Growth Hormone Up-regulates osteoblast, chondrocyte, and osteoclast activity 
IGF-I Up-regulates osteoblasts and chondrocytes 
Calcitonin 
Down-regulates osteoclasts 
Up-regulates osteoblasts 
Cortisol 
Down-regulates osteoblasts and chondrocytes 
Up-regulates osteoclasts 
Insulin Up-regulates osteoblasts and chondrocytes 
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Figure 2. The ‘Utah paradigm’, which incorporates input from environmental (e.g., 
diet, minerals), biomechanical, and local epigenetic factors in to Frost’s mechanostat 
model. Modified from Webster (2005): 8. 
 
1.2.2 Role of the Thyroid 
The thyroid plays a substantial role in human growth, from embryological development 
through senescence. In particular, thyroid hormone, growth hormone, insulin-like growth factors, 
and glucocorticoids play an important part in linear development during childhood (Figure 3). 
Thyroid hormone deficiencies in childhood can lead to shortened bones due to osteoblast and 
osteoclast imbalance, as well as inhibited chondrocyte activity in growth plates and premature 
suture closure in the skull (Harvey et al. 2002; Hershman 2009; Singer 2009; Browne et al. 2009; 
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Cray et al. 2013). Skeletal changes seen in the craniofacial complex make it an ideal anatomical 
region to study the effects of maternal thyroid levels on skeletal growth and development, as both 
endochondral and intramembranous ossification are involved during growth and development in 
the region.  
 
 
The thyroid is responsible for the secretion of hormones that act on almost every major 
system in the human body (Costanzo 2014). The active hormones produced by the thyroid are 
triiodothyronine (T3) and thyroxine (T4, also called I-thyroxine). The release of these hormones is 
stimulated by the release of thyroid-stimulating hormone (TSH) from the anterior pituitary gland, 
which is itself signaled by the release of thyrotropin-releasing hormone (TRH) from the 
hypothalamus (Singer 2009; Costanzo 2014). Once secreted, both T3 and T4 circulate via the 
 
Figure 3. Location and blood supply of the human 
thyroid hormone. From Gray’s Anatomy, Plate 1174 
(1918). 
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bloodstream, where they inhibit thyroid-releasing hormones in healthy individuals; this acts as a 
feedback loop to maintain normal levels of thyroid hormones in the body (Figure 4). While T3 is 
the more active of the two hormones, the epithelial cells of the thyroid produce substantially more 
T4, which is then converted to the more active T3 form by target tissues. Due to naturally increased 
levels of T3 and T4 during normal pregnancy, the role of maternal thyroid levels is difficult to 
study. The increased secretion of thyroid hormones by the mother arises due to increased secretion 
of human chorionic gonadotropin hormone (hCG) during pregnancy (Mestman 2009; Drake, Vogl, 
and Mitchell 2010). Since T3 and T4 significantly affect growth and development, the central 
nervous system, basal metabolic rate, overall metabolism, as well as the cardiovascular and 
respiratory systems (see Figure 4), any alterations, excesses, deficiencies, or abnormalities can 
have substantial effects on the human body (Singer 2009; Hershman 2009; Mestman 2009).  
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Figure 4. The role of thyroid hormones in the 
human body. 
 
The first scientific review of the relationship of the thyroid and the skeleton dates to the 
late 19th century, and focused on increased fracture rates in a patient with excess thyroid 
production, or hyperthyroidism (Von Recklinghausen 1891). This case study involving a young 
woman with thyrotoxicosis relied more on gross clinical observations than microbiological 
analyses of thyroid dysfunction, yet it represents the first serious foray in to the impact of the 
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thyroid on the skeleton. Von Recklinghausen’s notion of thyroid dysfunction causing bone 
demineralization would remain the dominant paradigm for decades to come. The concept of 
endogenous thyrotoxicosis causing bone loss, especially in old age, remains today in both clinical 
and research data (Cooper 1988; Grob 2014). Key research in the United States focused on the role 
of the thyroid dysfunction and overall metabolism, with side forays in to questions regarding diet 
(primarily iodine; Grob 2014). By the 1920’s, clinicians began to notice skeletal changes in 
hyperthyroidism patients, namely in the hips and the skull.  
This change towards studies of hormone levels in senescence, namely the higher 
prevalence rate of fractures and overall bone thinning and demineralization, was noted in multiple 
cases and linked to thyroid dysfunction (Judd 1920). With the advent of antithyroid hormone 
therapy treatment in the 1940’s, it appeared that thyroid-related mineral loss in bone was on the 
decline (Dhanwal 2011; Grob 2014). Again, research was concerned primarily with adult patients 
suffering from thyroid dysfunction, through research continued on the impact of exogenous thyroid 
hormone function. Most research was focused on parathyroid disorders due to their link with 
osteoclastic disruption, though continued research on the thyroid was essential due to its roll in 
overall metabolism and the prevalence of hormone treatments (Seeman et al. 1982; Hershman 
2009; Grob 2014). Levothyroxine (L-thyroxine), a commonly-prescribed synthetic mimic of 
thyroxine, has been shown to cause bone mineral loss in post-menopausal women (Paul et al. 
1988). Other studies show that thyrotoxicosis leads to increased osteoclastic activity in the adult 
skeleton, leading to increased mineral resorption of bone, and eventually a negative calcium 
balance (Cooper 1988). The advent of histomorphometric studies allows further researcher of bone 
mineral loss at the molecular level, demonstrating that excess thyroid leads to increases of bone 
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remodeling through interaction with both bone deposition and resorption (Murphy and Williams 
2004; Dhanwal 2011).  
Studies of this sort of hormonal imbalance are common in geriatric medicine, as the 
hormone imbalance largely affects elderly individuals, especially post-menopausal women (Grob 
2014). The role of thyroid dysfunction on young children accelerates growth and bone maturation, 
leading to premature bone fusion and shortened stature (Wojcicka, Bassett, and Williams 2013). 
However, studies of maternal thyroid levels on the skeleton of offspring are comparatively rare. 
The majority of studies concerning maternal thyroid levels focus primarily on the role of the 
disorder on the mother, citing the developing fetus only as a target of healthy birth (Talbert et al. 
1970). Even contemporary literature on the topic focuses more on diagnosis, management, and 
treatment of the mother and subsequent testing of the neonate. 
1.2.3 Thyroid and Craniofacial Studies 
Despite our contemporary understanding of maternal hyperthyroidism and its effects on 
offspring, little research is directed on its role in the long-term development of the offspring 
(Hershman 2009; Mestman 2009; Negro and Mestman 2011). Fetal thyroid hormone is active by 
ten weeks post-conception, so studies of the role of thyroid hormones, be they maternal or of the 
embryo, necessitate further evaluation (Burrow, Fisher, and Larsen 1994). The few in vivo studies 
of thyroid levels on bones conducted in animal models show that thyroid dysfunction leads to 
offspring cranial malformation, low birth weight, and mental deficiencies, though these changes 
have not been precisely quantified (Khoury, Becerra, and D’Almada 1989; Haddow et al. 1999). 
Maternal hyperthyroidism and the resulting thyrotoxicosis have also been linked to 
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craniosynostosis and cerebral developmental impairment in human populations (Daneman and 
Howard 1980; Rasmussen et al. 2007; Browne et al. 2009), as well as fetal hypertension and fetal 
growth restriction (Luewan, Chakkabut, and Tongsong 2011). The above studies demonstrate a 
marked moved towards maternal studies of thyroid levels on offspring growth and development, 
but do not specifically address the issues.  
In light of the lack of human studies, animal models are the obvious choice for research 
regarding the role of maternal thyroid levels on offspring growth and development. The earliest of 
these studies suggests that increased thyroxine exposure in rat fetuses may delay the appearance 
of ossification centers, though the actual timing of the delay has not been quantified (Weiss and 
Noback 1949). Embryonic chick long bone cultures exposed to excess thyroxine showed increased 
maturation rate of cartilage, with overall growth retardation at higher levels of thyroxine exposure, 
especially during later stages of bone development (Fell and Mellanby 1955). Further studies along 
this line show that this growth retardation in culture-grown long bones was a result of cartilage 
cell hypertrophy leading to premature growth cessation (Fell and Mellanby 1956). Exogenous 
exposure to thyroxine in developing chicks embryos showed similar results; embryos exposed to 
the hormone for eight days of incubation had shorter and lighter tibia than those of control groups, 
with specific deficiencies in the articular cartilage (Hall 1973). Mice have even been bred 
completely devoid of thyroid function (via lack of thyroid receptors) and are still viable, though 
they exhibit numerous deficiencies in bone histogenesis (Göthe et al. 1999; Harvey et al. 2002).  
Studies of the role of thyroxine in amphibians are prevalent, as the hormone is essential in 
determining whether long bones ossify before or after tadpole metamorphosis in amphibian taxa 
(Kemp and Hoyt 1969a; Kemp and Hoyt 1969b). Further studies in amphibians also demonstrate 
that exogenous thyroxine can affect the bone growth of the cranial vault by stimulating 
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chondrogenesis, though it has no effect on the onset of osteogenesis (Hall 2015). The broad 
applicability of these studies to mammal models, and eventually humans, are somewhat limited, 
through the tissue- and molecular-level implications provide promising avenues for future 
research. 
At the molecular level, the role of maternal thyroxine on the developing fetus itself is also 
poorly understood, though recent studies show that maternal thyroid hormones do in fact act on 
offspring thyroid receptors (Nucera et al. 2010). The role of in vivo thyroxine on osteogenesis has 
seen recent research demonstrating that excess thyroid hormone exposure results in increased gene 
product markers for osteogenesis (Cray et al. 2013). Further studies have also shown that, in mouse 
models, excess maternal thyroxine significantly alters offspring cranial base dimensions and shape 
(Cray, unpublished). Yet again, the existing studies regarding the role on maternal thyroxine levels 
on offspring development focus more on anomalies and birth defects rather than its role in normal 
variation. The cranium and especially the mandible, due to its complex growth process, represent 
a promising avenue of research regarding the role of maternal environment on offspring ontogeny. 
1.2.4 History of Mandibular Research 
1.2.3.1 History of Embryonic Mandibular Development 
The development of the craniofacial complex, and the mandible in particular, has a long 
and storied history spread across multiple fields, beginning with late-18th and early-19th century 
work in the budding field of embryological development. Formulated independently by Goethe 
and Oken and known at the time as the “vertebral theory of the skull”, the first dominant paradigm 
of embryological craniofacial development posited that the skull essentially developed as a set of 
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vertebrae and differentiated in segments similar to the rest of the trunk, and that all craniofacial 
cells arose exclusively from the mesoderm (Kingsbury 1926; Depew, Tucker, and Sharpe 2002). 
This theory dominated the study of craniofacial development in the 19th century, dictating the head 
be studied in the same manner as the segmentation of the trunk: 
“The upper arch is formed by the walls of the cavity containing the brain, 
and stands in the same relation to it, as does the neural arch of a vertebra to the 
spinal cord, with which that brain is continuous. The lower arch encloses the other 
viscera of the head, in the same way the ribs embrace those of the thorax” (Huxley 
1859: 382).  
 
In viewing the skull as such, adult crania were compared and discussions of dissimilarity 
formed the basis of scientific endeavor, omitting the review of embryological origins of the skull 
(Huxley 1859). In his eloquent dismantling of the vertebral theory, Huxley again and again stressed 
the importance of embryological study of craniofacial development, frowning upon the gradation 
approach of classification:  
“…the study of the mode in which skulls of vertebrate animals are 
developed, demonstrates the great truth which is foreshadowed by a careful and 
comprehensive examination of the gradations of form which they present in their 
adult state; namely, that they are all constructed upon one plan; that they differ, 
indeed, in the extent to which this plan is modified, but that all these modifications 
are foreshadowed in the series of conditions through which the skull of any one 
higher Vertebrata passes” (Huxley 1859: 424). 
 
The earliest of these embryological studies focused primarily on the differentiation of the 
various craniofacial structures from other body tissues. In particular, zoologist William King 
Gregory focused his research on the origins of craniofacial structures in both sea and land 
vertebrates.  
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Gregory’s work synthesized the previous insights of Huxley, Wiedersheim, Smith 
Woodward, and other prominent zoologists on the evolutionary relationship between autostylic 
(jaws directly attached to the cranium, as seen in tetrapods), hyostylic (jaws not attached directly 
the cranium, as seen in most fish), and amphystylic (upper jaw braced against the cranium, as seen 
in sharks), arguing that we must study the embryology differentiation of the first two branchial 
arches to adequately describe mandibular development (Gregory 1904). Though incorrect in his 
theoretical assumptions that all aspects of the craniofacial complex originated solely from 
mesodermal derivatives (Depew, Tucker, and Sharpe 2002), Gregory was pivotal in developing a 
better understanding of branchial arch differentiation, the role of evolutionary principles on this 
process, and the treatment of the mandible as an independent craniofacial region. In line with 
Gregory’s work is that of B.F. Kingsbury, a prominent zoologist and pioneer of histology at 
Cornell, who argued that the differentiation of the head did not follow segmentation similar to the 
rest of the body. Kingsbury used histological evidence to show the cephalocaudal progression of 
branchial arches, which remains the dominant paradigm of branchial arch development to this day 
(Kingsbury 1926). Of particular interest is Kingsbury’s argument that all aspects of the branchial 
arches are not, in fact, formed solely from the dorsal somites; after a lengthy comparison between 
the branchial arches in various other vertebrates, he proceeded to number the branchial arches 
cephalocaudally, and concluded calling on further study of the complex differentiation of 
craniofacial tissues (Kingsbury 1926). 
The swing from vertebral theory to that of Kingsbury marked a pivotal shift in the study of 
craniofacial development. Research now focused on more nuanced developmental models that 
more precisely described the complex transformation present in embryological development of the 
skull and mandible. Later studies would follow in Kingsbury’s footsteps to develop the 
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contemporary understanding of craniofacial growth and development, specifically the integration 
of the growth of the mandible, palate, and maxilla (Björk 1951; Moss and Young 1960; Frost 1964; 
Enlow 1968).  
 
1.2.3.1 History of Postnatal Mandibular Development 
Research on the postnatal growth of the mandible in anthropology is particularly 
interesting, as the skeletal element preserves well in the archaeological record and represents some 
of the first paleoanthropological finds in the 18th and 19th centuries. These early studies began to 
understand that the mandible and maxilla were jointly formed as a result of the interaction between 
mastication and other biomechanical needs upon the facial region. The earliest studies showed that 
occlusion and the biomechanical forces involved therein were key contributors to overall 
craniofacial and mandibular shape. These studies, largely carried out by removing muscles of 
mastication (Walkhoff 1902) or removal of teeth (Baker 1922) in animal models, demonstrated 
that teeth and occlusion affected mandibular growth. However, it could not be determined if these 
changes were a result of occlusion itself or the development and eruption of the teeth (Thoma 
1938). Key to the resolution of this debate was the concept that the mandible and maxilla are 
solitary objects, instead consisting of multiple regions under competing biomechanical and 
functional purposes (Scott 1938; Thoma 1938). This led researchers to recognize that the mandible 
has some basic genetic predetermination, though its growth and development are largely 
determined by environmental and functional demands on various regions of the skeletal anatomy 
(Lifshitz 1976). By using this model of mandibular development, further studies were conducted 
studying the role of alteration and/or removal of biomechanical loads on craniofacial shape in an 
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attempt to better understand the shape and function of the mandible in past hominin populations 
(Watt and Williams 1951; Lifshitz 1976). 
Orthodontic and dental literature regarding the growth and development of the mandible 
boomed in the late 1950’s and early 1960’s as researchers grasped the concept of varying inputs 
on different regions of the bone itself (Massler and Frankel 1951; Begg 1954; Ricketts 1960; 
Graber 1963). Researchers recognized that different areas of the skull can be considered ‘growth 
centers’, though the locations of these were hotly debated (Carlson 2005). The concept of genetic 
determinism crept in to craniofacial biology, arguing that growth was predetermined by an 
individual’s genetics (harkening back to racially-determined patterns of growth popular in the 
1800’s), and debate moved to where craniofacial growth was occurring. Some argued that it 
occurred at the sutures (creatively named the Sutural Theory), where skeletal growth occurred first 
as cartilaginous expansion at the sutures due to genetic signaling (Weinmann and Sicher 1947). 
Others argued that soft tissue drove the expansion of the face, such as the nasal septum “driving” 
the midface forward, and sutures simply “play catch up” to the main engine of facial growth (Nasal 
Septum Theory; Scott 1956). These theories of craniofacial growth would soon be dismantled and 
restructured by the work of multiple scientists proposing a more functional approach to the 
anatomy of the head and face (Carlson 2005). Key among these works are the concepts of and 
theories of three clinicians and scientists, all of whom built upon each others work to set the 
foundations for our current understanding of craniofacial growth and development.  
Some of the earliest work utilizing this more functional theory was that of Arne Björk, a 
Swedish dentist who looked at human subjects using longitudinal studies and radiographic 
techniques. Björk’s early work demonstrated an understanding of the dynamic process of 
mandibular development, primarily in regards to orthodontic treatment (Björk 1951), with key 
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insights in to the contribution of overall body size in the in craniofacial growth (Björk 1953). 
However, Björk is best remembered for his pivotal longitudinal study of mandibular and maxillary 
growth in adolescents. Recognizing the need for a holistic picture of craniofacial development, 
Björk and colleagues hammered small metallic implants in to various regions of the mandible and 
maxilla of young Scandinavian children; these children were then subjected to numerous 
cephalometric x-rays to establish not only which regions were growing at which ages, but also the 
magnitude of these growth changes (Björk 1955; Björk 1963; Björk 1968). The longitudinal nature 
of these studies was unprecedented, and for both logistical and ethical reasons today, this research 
has not been matched. Overall, Björk and colleagues established that postnatal mandibular growth 
is a result of the posterior and superior growth of the ascending ramus, growth of the alveolus with 
subsequent drifting of the dental arcade, the relative lack of growth along the inferior border of the 
mandible, and the overall forward and downward position of the mandible in relation to the rest of 
the head due to growth in the cranial base (Björk 1968; Björk and Vibeke Skieller 1983). These 
studies did not identify the factors causing the differential growth of the various regions of the 
mandible, but did set the stage for our current understanding of how - and more importantly why 
- these changes happen.  
While Björk and colleagues made enormous strides in understanding changes in the size 
and shape of the human mandible from birth to adulthood, they never adequately described why 
these changes were taking place. The key researcher in this realm was Melvin Moss, an American 
dentist best known for his Functional Matrix Theory. The Functional Matrix Theory began in 1960, 
and states that the form of all cranial skeletal elements is a direct result of their function (Moss and 
Young 1960). As such, it is often easier to summarize Moss’ model by stating that the craniofacial 
skeleton does not grow, but rather is grown. This concept argues that cranial growth is a result of 
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not just genetic predisposition, but the sum of all internal and external factors acting on the cranium 
as a result of its function (Moss and Young 1960; Moss 1968; Moss and Rankow 1968). What 
would now likely be termed as ‘epigenetics’ was to Moss and his colleagues the sum total of all 
functions on the skull necessitated by the sum of its functions: house and protect the brain and 
other organs of the head, provide leverage for mastication and movement, and the incorporation 
of all other soft-tissues of the cranium (Moss and Salentijn 1969b; Moss and Salentijn 1969a). 
Moss divided the skull in to two functional areas: the ‘neural’ and the ‘facial’ components, and 
within each of these components were the total of all regions related to the organs, such as the 
brain, the eyes, the ears, and so on (Moss and Young 1960). These can be further divided in to 
their constituent skeletal units: macroskeletal units, such as the mandible or maxilla, and 
microskeletal units, such as the coronoid process or the chin. Finally, Moss identified either 
capsular matrices (eye, nasal, oral) or periosteal matrices (areas of active growth and 
transformation). Therefore, the overall growth of the larger macroskeletal units is dictated by the 
growth of the smaller microskeletal units such as processes and muscle attachments, which are in 
turn dictated by the type of matrix at the site (Moss and Young 1960; Moss 1968).  
Moss’ Functional Matrix Theory has held up remarkably well in the decades since its 
inception (Moss 1997a; Moss 1997b). The main debate against the theory revolves around the 
concept of open spaces within the face and how ‘nothing’, or the lack of soft tissue, can cause 
growth of the face. To compliment his Functional Matrix Theory, which relies on periosteal 
growth, Moss proposed a capsular matrix aspect to account for the growth of patent areas of the 
face, namely the vomernasal organ. In the absence of soft tissue and the corresponding functional 
matrices, Moss argued that patency of the airway and translational growth of other functional 
matrices resulted in the open aspect of humans’ nasal complex (Moss and Salentijn 1969b; Moss 
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and Salentijn 1969a). This concept, often termed “spaces grow faces”, stood in stark contrast to 
the Nasal Septum Theory and the Sutural Theory of craniofacial growth (Weinmann and Sicher 
1947; Scott 1956). These theories adequately explained the patency of the nasopharynx, either 
through growth at the sutures causing expansion of the open space, or by the growth of the 
cartilageof nasal septum, which has a growth vector; it would take some time before these two 
theories were entirely disproven (see Siegel et al. 1990), and Moss’ concept of the functional 
matrix and capsular matrix remain the dominant paradigm in craniofacial biology. 
This cascade of growth processes, the lynchpin of modern craniofacial growth theory, is 
easily demonstrated with the example of the eye. As the eyeball itself grows (in a capsular matrix), 
it exerts function demands on the surrounding bone of the eye orbit; these demands cause periosteal 
reaction in some regions of the orbit, resulting in bone deposition, and resorption in other regions. 
As a result, the eye grows larger, resulting in the growth of the eye orbit of the skull, which is 
constrained by the growth demands of the surrounding regions, namely the vomernasal complex 
below and the brain above and behind. The functional matrix here, the eyeball, dictates the skeletal 
growth in the region.  
This interaction between different functional needs in different regions, the functional 
matrices, results in the overall growth pattern of the human skull (Moss and Young 1960; Moss 
and Rankow 1968). The same principle can then be applied to any functional matrix of the skull, 
for example the masseter, which comprises one functional matrix associated with a single function: 
to elevate the mandible during mastication. This results in two skeletal aspects of the matrix 
(skeletal matrices), the angle of the mandible and the inferior aspect of the zygomatic arch, where 
the superior aspect of the masseter muscle attaches. As the masseter fulfills its function, 
contracting and thus elevating the mandible, it dictates that the zygomatic arch and the angle of 
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the mandible serve as attachments points for the biomechanical loading, and thus take the 
recognizable shape over the course of growth and development. In sum, the bones of the skull are 
grown as a result of the functional needs placed upon them, and do not grow by some 
predetermined design. 
The third key researcher in the area of postnatal growth and development is orthodontist 
Donald Enlow, who sought to better understand exactly how the adult midface and mandible come 
to its final shape from birth to adulthood. Building upon the work of Björk and Moss, as well as 
numerous studies in the 1960’s and 1970’s utilizing removal or paralysis of certain musculature 
of the face, Enlow geared his work primarily towards orthodontics students and practitioners. 
While he recognized the dearth of research regarding the intricacies of how the human mandible 
developed from birth to adult form from a clinical perspective, he applied his research towards a 
more theoretical understanding of craniofacial growth. Enlow also incorporated various advances 
in histology to look at specific regions of the mandible to establish exactly where bone deposition 
and resorption were occurring during the growth process. Key amongst these ideas are the concepts 
of remodeling, drift, and displacement. As the human craniofacial complex grows, primarily in an 
anterior and inferior direction in response to the growing brain, the face is displaced anterior and 
inferior in relation to the cranial base (Enlow 1968). The displacement of the mandible, therefore, 
occurs at the temporomandibular joint, while the mandible is simultaneously remodeling, with 
bone deposition occurring and the posterior and superior aspects of the ramus and bone resorption 
occurring on the anterior margin (Enlow 1982; Enlow 1990). Bone remodeling is also occurring 
at anterior and inferior margins of the endocranium and the posterior and superior margins of the 
vomernasal region, thus maintaining occlusion (Enlow 1982). Arguably the most influential aspect 
of Enlow’s work was the concept of the V-principle, wherein bone deposition occurs along the 
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inner side of a “V” shaped region (e.g., the hard palate) and resorption occurs on the outer side of 
the “V”; as a result, the region grows and expands at the same time (Figure 5; Enlow 1982; Enlow 
1990; Enlow and Hans 1996). Enlow’s work incorporates Moss’s Functional Matrix theory, 
namely the maxilla and mandible, to better understand the variations in occlusion seen by 
clinicians. The combination of the work of Björk, Moss, Enlow, and the research that they use to 
build their growth models led to our current understanding of facial growth (see section 1.2.5). 
 
 
Figure 5. Enlow’s “V” Principle. The earliest stage of 
development (A) grows through the “V” principle to the 
later stage (B) through deposition (+) and resorption (-). 
Adapted from Enlow 1982: 41.  
 
1.2.3.2 History of Anthropological Mandibular Research 
Björk, Enlow, and Moss certainly were not the only researchers concerned with the topic 
of mandibular growth and development. Whereas these scientists found a captive audience 
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primarily in dentistry and orthodontics, anthropologists were particularly interested in questions 
related to paleoanthropological specimens. Mandibles, such as the Mauer mandible of Germany 
and Peking Man of China, were common among paleoanthropological finds in Europe, Asia, and 
Africa during the 19th and 20th centuries. In fact, due to their high preservation rates, mandibles 
have always represented some of the most common finds of extinct hominin species (Smith and 
Ahern 2013). The evolutionary trajectory of the mandible has long been a focal point for 
paleoanthropological research, dating back to some of the earliest hominin discoveries (Huxley 
1859). Key amongst these more anthropologically leaning works are those of DuBrul and Sicher 
(1954), who sought to explain the overall function of the hominin mandible and chin as an adaptive 
feature. Their extensive survey of primate, fossil, and modern chin morphology remains a 
cornerstone in anthropological literature as an explanatory model for the chin (and lack thereof) in 
all primates except for modern humans, tracing our chins in part to the vertical nature to bipedality 
and the upright nature of human posture and compensatory changes as a result of the more vertical 
orientation of the human head (DuBrul and Sicher 1954). This anthropological fascination with 
the human chin is not new, and presence of the trait has been used since the beginning of the field 
to debate the inclusion of specimens from our taxa, leading Arthur Keith and others to use the 
mandible and chin as an exclusionary feature in human phylogenetic debates revolving around the 
Piltdown hoax in the early 20th century (Hrdlička and Pearson 1911; Robinson 1913; Keith 1916; 
Wallis 1917; Keith 1928). This “membership” within our species has not faded from contemporary 
debates, either, as the chin has played a role in debates regarding hominin speech, diet, and overall 
morphology and variation (Lieberman and Crelin 1971; Carlisle and Siegel 1974; Schwartz and 
Tattersall 2000; Antón 2002; Lieberman 2011; Pampush and Daegling 2016).  
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The staying power of the “chin debate” is largely due to the focus of many anthropologists 
on the uniqueness of the chin and its ability to predict “humanness”; in the lack of large samples 
of paleoanthropological material, the mandible often represents the best source of data for 
phylogenetic reconstructions (see Dobson and Trinkaus 2002; Kesterke and Ahern 2007; 
Lieberman 2011). The roles of the chin and the mandible itself have been evaluated using 
biomechanical and electromyographic data, which suggests that the primate mandible shape, 
specifically fusion of the mandibular symphysis, also develops in response to torsion caused by 
mastication (Hylander 1975; Hylander 1979). Evidence also suggests that the primate mandible 
developed in part to counteract shear caused in unilateral loading (Hylander 1984), and is  
allometrically scaled with body size and masticatory habits (Hylander 1985). The works of 
Hylander demonstrate the dominant assumption underlying the enigma of the human chin: 
biomechanical adaptation.  
The chin as an adaptation to loading has been supported by both microscopic and 
macroscopic studies, as well (Riesenfeld 1969; Daegling 2001; Dobson and Trinkaus 2002). The 
advent of geometric morphometrics allows more detailed modeling of load vectors in the human 
chin, further supporting the theory that the primate mandible and human chin have adapted to the 
nuanced loading resulting from unilateral mastication (Ichim, Swain, and Kieser 2006; Gröning, 
Fagan, and O’Higgins 2011; Gröning, Fagan, and O’Higgins 2012). This strong evidence for the 
chin as an adaptive feature has led many anthropologists to use it as a defining feature for the 
inclusion or exclusion in phylogenetic reconstructions based solely on mandibular form (Thayer 
and Dobson 2010; Garvin and Ruff 2012; Bejdová et al. 2013). The outcomes of these studies 
demonstrate the importance of a better understanding of mandibular growth and development in 
the study of anthropology and human evolution. 
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The review above brings about the contemporary understanding of mandibular 
development. Dysfunction and dysmorphology of the craniofacial complex is relatively common 
compared to other aspects of human anatomy, and are therefore beyond the scope of this 
dissertation. As such, this chapter focuses on the normal growth and development of the human 
mandible in an attempt to display the standard patterns of growth observed through centuries of 
research on the human mandible. 
1.2.5 Normal Prenatal Growth and Development of the Mandible 
Key to the study of mandibular development is an understanding of the first pharyngeal 
arch formation and its interaction with Meckel’s cartilage. Meckel’s cartilage has a long 
evolutionary history, being present in most vertebrates in some form or another (Hall 2015). In 
mammals, this tubular cartilaginous structure arises primarily from neural crest cells in the 
mandibular prominences and eventually ossifies to form the mandible, though it is not through 
traditional endochondral formation seen in other long bones. The role of Meckel’s cartilage in 
animal models has long been studied as a viable analog to human mandible growth and 
development (Bhaskar, Weinmann, and Schour 1952; Frommer and Margolies 1970). Correlating 
the fetal development of the mouse and human mandibles, particularly Meckel’s cartilage, was an 
integral aspect of developmental biology through the later part of the 20th century (Bhaskar, 
Weinmann, and Schour 1952; Frommer and Margolies 1970; Siegel and Mooney 1990), and the 
use of mouse models for the study of craniofacial ontogeny is now recognized as a valuable 
window in to growth and development (Miettinen et al. 1999; Hill, Reeves, and Richtsmeier 2007; 
Feng et al. 2009). Within these mouse models of growth and development, common correlations 
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between mouse developmental stages and human developmental stages have been established, 
called Carnegie Stages. For example, the first Carnegie Stage (C1) represents a fertilized oocyte 
shortly after conception, whereas Carnegie Stage 3 (C3) represents the formation of the blastocyst 
cavity. Due to the more rapid development of mice compared to humans, these stages occur on 
different temporal scales, but the Carnegie Stages between the two species are comparable (see 
Table 2). 
Normal mandibular development begins early after conception around the 4th week post-
conception. This period of embryological development is key to the normal form and function of 
the human craniofacial development, and corresponds to the 8th day of mouse craniofacial 
development (Table 2). Mouth development begins with the stomodaeum, a depression in the 
ectoderm surrounding the primordial face that will eventually form the oral cavity (Depew, Tucker, 
and Sharpe 2002). A period of cell rearrangement and death occurs in the region, eroding the 
barrier between the surface ectoderm and the endoderm of the foregut at 22 days (E9.5 in mice; 
Sperber 2002; Schoenwolf et al. 2009). The formation of the first pharyngeal arch is apparent by 
24 days post-conception (E10.0 in mice), shortly after the stomodaeum is established, and the rapid 
growth of these structures marks the beginning of mandibular development. The first pharyngeal 
arch will eventually give rise to Meckel’s cartilage, leading to the development of the mandible, 
incus, and malleus; the second pharyngeal arch gives rise to Reichert’s cartilage and the stapes; 
the third pharyngeal arch gives rise to the hyoid (Sperber 2002; Depew, Tucker, and Sharpe 2002; 
Jiang, Bush, and Lidral 2006; Hall 2015).  
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Table 2. Stages of mandibular development in both humans and mice. 
Carnegie 
Stage 
Human 
Agea 
Mouse 
Agea Description of craniofacial and mandibular development 
9 20 9.0 
The neural plate is expanding and begins to fold as gastrulation 
continues in the primitive streak. Neural crest cells migrating towards 
the facial region. Somite segmentation begins as stomodaeum 
appears. 
10 22 9.5 
Neural fold fuses and begins to close. Paraxial mesoderm continues to 
segment in to somites. Stomodaeum deepens. 
11 24 10.0 
Neural tube closure continues. Paraxial mesoderm continues 
segmentation, otic placodes being sinking, first and second 
pharyngeal arches form caudally to the frontonasal prominence. 
Stomodaeum is widens as prominences swell. 
12 26 10.5 
Brain growth causes lateral facial expanse. Paraxial mesoderm 
continues segmentation, third pharyngeal arch becomes apparent, and 
stomodaeum deepens. Mandibular prominences merge in the first 
pharyngeal arch, forming a continuous structure. 
13 28 11.0 
Paraxial mesoderm continues segmentation as nasal pits form from 
olfactory placodes, and fourth pharyngeal arch becomes apparent. 
14 33 11.5 
Optic placodes and nasal pits readily apparent. Paraxial mesoderm 
continues segmentation. Medial and lateral prominences are apparent 
around nasal pits. 
15 36 12.0 
Lens pits close and stomodaeum deepens as medial and lateral 
prominences begin growing towards each other, coming in contact. 
16 40 12.5 
Nasal pits move ventrally, auricular ridges appear. Medial and lateral 
nasal prominences contact and epithelial fin forms. 
17 42 13.0 
Nasal pits continue ventral movement and auricular ridges become 
more prominent. The medial nasal prominences merge, forming the 
upper lip and nose. Meckel’s cartilage appears in the first pharyngeal 
arch. 
18 44 13.5 
Nasal pits continue ventral movement and medial and maxillary 
prominences come in contact above the mandibular prominence. 
Epithelial fin dissolves and maxillary prominences begin to fuse. 
19 48 14.0 
Nasal pits continue ventral movement as medial and maxillary 
prominences fuse, forming a continuous upper lip. Ossification 
begins. 
20 52 14.5 Nasal pits continue ventral movement and ossification continues. 
21 54 15.0 
Nasal pits continue ventral movement, eyelids, eyes, nose, and 
external acoustic meatus all apparent. 
22 55 15.5 Nose becomes recognizable, and eye pigmentation is apparent. 
23 58 16.0 Ossification continues, differentiation of cranial structures complete. 
aDays post-conception (adapted from Sperber 2002; Depew, Tucker, and Sharpe 2002) 
 
As the brain continues to grow, it forces the nasal and maxillary prominences ventrally to 
accommodate the growing forebrain, and the rapid expanse of these swellings leads to eventual 
contact around 40 days post-conception (E12.5 in mice; Sperber 2002; Jiang, Bush, and Lidral 
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2006). The medial upper lip and nose are formed by 42 days post-conception (E13.0 in mice), and 
the eyelids, eyes, nose, and external acoustic meatus are all readily apparent by 54 days post-
conception (E15.0 in mice). This complex process (Table 2) is responsible for the recognizable 
human face, and any interruptions, teratogenic response, or cellular dysfunction or shortage during 
this time of development can result in any number of facial deformities (Radlanski and Renz 2006; 
Schoenwolf et al. 2009).  
The human embryo consists of five pairs of pharyngeal arches, numbered Arches 1-6. Arch 
5 rarely develops in humans, and even then it results in a negligible contribution to craniofacial 
growth and development (Sadler 2012). Arising from the mesoderm of the first pharyngeal arch, 
Meckel’s cartilage first appears around 42 days post-conception (Table 2) as solid hyaline cartilage 
surrounded by a fibrocellular capsule (Schoenwolf et al. 2009). Nested within the pharyngeal arch, 
the structures run from the midline of the fused mandibular process to the otic capsule (Figure 6 
and Figure 7). Both the right and left sides of the first pharyngeal arch contain a single Meckel’s 
cartilage, as the two structures are not fused on the midline and only contact each other through a 
thin mesenchymal sheet (Figure 6; Rodríguez-Vázquez et al. 1997). Integral to the development 
of this cartilage, and the eventual mandible, is the development of the lingual nerve of the 
mandibular branches of the trigeminal nerve; the lingual nerve develops along the medial aspect 
of each Meckel’s cartilage, while the inferior alveolar nerve runs along the lateral aspect (Figure 
7; Gray 1918; Drake, Vogl, and Mitchell 2010). By roughly 45 days post-conception, mesenchyme 
condenses anteriorly to the cartilage just lateral to the midline as the inferior alveolar nerve begins 
to branch in to the mental and incisive branches. The primary intramembranous ossification center 
of the mandible appears at this time, spreading both anteriorly and posteriorly, as well as inferiorly 
below the incisive nerve to form a groove (later becoming the incisive canal; Orliaguet et al. 1993). 
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Overall, the ossification of the fetal mandible displays a posterior spread of bone towards the 
ascending rami, forming a recognizable mandible by the 10th week post-conception (Frommer and 
Margolies 1970; Schoenwolf et al. 2009).  
 
Figure 6. Meckel’s cartilage within the pharyngeal arches (lateral 
view). 
 
 
Figure 7. Development of the alveolar process of the 
mandible (superior view). 
 
 Chondrocytes are present throughout the developmental lifespan of Meckel’s cartilage, 
and the complex interplay of ossification of the mandibular body and cell hypertrophy and death 
lead to the incorporation of the mandibular nerves and vessels within the developing bony 
38 
 
mandible (Figure 8-Figure 11). Chondrocytes are largely responsible for the eventual fate of 
Meckel’s cartilage: in the distal region of Meckel’s cartilage, chondrocytes atrophy and ossify 
endochondrally. Chondrocytes in the middle region become fibrous tissue, while chondrocytes 
from the posterior region differentiate in to two separate cartilages that will become the incus and 
the malleus (Figure 8; Orliaguet et al. 1993; Schoenwolf et al. 2009; Hall 2015). The lingual aspect 
is replaced by fibrous tissue to become the sphenomandibular ligament, while small patches of 
cartilage appear along the anterior edge of the coronoid and within the condylar processes 
(Radlanski, Renz, and Klarkowski 2003).  
The alveolar process of the mandible forms shortly after the deciduous tooth buds appear, 
ossifying in bands of bone along the medial and lateral margins of the buds and eventually forming 
septa between each of the individual teeth (Radlanski, Renz, and Klarkowski 2003; Radlanski and 
Renz 2006). The mandibular canal forms deep to these newly formed crypts, separated from the 
rest of the alveolar process by a horizontal band of bone (Figure 10 and Figure 11). Once this 
primitive mandible is formed, the further growth of the mandible (both pre- and post-birth) is 
governed by growth in the condyles, coronoid processes, and at the mandibular symphysis (Enlow 
1982; Enlow 1990; Enlow and Hans 1996). As such, Meckel’s cartilage effectively disappears, 
leaving only the developing mandible, ear ossicles (which will begin ossification at 16 weeks post-
conception), and various tissues surrounding the mandible itself (Schaefer, Black, and Scheuer 
2009).  
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Figure 8. Development of Meckel’s cartilage within the first 
pharyngeal arch (lateral view towards midline). From 
Gray’s Anatomy, Plate 178 (1918). 
 
 
Figure 9. Development of Meckel’s cartilage within the first 
pharyngeal arch (lingual view). From Gray’s Anatomy, Plate 
179 (1918). 
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Figure 10. Development of Meckel’s cartilage within the first 
pharyngeal arch (lateral view towards midline). From 
Gray’s Anatomy, Plate 180 (1918). 
 
 
Figure 11. Development of Meckel’s cartilage with the first 
pharyngeal arch (lingual view). From Gray’s Anatomy, Plate 
181 (1918). 
 
1.2.6 Postnatal Mandibular Growth and Development. 
The postnatal growth of the mandible has been extensively studied, particularly in light of 
its significance for both anthropological and orthodontic research. Anthropological research has 
focused on overall morphology of the bone, as implications of both size and shape have far-
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reaching significance for paleoanthropology. Orthodontic research in particular has studied the 
growth of the subadult and adult mandible, as corrective intervention and the timing thereof are 
particularly important for correcting various malocclusions and eruption problems. Much of this 
research focuses on maxillary growth and development, as the ontogeny of the midface involves a 
complicated interplay of growth, transposition, and translation of the various cranial complex 
(Moss and Salentijn 1969b; Enlow 1982). The mandible, however, also develops from a complex 
interplay of the various musculature and other soft tissues contributing to the bone. A 
contemporary understanding of the postnatal growth and development of the human mandible, 
based largely on the work of Björk, Moss, and Enlow, is described here.  
Early postnatal development of the mandible is best visualized as a set of individual 
functional matrices (Moss and Rankow 1968): 
(1) the alveolar processes 
(2) the coronoid processes 
(3) the angular processes 
(4) the mandibular bodies 
(5) the condyles  
(6) the chin  
 
The functional matrix of the alveolar process is the teeth, meaning they dictate the growth 
and development of this area of the mandible (Moss and Rankow 1968; Moss and Salentijn 1969b). 
The temporalis muscle is the functional matrix of the coronoid process, being responsible for the 
growth and development of this aspect of the mandible (Moss and Rankow 1968). The functional 
matrix of the angle of the mandible are the masseter and medial pterygoid muscles, while the 
function matrix of the chin is the digastric muscles; similar resection/paralysis studies have shown 
that immobilization of these muscles leads to dysmorphology of that particular microskeletal unit 
(Moss 1968; Moss and Salentijn 1969a). The functional matrix of the mandibular body varies 
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slightly, though it adheres to the same principle of growth, where the nerves and vessels of the 
mandibular canal dictate the growth and development of the region.  
The condyles of the mandible exhibit a more complicated growth pattern than those of the 
other microskeletal units of the mandible due to their origins as secondary cartilage. Secondary 
cartilage growth differs from that of primary cartilage growth in that it is largely dependent on 
biomechanical loads for proper formation (Sperber 2001). Whereas primary cartilage has its own 
growth vector, secondary cartilage does not form or forms improperly in the absence of mechanical 
pressure, resulting in ossification (Hall 1993). The basic concept of growth at the condyles is that 
of cartilaginous growth, though secondary cartilage undergoes metaplasia, where it is directly 
transformed in to osteoblasts and osteocytes (Moss and Rankow 1968; Enlow 1982). 
Condylectomy severely limits the growth of the condylar region in animal models, though it does 
not directly affect the overall growth and development of the all microskeletal units of the 
mandible (Moss and Rankow 1968; Hall 1993). The growth and development of the mandible 
therefore consists of a number of microskeletal units with a relationship to one another; these units 
develop independently of each other, and only drastic and massive changes in one unit can cause 
a cascade affecting the surround units (Moss and Rankow 1968; Moss and Salentijn 1969b). 
The postnatal growth of the mandible occurs through the “V” principle, with the 
overarching appearance of the mandible growing anteriorly and inferiorly as appositional growth 
and condylar growth against the glenoid fossa of the cranial base (Figure 12; Enlow and Hans 
1996). The anterior margin of the chin grows appositionally as bone is deposited and the anterior-
inferior border with subsequent resorption on the posterior margin. Along the alveolus, growth 
occurs to accommodate the erupting teeth (both deciduous and adult) throughout ontogeny, with 
some resorption along the anterior margin just below the first and second incisors; this process 
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helps form the recognizable human chin (Enlow 1982; Enlow 1990). The mandibular body grows 
both medially and laterally as the angular process grows as a result of mechanical response to both 
the masseter and medial pterygoid muscles. The coronoid process grows superiorly in response to 
the temporalis muscle, and the condyle grows superiorly and posteriorly, effectively “pushing” the 
mandible forward and downward away from the cranial base (Figure 12; Enlow 1982; Björk and 
Vibeke Skieller 1983; Enlow and Hans 1996). The sum of all these interconnected processes 
results in the recognizable human mandible in adults. 
 
 
Figure 12. Postnatal growth of the human mandible. Adapted from 
Enlow (1982). 
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1.3 RESEARCH GOALS AND DESIGN 
This review highlights the complex nature of human mandibular growth and development. 
These processes demonstrate how the mandible can be envisioned as a set of microskeletal units 
with independent growth vectors and trajectories. It has also been shown that thyroid hormone has 
a direct effect on bone growth, particularly in the craniofacial complex. As such, this research 
proposes that alteration in maternal thyroxine levels will therefore have an effect on the ontogeny 
of the offspring mandible. It is expected that heightened levels of maternal thyroxine will result in 
shape changes of the offspring mandible in all areas of mandibular growth, particularly areas 
related to muscle attachments and areas of the mandible that grow in response to occlusion or the 
cranial base.  
1.3.1  Hypotheses 
The goal of this dissertation is to utilize isogenic mouse model data and micro-CT scanning 
of mandibles of mice exposed to exogenous thyroxine during fetal development, mimicking 
maternal hyperthyroidism. The primary hypothesis of this research is that mice exposed to excess 
exogenous thyroxine during fetal development will demonstrate altered shape compared to the 
unexposed control mice. 
 
Secondary Predictions: 
(1) The shape changes in exposed mice will be most pronounced in regions of the mandible 
associated with muscular attachment (mandibular angle, coronoid process). 
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(2) The shape changes in exposed mice will be more pronounced as age increases. 
 
(3) The shape changes in exposed mice will be more pronounced as thyroxine 
dosage increases. 
 
These hypotheses will be assessed using Euclidean Distance Matrix Analysis and 
geometric morphometric methodologies. The EDMA methodology will be used to address any 
size changes, as well as basic shape changes, associated with the increased maternal thyroxine 
levels. The GM methodology is used exclusively for shape analysis, and will adequately describe 
and evaluate any shape changes present in the sample. Under these hypotheses, any size and/or 
shape changes in the offspring mandibles are attributable to increased maternal thyroxine levels.  
1.4 RESEARCH SIGNIFICANCE 
 
The results of this research will advance anthropological and clinical studies in numerous 
ways. While postcranial skeletal studies have focused on the role of thyroid dysfunction in poor 
bone formation and suture fusion, cranial studies have addressed issues of suture homeostasis, 
craniosynostosis, and clefting (Hanken and Summers 1988; Göthe et al. 1999; Allan et al. 2000; 
Harvey et al. 2002; Luewan, Chakkabut, and Tongsong 2011). This study will add to the scant 
literature concerning the role of maternal thyroid function and the ontology of the mandible; in 
doing so, this research provides a framework for future studies regarding the role of the maternal 
endocrine system in relation to offspring growth and development. This research also adds to 
existing literature concerning the role of maternal environmental contribution to offspring 
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craniofacial growth and development (Daneman and Howard 1980; Johnston and Bronsky 1995; 
Talaeipour et al. 2005; Kau et al. 2006; Rasmussen et al. 2007; Cray et al. 2013; Šešelj, Duren, 
and Sherwood 2015). The complex gene-environment interaction during craniofacial ontogeny 
cannot be completely understood by any single study, though this research project adds to the 
mounting literature documenting the intricate interaction between body systems during growth and 
development. 
The proposed research also contributes to research concerning the role of maternal health 
and wellness during pregnancy. Clinical research focuses on the etiology and pathology of 
endocrine disorders (Hershman 2009; Mestman 2009; Singer 2009), or on the disorders of the 
individuals affected (Brixen and Eriksen 1999; Adler 2000; Luewan, Chakkabut, and Tongsong 
2011), but rarely addresses the implications of such maladies on developing embryos. The 
increasing prevalence of thyroid dysfunction in modern populations promises to have profound 
impacts in future medical and cultural studies regarding maternal health and wellness (Allan et al. 
2000; Luewan, Chakkabut, and Tongsong 2011; Grob 2014).  
More broadly, the results will be of interest to clinicians and other researchers interested in 
pregnancy care, be it prenatal planning, screening, or maternal care. While this study focuses 
primarily on biological aspects of maternal endocrine levels, its anthropological background 
showcases the potential for studies on maternal environment. Hyperthyroidism, either 
autoimmune- or pregnancy-induced, affects a large number of potential mothers both in the U.S. 
and abroad (Canaris et al. 2000; Hollowell et al. 2002; Murphy and Williams 2004), so the very 
nature of this research displays its broad applicability to biological anthropology research. 
Furthermore, the endocrine system plays a substantial role in the development of metabolic disease 
processes in the past and these endocrine dysfunctions (e.g., hypothyroidism, hyperthyroidism, 
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hyperparathyroidism, rickets, scurvy) have played important roles in shaping ancient and historical 
populations (Ortner and Mays 1998; Ortner 2003; Brickley and Ives 2006; Mays, Brickley, and 
Ives 2006; Mays, Brickley, and Ives 2007). Thus, the potential of this study to identify cranial and 
mandibular shape changes associated with maternal hyperthyroidism in modern populations 
provides a springboard for future studies utilizing shape analysis to evaluate endocrine disorders 
in the past. 
Finally, this study will further demonstrate the overall efficacy of animal models in the 
study of human growth and development. Anthropologists have long been interested in variable 
growth rates and craniofacial morphology of the earliest hominin populations (Viòarsdóttir, 
O’Higgins, Paul, and Stringer 2002; Hennessy and Stringer 2002), and the large samples provided 
by animal models such as the one proposed here demonstrate the power of geometric-
morphometric analyses as correlates for human ontogeny. Clinicians will benefit from the 
additional data produced regarding the teratogenic effects acting on developing embryos, as well 
as additional information relating to the chemical pathways of bone growth and development. This 
investigation therefore balances anthropological and clinic research to provide a framework for 
future studies in skeletal biology, human growth and development, pathology and paleopathology, 
and craniofacial biology. 
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2.0  MATERIALS AND METHODS 
This dissertation utilizes an isogenic mouse model and micro-CT scanning of mice exposed 
to exogenous thyroxine during fetal development to mimic maternal thyrotoxicosis. This project 
is an extension of a larger, NIH-funded project being conducted by Dr. James Cray at Georgia 
Regents University and continued at the Medical University of South Carolina, who was 
responsible for the maintenance of the animal sample, the administration of thyroxine dosages, the 
sacrifice of the litters, the embedding of the animal bodies for later histological processing, and 
the CT scanning of the skulls. The Georgia Regents University Animal Care and Use Committee 
approved all data collection and care of the animal subjects, and much of the data from the sample 
are stored at the University of Pittsburgh 
2.1 ANIMAL MODEL 
The 241 mice used for this project are C57BL-6 background specimens (Timed Pregnant; 
Jackson Laboratories, Bar Harbor, ME), a strain of mice commonly used in animal model studies 
(Crawley et al. 1997). The thyroxine dosage was given as levothyroxine (a synthetic compound 
identical to thyroxine) to pregnant dams at 13 days post-conception through drinking water under 
normal consumption of 3-5 ml of water/day. This time period in embryological development 
corresponds to the period of cranial development prior to sutural closure, and therefore represents 
a crucial time for the effect of teratogens on overall craniofacial development (see Chapter 1; 
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Morriss-Kay and Wilkie 2005). The light cycles utilized were standard 12:12 cycles, and sacrifice 
of mice was conducted using CO2 inhalation with concurrent cervical dislocation, in compliance 
with ARRIVE Guidelines. 
Dams were separated in to a control group with no maternal thyroxine treatment (n=63 
resulting pups), a low dosage group receiving ~0.25 mcg of thyroxine/day (n=67 resulting pups), 
a medium dosage group receiving ~0.50 mcg of thyroxine/day (n=46 resulting pups), and a high 
dosage group receiving ~1.0 mcg of thyroxine/day (n=65 resulting pups). Litters were serially 
selected for sacrifice at 15 days (49 mice), 20 days (74 mice), and 25 days (118 mice); seven litters 
were sacrificed for each time period (21 total litters), resulting in total dam numbers larger than 14 
per group required by preliminary tests for most groups (α=0.05, β=80, n= 336; Cray, pers. 
comm.). The resulting litters within the 15-, 20-, and 25-day samples are adequate to establish 
parity between mothers, offspring, and variation within each of the selected age groups (Table 3). 
Control group mothers were bred multiple times, but any mothers receiving thyroxine were utilized 
only once. The age groups of the sacrificed offspring were selected due to their approximate 
correlation to juvenile and adolescence in humans; final brain development in mice is complete 
12-14 days after birth, and mice are considered juvenile until 24 postnatal days (Depew, Tucker, 
and Sharpe 2002; Morriss-Kay and Wilkie 2005).  The dosages of thyroxine were also chosen as 
correlates to therapeutic dosages (10-250 mcg/day) used in human clinical trials (Cray, pers. 
comm.). Due to sample constraints, namely the absence of data of 15-day old mice that received a 
medium developmental dose of levothyroxine, some age groups were underrepresented. Sex data 
for the sample was not available for parts of the 15-day old mice, precluding this sample from 
certain statistical tests (see Section 3.0), but available data are presented in Table 3. Sample sizes 
are still sufficient to address age- and dose-dependent shape variation (Table 3).  
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Table 3. Sample sizes of C57BL/6 individuals and associated age, sex, and thyroxine 
dosages utilized for this study. 
 Dosage 
TOTAL 
Age Control (sex) 
Low Dose 
(sex) 
Medium Dose 
(sex) 
High Dose 
(sex) 
15 Days 21 
(unknown) 
19 
(8M, 11F) 
0 
(unknown) 
9 
(4M, 5F) 
49 
20 Days 19 (10M, 9F) 
11 
(9M, 2F) 
17 
(13M, 4F) 
21 
(14M, 7F) 74 
25 Days 23 
(13M, 10F) 
31 
(13M, 18F) 
29 
(14M, 15F) 
35 
(20M, 15F) 
118 
TOTAL 63 67 46 65 241 
 
2.2 MICRO-CT SCANNING 
The skulls of all mice were separated from the bodies in Dr. Cray’s lab and fixed for 3D 
micro-computed tomography (micro-CT) scanning utilizing a SkyScan 1172 (Kontich, Belgium) 
set at 19.36μm voxel resolution. To adequately visualize and later landmark the mandibles, the 
output images from the micro-CT scanner (saved as .bmp files) must be constructed as a stack of 
image files. This stacking was conducted using the Amira software program 
(http://www.fei.com/software/amira-3d-for-life-sciences/), a powerful tool for both compiling imaging 
outputs and visualizing these outputs for landmarking and analysis. The .bmp stacks were 
compiled in Amira by Dr. Trish E. Parsons, a postdoctoral fellow at the University of Pittsburgh’s 
Center for Craniofacial and Dental Genetics (CCDG) and saved as Amira files (.am file format) 
on the Center’s servers. The images were downsampled in ImageJ (see Schneider, Rasband, and 
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Eliceiri 2012) to improve rendering performance, and the minor loss of image resolution associated 
with resampling would not affect the landmarks selected for this project (Parsons et al. 2014). 
Once these images were imported in to Amira, a Gaussian smoothing filter was applied (σ= 0.3 in 
X, Y, and Z; isometric kernel size =3; Parsons et al. 2014). No hole-filing or smoothing algorithms 
were applied to the imported image.  
The finalized Amira files were utilized for multiple projects within Dr. Cray’s larger 
research project. These finalized Amira files marked the starting point for data collection on the 
present project, which began with mandible visualization and landmarking. For the current study, 
thresholds were first selected for optimal viewing of landmarks with the Amira package; thresholds 
within Amira refer to the opacity thresholds for the imported images, meaning a higher threshold 
setting results in clear reconstruction of denser, less lucent structures (e.g., teeth) are rendered 
without that addition of thinner, more lucent structures (e.g., suture edges, thinner cortical bone). 
For this project an image threshold of 42 was chosen, as it allowed both the accurate depiction of 
gross landmarks without loss of rendering at thinner aspects of the mouse mandibles (Appendix 
A).  
2.2.1  Landmarking 
Once saved as .am files, the reconstructed images of the mouse crania were visualized in 
Amira for landmarking and the export of landmark data sets; for a step-by-step guide of the 
landmarking process, see Appendix A. Landmarking refers to the placement of digital landmarks 
on a three-dimensional image, resulting in x, y, and z coordinates for each landmark on each 
mandible. Landmarks cannot be arbitrarily assigned, and must represent homologous points on 
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each individual shape, adequately cover the form, and be reliably found in consistently relative 
positions (Zelditch et al. 2004). The landmarks represent fixed points on the shape being analyzed, 
and are selected to represent accurate and replicable representation of the shape being studied 
(Bookstein 1991). Not all landmarks are necessarily useful; Bookstein (1991) identified three types 
of landmarks: 
 
Type 1: discrete points such as intersections or foramina 
Type 2: points located along maximal or minimal curvatures 
Type 3: points along extremes defined by other points 
 
For this project, only Type 1 and Type 2 landmarks were selected, as Type 3 landmarks 
are considered “deficient” due to their reliance on the placement of other landmarks (Bookstein 
1991). Once identified on each subject, these landmarks can be exported to various software 
packages, allowing for the easy manipulation, visualization, and evaluation of both size and shape 
of each individual mandible. 
A total of 32 landmarks were selected for this project, with 16 points being mirrored on 
both sides of the mandible (Figure 13). These landmarks represent a common set of mouse 
mandibular landmarks used in numerous other Euclidean Distance Matrix Analyses and geometric 
morphometric analyses (Klingenberg and Leamy 2001; Klingenberg et al. 2001; Hennessy and 
Stringer 2002; Klingenberg, Leamy, and Cheverud 2004), and are selected within Amira in the 
appropriate order (Table 4). Only the 16 landmarks from the left mandible of each sample were 
utilized for this dissertation. These landmarks adequately encapsulate the overall shape and size of 
each mandible to allow for the evaluating of any shape changes occurring due to maternal 
thyroxine levels. 
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Once landmarked, the file is saved in a new directory on the CCDG servers, and the 
landmark data were exported as .ascii files for import in to Microsoft Excel (Microsoft Excel for 
Mac 2011) as a .csv spreadsheet of uniform landmark data.  
 
Table 4. Order of mandibular landmarks (left side). These landmarks are mirrored 
on the right side of each mandible and excluded from this study. 
Side 
Landmark 
Number Landmark 
Left 
1 Anterior superior incisor alveolar rim (midline) 
2 Anterior edge of mental foramen 
3 Anterior edge molar alveolar rim (midline) 
4 Intersection molar alveolar rim and coronoid process 
5 Apex of coronoid process  
6 Posterior base of coronoid process (midline) 
7 Anterior edge of mandibular condyle (midline) 
8 Posterior edge mandibular condyle (midline) 
9 Most anterior point of subcondylar incisive 
10 Posterior tip of mandibular angle 
11 Most superior point of inferior border of mandibular angle 
12 Anterior edge of inferior border of masseteric ridge 
13 Most inferior point on mandibular symphysis 
14 Anterior inferior incisor alveolar rim (midline) 
15 Anterior edge of mandibular foramen 
16 Most posterior point along molar alveolar border 
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Figure 13. Landmarks utilized for this study (left mandible). 
2.2.2 Observer Error 
To ensure accuracy in landmark placement, observer error trials were conducted during 
data collection. Prior to data collection, 30 mandible images were selected and landmarked as a 
practice run. These same 30 mandibles were then landmarked a second time, and the landmark 
files (.ascii files) were saved in a separate directory. Finally, these same 30 mandibles were 
landmarked a third time for comparison with the second run. Each of the three runs was separated 
by at least a week to avoid memory bias in placing each landmark. By doing so, intraobserver error 
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could be calculated using a modified reliability analysis and intraclass correlation coefficient tests 
conducted in SPSS v23.0.0.0 (IBM SPSS Statistics for Macintosh 2015). Intraclass correlation 
(ICC) is a useful estimate of reliability of quantitative data, effectively measuring the reliability of 
the single researcher in placing the landmarks consistently across structures (Landers 2015). These 
calculations, similar to those of a Pearson’s correlation coefficient, result in an intraclass 
correlation calculation (1.000 being perfect correlation between landmark placement between all 
30 mandibles), a 95% confidence interval across each landmark across all 30 mandibles, and 
associated degrees of freedom (Landers 2015). For this study, a threshold of 0.90 was selected in 
accordance with most scientific publishing standards for research; as such, any values below 0.90 
were highlighted and evaluated as instances of intraobserver error. No such errors were found in 
this study, suggesting that landmark placement was precise across all landmarking procedures 
conducted for this study (Table 5).  
 
Table 5. Intra-observer error calculations. 
 Intraclass Correlation 
Coefficients 
Landmark x y z 
1 Anterior superior incisor alveolar rim (midline) 0.999 1.000 0.997 
2 Anterior edge of mental foramen 1.000 1.000 0.999 
3 Anterior edge molar alveolar rim (midline) 1.000 1.000 0.999 
4 Intersection molar alveolar rim and coronoid process 1.000 1.000 0.998 
5 Apex of coronoid process 1.000 1.000 1.000 
6 Posterior base of coronoid process (midline) 0.999 0.999 0.999 
7 Anterior edge of mandibular condyle (midline) 1.000 1.000 0.999 
8 Posterior edge mandibular condyle (midline) 1.000 0.999 0.998 
9 Most anterior point of subcondylar incisive 1.000 0.999 1.000 
10 Posterior tip of mandibular angle 1.000 1.000 1.000 
11 Most superior point of inferior border of mandibular angle 1.000 0.999 0.999 
12 Anterior edge of inferior border of masseteric ridge 1.000 1.000 0.999 
13 Most inferior point on mandibular symphysis 1.000 1.000 1.000 
14 Anterior inferior incisor alveolar rim (midline) 1.000 1.000 0.990 
15 Anterior edge of mandibular foramen 1.000 0.999 1.000 
16 Most posterior point along molar alveolar border 0.999 1.000 0.997 
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2.3 EUCLIDEAN DISTANCE MATRIX ANALYSIS 
The first method of statistical analysis utilized is Euclidean Distance Matrix Analysis 
(EDMA). The EDMA methodology arose out of more traditional morphometric studies utilizing 
linear distances between landmark points to evaluate the overall size differences and/or changes 
between two or more biological specimens. This method employs the same landmarks used for 
geometric morphometric analyses, and is used to compliment rather than compare any shape 
changes demonstrated by geometric morphometric approaches. This method does not require 
superimposition methods used by geometric morphometric approaches, as the selection of such a 
method can affect the landmarks and estimates (Rohlf and Marcus 1993). As such, EDMA 
provides a lens with which to evaluate form of an object without rotation and scaling associated 
with geometric morphometrics. 
The EDMA method was pioneered in the 1990’s as a method of evaluating form of an 
object by calculating mean distances between all landmarks within a sample (Lele and Richtsmeier 
1991; Lele 1993; Lele and Richtsmeier 2001). The form of an object with K landmarks is thus 
defined by a matrix of distances between each landmark, with K rows and K columns, otherwise 
called a form matrix (FM). Since each landmark has a distance calculated between each other 
landmark, the total number of distances (K) is defined as: 
𝐾𝐾 = 𝑛𝑛(𝑛𝑛 − 1)2  
For each age and control group, the mean distance between each landmark will then be 
calculated and entered in to a form matrix, allowing for arithmetic and statistical comparisons of 
each form matrix between the groups (Lele and Richtsmeier 1991; Lele and Richtsmeier 2001). 
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For example, two separate groups (group A and group B) are entered in to form matrices FM(A) 
and FM(B). These two matrices are then compared, resulting in a form distance matrix (FDM) 
representing differences in mean distances between the two original matrices, resulting in FDM 
(A,B), or the difference FM(A) - FM(B). This new FDM results in size and shape differences 
between the two groups A and B, and can also be scaled to accounted for size differences between 
samples not of interest to the project (Lele and Richtsmeier 1991; Lele and Richtsmeier 2001). 
Once the landmark data for each age and treatment are entered as form matrices, further 
statistical calculations can be conducted. Working from the null hypothesis that the forms of each 
age and treatment group are the same, EDMA uses a suite of standard parametric and 
nonparametric statistical tests to evaluate size and shape of each FM (Lele and Richtsmeier 1991; 
Lele 1993). Test statistics are calculated through bootstrap resampling of the data, allowing for the 
evaluation of differences between each of the samples, should they exist (Lele 1993). It should be 
noted that that a significance level of 0.90 is used due to the involvement of bootstrap resampling 
and scaling factors, which can affect the tails of each constructed distribution and to lead to errors 
in interpretation (Lele and Cole 1996). Alpha (α) levels for each test are noted both here and in the 
results section. 
Further testing allows for identification of specific areas of differences between two or 
more groups using 90% confidence intervals for each distance within each group (Lele and 
Richtsmeier 1995). This method has been used successfully in past studies to calculate shape 
distance matrices (SDM) to generate a distribution of values for each calculated mean distance 
(Lele and Richtsmeier 1995; Lele and Cole 1996; Lele and Richtsmeier 2001). A simple 
identification of any statistically significant results in the form (shape) differences can be 
conducted by comparing of these SDM’s and their associated upper and lower bounds and 
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identifying any that do not contain the null value (omnibus testing). Omnibus testing allows one 
to assume that the forms compared between the two samples are not the same (Lele and Cole 1996; 
Lele and Richtsmeier 2001). This comparison is done using a Monte Carlo bootstrapping method, 
which begins with the calculation of form matrices for each sample, FM(A) and FM(B), and a 
variance-covariance matrix for the samples. These matrices are then used to generate a new sample 
of observations for each sample using Gaussian perturbation models, which results in two new 
samples of observations for group A and group B, which are again used to create a new FDM; this 
process is repeated many times (typically 1,000; Lele and Richtsmeier 2001). The Monte Carlo 
method and a regular bootstrapping method are very similar, differing only in the fact that the 
Monte Carlo method utilizes a Gaussian model whereas the bootstrapping is random. Since both 
methods use randomized procedures and result in different estimates each time the analysis is 
conducted, though the high number of repetitions means the differences between each run will not 
confound any conclusions (Lele and Richtsmeier 2001). The 90% confidence intervals are then 
obtained, meaning that they are element-wise confidence intervals and are therefore computed for 
each linear distance and can only be used to identify form differences between linear distances; 
this method does not used to determine if forms are statistically different, and is instead used to 
determine where shape differences are occurring between the two samples (Lele and Richtsmeier 
2001). 
Hypothesis testing in EDMA is facilitated using the null-hypothesis that the two shapes 
being compared are the same. Once an empirical distribution is calculated using Monte Carlo 
resampling and confidence intervals have been computed, the upper and lower bounds of the 
distribution are evaluated. Using the accepted alpha level (α=0.90), any linear distance with upper 
and lower bounds that exclude the null value is considered significantly different between the two 
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groups (Lele and Cole 1996; Lele and Richtsmeier 2001). Finally, the upper and lower 5% of the 
bootstrapped samples (resulting in the necessary 90% interval) are removed, and the remaining 
sample is sorted low to high: if the 90% confidence interval for a distance does not contain the 
null-value (zero), then the null hypothesis that the two forms are the same is rejected.  
 
2.3.1  Application of Euclidean Distance Matrix Analysis 
For this project, the 16 landmarks collected on the left side of each mandible will first be 
represented as a set 120 linear distances. Outliers will first be evaluated for landmark placement 
error and removed if necessary. Due to the fact that EDMA is an older, unsupported beta software 
program, some planned analyses could not be conducted. The geometric mean was used to scale 
the data for this project, effectively removing size from the sample, by calculating the geometric 
mean of each of the 16 linear distances on the left side of the mandible. Any skulls within the 
sample that were not fit during the initial rendering process could not be evaluated, which removed 
the 15-day controls from the sample. The medium dose group was also excluded from analysis 
due to the lack of 15-day old samples within the sample. As such, a total of four form matrices 
(FM) will be calculated for this project to adequately quantify shape differences in relation to the 
project hypotheses: 20-day low dose, 20-day high dose, 25-day control, and 25-day high dose. The 
low dose groups are compared to the high dosage groups within each age. These groups were 
utilized for all calculations within WinEDMA, the program used for all aspects of EDMA for this 
project (Cole 2003).  
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A form matrix (FM) was first created for each sample being compared (e.g., 20-day low 
dose and 20-day high dose), and was then divided by the scaling factor (the geometric mean of the 
distances) to create a shape matrix (SM) for each sample. These SM’s were then compared, and a 
new matrix was calculated for the shape differences between the two samples (Appendix B). A Z-
statistic was calculated (alpha = 0.10), and resampled (1,000 resamples with replacement) to create 
a new shape-difference matrix (SDM). This SDM is then sorted, allowing easy identification of 
any linear distance that rejects the null hypotheses (the 90% confidence interval does NOT contain 
zero). This element-wise method allows for differentiation of regions of the mandible that are 
different between the two samples, which were then depicted on micro-CT scans and 
reconstructions for easy visualization of shape changes. Complete outputs for EDMA are presented 
in Appendix B.  
2.4 GEOMETRIC MORPHOMETRIC ANALYSIS 
The second method of statistical evaluation utilized is geometric morphometrics (GM). 
The field of GM arose throughout the 20th century, following numerous scholarly debates 
regarding the best method(s) of evaluating relationships between biological entities. Geometric 
morphometrics has become as staple method within the field of biology, and is used here to 
compliment the traditional morphometric analyses provided by the EDMA approach.  
“The study of form may be descriptive merely, or it may become analytical. We 
begin by describing the shape of an object in the simple words of common speech: 
we end by defining it in the precise language of mathematics; and the one method 
tends to follow the other in strict scientific order and historical continuity.” 
(Thompson 1915) 
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The field of geometric morphometrics arose from traditional morphometric analyses, 
which sought to evaluate similarities and differences between biological entities, and stems from 
debate between two prominent biostatisticians in the early 20th century (Bookstein 1991). The two 
scientists, William Bateson and Karl Pearson, argued about continuous or discontinuous 
evolutionary processes and the best method of evaluating these processes (Bateson 1902; Pearson 
1902; Bookstein 1991). Traditional morphometric analysis, like that utilized by Bateson and 
Pearson, relies on measures of size, namely length, width, height, and depth (Zelditch et al. 2004). 
These measurements result in data amicable to quantifying and analyzing size, but fail to 
adequately deal with the overall shape of the biological entity being investigated. Prominent 
Cambridge mathematician D.G. Kendall best demonstrates the value of shape studies: “If we are 
not interested in the location, orientation or scale of the resulting configuration, then we find 
ourselves working with a continuous stochastic process describing its change of shape” (Kendall 
1977: 428). Therefore, the overall goal of geometric morphometrics is the analysis of shape once 
size has been removed, allowing geometric relationships between specimens to be evaluated 
without the potentially confounding elements of size (Adams, Rohlf, and Slice 2013a).  
The pioneer of shape studies in the field of biology was D’Arcy Thompson, who worked 
during the early 20th century to define how shapes could be morphed (in his words, deformed) in 
to another (Thompson 1917; Zelditch et al. 2004). Thompson showed that change in shape could 
be described by using a Cartesian coordinate system; by overlying a coordinate system over a 
shape, then dividing this system in to a rectangular grid, Thompson could then study how the shape 
of one organism deformed in to another (Thompson 1917; Zelditch et al. 2004). The arguments 
put forth by Thompson went largely unappreciated until the 1980’s and 1990’s, when his worked 
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was resurrected and incorporated in to the developing field of geometric morphometrics. The term 
‘geometric morphometrics’ was popularized in the late-1980’s and early-1990’s as biologists built 
upon the ideas of Thompson and the relatively new advances in computing to develop powerful 
new tools to evaluate shape (Corti 1993; Rohlf and Marcus 1993).  
As studies of shape became more prominent, especially in anthropological and anatomical 
settings, the methodology associated with geometric morphometrics became increasingly 
complex. The foundation of geometric morphometrics, landmark analysis, was expanded to 
incorporate outlines, curves, and more elaborate surfaces (Adams, Rohlf, and Slice 2013a). The 
central tenet of geometric morphometrics became the “Procrustes Paradigm”, or the statistical 
underpinnings and analytical analyses of landmark superimposition (Kendall 1981; Adams, Rohlf, 
and Slice 2013a). Contemporary trends in geometric morphometric analyses have moved towards 
three dimensional data, phylogenetic recreation, and inclusion of larger and more complex datasets 
thanks to advances in computing and imaging. 
Geometric morphometric analysis begins with the identification of necessary landmarks of 
the shape of specimen of interest (see Table 4 and Figure 13). Next, these landmarks undergo a 
generalized Procrustes analysis, which superimposes the landmarks of every specimen in the study 
group in to a common coordinate system (Rohlf and Marcus 1993; Zelditch et al. 2004).  The 
Procrustes analysis utilizes least-squares, a type of regression analysis of data fitting, wherein the 
observed landmark locations are centered, scaled, and rotated to the centroid size of the average 
configuration (Zelditch et al. 2004; Klingenberg 2011). The end result of this superimposition are 
Procrustes shape coordinates relating to each object in space, allowing for the comparison of the 
shape of each specimen regardless of size variables.  
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The next step in geometric morphometrics is the applications of multivariate statistical 
models, ranging from regression to multivariate analysis of variance (MANOVA) to principle 
component analysis (PCA) to discriminant function analysis (Rohlf and Marcus 1993; Rohlf and 
Corti 2000; Zelditch et al. 2004). Statistical tests are chosen based on the hypotheses of the study: 
covariation patterns can be established using partial least squares (PLS), while shape differences 
can be evaluated using multivariate regression (Rohlf and Corti 2000; Adams, Rohlf, and Slice 
2013a). Of particular interest to anthropologists and anatomists are visualization and explanation 
of shape changes, typically achieved through the use of PCA and discriminant function analysis 
(Adams, Rohlf, and Slice 2013b). Harkening back to D’Arcy Thompson’s “deformation” of 
shapes, these visualizations allow researchers to evaluate the direction and magnitude of shape 
changes in visual planes (Figure 14). The use of GM also allows for testing not available to 
conventional linear metric analysis (Hallgrimsson et al. 2015). Finally, GM analyses also showcase 
the vast range of inter- and intra-species variability of tissue shape, and the ontogeny of the 
mandible is of particular interest to paleoanthropologists and paleontologists alike (O’Higgins and 
Collard 2002; Viòarsdóttir, O’Higgins, Paul, and Stringer 2002; Viòarsdóttir and O’Higgins 2003). 
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Figure 14. Visual explanation of the steps involved in geometric morphometric analysis. 
2.4.1  Application of Geometric Morphometric Analysis 
The landmarks defined in Amira were imported in to MorphoJ (Klingenberg 2011), a 
popular free program for geometric morphometric analysis. Only landmarks from the left side of 
the mandible were utilized for GM studies in this project, as some mandibles were misaligned 
during the embedding process, which could potentially introduce false interpretations of torsion 
between the two mandibular halves during shape analyses. Data points were evaluated first in 
Microsoft Excel to verify correct import of landmarks from Amira to .ascii file format. Once 
verified in Excel, all landmarks, qualifying variables (age, treatment, sex), and potential covariates 
(age) were exported as plain text (.txt) files for import in to MorphoJ. Landmarks were imported 
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as three-dimensional data with no object symmetry and subjected to a preliminary Procrustes fit 
for transformation in to tangent space (Klingenberg 2011). Preliminary transformation was 
conducted by aligning landmarks by principle axis for easy identification of outliers or any quality 
control issues with the landmark data (e.g., landmark transposition, missing landmarks: Figure 15).  
No data points for this project were excluded from the analysis based on outliers. Landmarks were 
then verified and again evaluated for outliers or potential data control issues (Figure 16). Finally, 
a covariance matrix was generated based on all landmarks, and qualifiers and covariates were 
imported for data grouping and later analysis of subsets of mandibles (see Section 3.0 ). 
 
Figure 15. MorphoJ output for identification of outliers and quality control of landmark data. 
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Figure 16. MorphoJ output of all landmarks (both sides of the mandible to double-
check for swapped landmarks) prior to data grouping using qualifier variables of age 
and dosage. 
 
Once all landmark data were imported and fit using Procrustes transformation, evaluation 
of shape differences between ages and doses began. Wireframes were created for each age and 
treatment group, allowing for easier visualization of any shape changes. MorphoJ allows for 
various analyses, ranging from principle component analysis (PCA), analysis of variance 
(ANOVA) based on the Procrustes fit, matrix correlation, partial least squares (PLS), canonical 
variate analysis, and discriminant function analysis (Klingenberg 2011). Due to sample sizes and 
hypotheses, not all analyses necessarily apply; this research utilizes PCA and discriminant function 
analysis to evaluate any shape changes occurring in the mouse mandibles based on age and/or 
treatment. The full MorphoJ protocol for this dissertation is presented in Appendix C. 
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2.5.1.1 Principle Component Analysis 
 Principle component analysis is a type of multivariate analysis pioneered in the early 20th 
century (Hotelling 1933). With principle component analysis (PCA), variables are plotted against 
one another and a directionality of the correlation, or the distance along the long axis of the 
scatterplot, represents the first principle component (PC). This PC can be said to explain the largest 
portion of variation between the two groups by summing the squared distances from the line 
(Figure 17). While this PC explains the most variation within the plotted sample, it does not explain 
all the variation. The variation that is not explained by the first PC can be captured using a second 
PC, which runs perpendicular to the first PC (Figure 17). This process of PCA can be used for both 
two- and three-dimension data, and is one of the hallmarks of GM analysis (Zelditch et al. 2004). 
In three-dimensional data, the third PC will again run perpendicular to both the first and second 
PC’s. Additional PC’s can be calculated until all variation within the sample is explained, and 
these PC’s are then used to explain variation within the sample (Claude 2008).  
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Figure 17. Visual depiction of principle component analysis, where PC1 explains the 
largest proportion of variation and PC2 explains the remaining variance within the 
population. 
 
For this project, data were evaluated both across the whole group and within each treatment 
group. Eigenvalues, which are measures of the amount of variation explained by each PC, were 
calculated for each specimen. Principle components were then selected that explained ~90% of the 
variance within the group (Figure 18). These PC’s can then be interpreted visually as wireframe 
figures, lollipop figures, or scatterplots with confidence ellipses around each group (Figure 19). 
This allows for interpretation of results by demonstrating the variation between PC’s as an 
explanation of shaped changes between groups (Zelditch et al. 2004; Claude 2008; Klingenberg 
2011). 
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Figure 18. Sample eigenvalues showing the % of variation explained by a principle 
component. 
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Figure 19. Sample visualizations of PCA from MorphoJ software. 
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2.5.1.2 Canonical Variate Analysis 
Canonical variate analysis (CVA) is similar to discriminant function analysis, as it is 
attempts to differentiate samples in to known groups (Klingenberg 2011). Unlike discriminant 
function analysis, which can only be used to distinguish between two known groups, CVA allows 
regression in to multiple groups based on highest calculated correlation. With CVA, MorphoJ finds 
the axes that best discriminate between groups; these axes, called canonical variates (CV’s), 
separate the groups based on maximum between-group variance in relation to with-in group 
variance in each dimension (Zelditch et al. 2004). This discrimination results in scores that are 
then used to differentiate between groups, including any individuals of unknown group affiliation 
(Zelditch et al. 2004; Claude 2008). The most intuitive aspect of CVA results are once again 
wireframe and scatter plots, both of which depict variation among the data in relation to the 
canonical variates (Figure 20). Furthermore, CV’s can be used to separate the sample in to groups 
via scatterplots. For smaller samples such as the one used in the present study, CVA is an adequate 
substitute for tests predictive tests such as discriminant function analysis.  
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Figure 20. Sample visualizations of CVA from MorphoJ software. 
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2.5 DATA MANAGEMENT PROTOCOL 
All data and protocol were saved on the CCDG servers for security and ease of backup. 
The analysis and software outputs for each test were saved, and the data master data files are also 
maintained on the servers. All protocols are attached as appendices, and results are presented in a 
manner that best display the results of the study; as such, not all analyses are presented in the 
results section. Further unconventional or unanticipated statistical tests and data manipulation are 
explained in Section 3.0 as needed. Naming protocols are detailed in protocols, and all images 
were exported as both .bmp and .svg outputs for visual manipulation. 
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3.0  RESULTS 
The two methods utilized for this project, EDMA and GM, represent two separate methods 
of evaluating shape differences within a biological sample. While these methods are different both 
statistically and theoretically, they both utilize mandibular landmarks to effectively quantify the 
overall shape changes between age and dosage groups within the sample. It should be noted, 
however, that EDMA is not an effective method of verifying or falsifying GM results, and vice-
versa. The methods are meant to complement each other and help provide a better overall picture 
of any shape changes occurring in the present sample. 
3.1 EUCLIDEAN DISTANCE MATRIX RESULTS 
3.1.1  Age-Based EDMA Results 
All 16 landmarks were utilized for each of the mandibles in the study. Each sample was 
statistically bootstrapped (1,000 resamples) to allow for further statistical sampling utilizing a 90% 
confidence interval to determine statistical significance. Geometric mean of each sample was used 
to scale the form matrix for each sample. Additional parameters and tests not presented in the 
results are provided in Appendix B. 
3.1.1.1 15-Day EDMA Results 
A total of 28 individuals (19 low dosage and nine high dosage) were evaluated within the 
15-day sample. These matrices represent the mean distance between each landmark for the two 
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groups. Unfortunately, due to unknown errors with the EDMA software and the dataset for this 
project, EDMA could not be conducted on the 15-day sample. The errors may be linked to scaling 
issues within the Amira software, the ability of the EDMA software to handle populations with 
large variance between landmark locations, or a combination of both. Contact was made with the 
software authors and researchers working with the rendered Amira files, but no consensus 
explanation could be reached. As such, the 15-day samples were not included in the EDMA 
analyses. As no outliers were seen in either Excel or GM analyses, it was concluded that the errors 
were in only the EDMA data. 
3.1.1.2 20-Day EDMA Results 
A total of 32 individuals were examined within the 20-day old mandibular sample (11 low 
dosage individuals and 21 high dosage individuals). Each linear distance for each subset was 
averaged across all individuals within the group to generate form matrices for the 20-day low 
dosage group (Table 6) and for the 20-day high dosage group (Table 7). To effectively remove 
size from these matrices, each value within the form matrices was again divided by the geometric 
mean of each sample (107.81 for the low dosage group, 108.78 for the high dosage group) to 
produce two new shape matrices: one for the 20-day low dosage group (Table 8) and one for the 
20-day high dosage group (Table 9). The omnibus test for the 20-day old sample produced a Z-
statistic of 0.3365 and associated 90% confidence interval (0.1444 to 0.5648), so the null 
hypothesis that the shapes of the two samples are the same was disproven. The shape matrices 
scaled by geometric mean were then subjected to the Monte Carlo resampling (1,000 resamples) 
to produce a shape-difference matrix between each landmark. This new shape-difference matrix 
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(SDM) was also sorted, lowest to highest, based on the arithmetic difference between each 
landmark (Table 10), and the 20 lowest and 20 highest of the group were plotted (Figure 21).  
 Within the 20-day sample, 15 linear distances rejected the null hypotheses of both groups 
having the same shape by having 90% confidence intervals that did not contain zero (Table 10). 
Fourteen of these involved Landmark 1 (anterior superior incisor alveolar rim). More specifically, 
the shape differences involving the position of the superior aspect of the alveolus at the incisor 
was significantly different in regards to every landmark with the exception of Landmark 13 (most 
inferior point along the mandibular symphysis; Table 10). Finally, the linear distance between 
Landmarks 5 and 6 (apex of the coronoid process and posterior base of the coronoid process), 
suggesting shape changes in this region (Figure 22). Shape changes were not significant in other 
posterior aspects of the mandible, specifically the condyle or mandibular angle. 
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Table 6. Mean form matrix for the 20-day low dose sample. 
 L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12 L13 L14 L15 L16 
L1 0                
L2 596.31 0               
L3 580.74 22.82 0              
L4 569.00 71.67 51.05 0             
L5 542.29 137.03 115.23 66.17 0            
L6 554.37 120.71 99.68 49.05 20.34 0           
L7 558.46 156.86 136.85 85.84 35.86 39.18 0          
L8 574.50 183.50 165.04 114.83 70.03 72.03 34.37 0         
L9 606.61 136.64 123.09 81.49 81.56 66.94 61.99 63.92 0        
L10 628.62 161.51 150.50 112.64 111.11 98.30 85.48 74.26 32.47 0       
L11 616.16 94.45 86.59 64.02 102.83 82.87 99.17 111.56 50.49 68.31 0      
L12 622.70 53.02 57.84 73.18 134.44 114.59 142.16 160.88 103.05 120.81 53.32 0     
L13 619.38 39.21 59.69 102.47 168.45 150.41 183.41 206.30 152.44 171.82 103.89 51.54 0    
L14 605.87 40.70 60.88 111.60 176.04 160.45 197.06 223.85 175.74 198.87 130.73 81.72 37.12 0   
L15 586.30 130.01 113.39 66.35 57.67 43.21 42.28 55.74 24.07 55.15 57.94 105.29 151.12 170.20 0  
L16 580.10 85.98 70.36 33.73 73.54 53.49 78.98 100.77 56.51 84.98 37.68 65.52 106.23 125.12 47.54 0 
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Table 7. Mean form matrix for 20-day high dose sample. 
 L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12 L13 L14 L15 L16 
L1 0                
L2 573.70 0               
L3 555.28 22.32 0              
L4 541.43 71.10 52.09 0             
L5 510.86 135.35 115.04 65.26 0            
L6 522.72 120.23 100.61 49.27 18.36 0           
L7 527.88 156.80 138.48 86.44 37.95 40.93 0          
L8 545.16 183.75 167.13 115.82 72.47 74.53 34.79 0         
L9 582.62 135.97 124.71 82.19 83.18 70.51 63.35 65.41 0        
L10 607.74 162.31 153.66 114.89 114.15 103.19 87.74 76.19 33.90 0       
L11 594.46 94.79 89.07 65.32 103.48 85.75 99.89 112.23 49.80 68.86 0      
L12 603.27 53.08 59.62 74.00 134.43 116.45 143.14 162.03 102.89 121.86 54.01 0     
L13 600.67 41.42 60.84 104.04 169.22 152.62 185.47 208.67 153.90 174.56 106.12 53.55 0    
L14 585.79 42.11 60.63 112.20 175.64 161.13 198.23 225.30 176.17 200.61 131.91 82.25 36.79 0   
L15 559.19 129.81 115.13 66.81 58.01 45.66 42.09 56.01 25.42 57.60 58.74 106.23 153.29 171.23 0  
L16 552.76 87.13 72.82 36.53 74.97 57.07 80.39 102.40 59.74 89.21 42.02 68.51 108.21 126.44 50.54 0 
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Table 8. Mean shape matrix for the 20-day low dose sample. 
 L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12 L13 L14 L15 L16 
L1 0                
L2 5.531 0               
L3 5.386 0.212 0              
L4 5.278 0.665 0.474 0             
L5 5.030 1.271 1.069 0.614 0            
L6 5.142 1.120 0.925 0.455 0.189 0           
L7 5.180 1.455 1.269 0.796 0.333 0.363 0          
L8 5.329 1.702 1.531 1.065 0.650 0.668 0.319 0         
L9 5.626 1.267 1.142 0.756 0.757 0.621 0.575 0.593 0        
L10 5.831 1.498 1.396 1.045 1.031 0.912 0.793 0.689 0.301 0       
L11 5.715 0.876 0.803 0.594 0.954 0.769 0.920 1.035 0.468 0.634 0      
L12 5.776 0.492 0.536 0.679 1.247 1.063 1.319 1.492 0.956 1.121 0.495 0     
L13 5.745 0.364 0.554 0.950 1.562 1.395 1.701 1.913 1.414 1.594 0.964 0.478 0    
L14 5.620 0.377 0.565 1.035 1.633 1.488 1.828 2.076 1.630 1.845 1.213 0.758 0.344 0   
L15 5.438 1.206 1.052 0.615 0.535 0.401 0.392 0.517 0.223 0.511 0.537 0.977 1.402 1.579 0  
L16 5.381 0.797 0.653 0.313 0.682 0.496 0.733 0.935 0.524 0.788 0.349 0.608 0.985 1.161 0.441 0 
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Table 9. Mean shape matrix for the 20-day high dose sample. 
 L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12 L13 L14 L15 L16 
L1 0                
L2 5.274 0               
L3 5.105 0.205 0              
L4 4.977 0.654 0.479 0             
L5 4.696 1.244 1.058 0.600 0            
L6 4.805 1.105 0.925 0.453 0.169 0           
L7 4.853 1.441 1.273 0.795 0.349 0.376 0          
L8 5.012 1.689 1.536 1.065 0.666 0.685 0.320 0         
L9 5.356 1.250 1.146 0.756 0.765 0.648 0.582 0.601 0        
L10 5.587 1.492 1.413 1.056 1.049 0.949 0.807 0.700 0.312 0       
L11 5.465 0.871 0.819 0.600 0.951 0.788 0.918 1.032 0.458 0.633 0      
L12 5.546 0.488 0.548 0.680 1.236 1.071 1.316 1.490 0.946 1.120 0.496 0     
L13 5.522 0.381 0.559 0.956 1.556 1.403 1.705 1.918 1.415 1.605 0.976 0.492 0    
L14 5.385 0.387 0.557 1.031 1.615 1.481 1.822 2.071 1.620 1.844 1.213 0.756 0.338 0   
L15 5.141 1.193 1.058 0.614 0.533 0.420 0.387 0.515 0.234 0.530 0.540 0.977 1.409 1.574 0  
L16 5.081 0.801 0.669 0.336 0.689 0.525 0.739 0.941 0.549 0.820 0.386 0.630 0.995 1.162 0.465 0 
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Table 10. Sorted shape difference matrix for the 20-day samples (low dose and high dose), 
with difference estimate, lower bound (LB), and upper bound (UB). 
No. Landmarks Estimate LB UB No. Landmarks Estimate LB UB 
1 L6 L10 -0.037 -0.080 0.004 31 L2 L14 -0.010 -0.030 0.011 
2 L11 L16 -0.037 -0.076 0.010 32 L13 L16 -0.009 -0.052 0.033 
3 L10 L16 -0.032 -0.082 0.017 33 L8 L9 -0.008 -0.028 0.011 
4 L6 L16 -0.028 -0.072 0.016 34 L5 L9 -0.008 -0.037 0.021 
5 L6 L9 -0.027 -0.057 0.003 35 L6 L13 -0.008 -0.059 0.043 
6 L9 L16 -0.025 -0.068 0.022 36 L6 L12 -0.008 -0.047 0.034 
7 L15 L16 -0.024 -0.062 0.015 37 L13 L15 -0.008 -0.056 0.038 
8 L4 L16 -0.023 -0.061 0.016 38 L7 L9 -0.007 -0.033 0.018 
9 L12 L16 -0.022 -0.071 0.029 39 L5 L16 -0.007 -0.053 0.040 
10 L6 L11 -0.020 -0.054 0.012 40 L4 L11 -0.007 -0.039 0.023 
11 L6 L15 -0.019 -0.039 0.001 41 L8 L16 -0.007 -0.044 0.031 
12 L5 L10 -0.019 -0.059 0.021 42 L3 L15 -0.007 -0.036 0.021 
13 L10 L15 -0.018 -0.044 0.007 43 L7 L16 -0.006 -0.042 0.029 
14 L2 L13 -0.017 -0.057 0.020 44 L4 L13 -0.006 -0.053 0.037 
15 L6 L8 -0.017 -0.042 0.008 45 L3 L13 -0.006 -0.049 0.034 
16 L3 L16 -0.017 -0.056 0.023 46 L3 L8 -0.006 -0.041 0.028 
17 L5 L8 -0.017 -0.043 0.010 47 L3 L4 -0.005 -0.021 0.010 
18 L3 L10 -0.017 -0.065 0.027 48 L8 L13 -0.005 -0.057 0.046 
19 L5 L7 -0.016 -0.037 0.005 49 L3 L9 -0.005 -0.043 0.031 
20 L3 L11 -0.016 -0.052 0.020 50 L7 L13 -0.004 -0.054 0.044 
21 L12 L13 -0.014 -0.038 0.010 51 L3 L7 -0.004 -0.032 0.023 
22 L7 L10 -0.014 -0.047 0.021 52 L2 L16 -0.004 -0.053 0.046 
23 L6 L7 -0.013 -0.032 0.006 53 L11 L15 -0.003 -0.026 0.021 
24 L11 L13 -0.012 -0.046 0.023 54 L11 L12 -0.002 -0.025 0.018 
25 L8 L10 -0.012 -0.039 0.014 55 L14 L16 -0.002 -0.055 0.048 
26 L3 L12 -0.012 -0.047 0.025 56 L4 L12 -0.002 -0.040 0.037 
27 L4 L10 -0.011 -0.052 0.030 57 L7 L8 -0.001 -0.017 0.014 
28 L10 L13 -0.011 -0.067 0.036 58 L9 L13 -0.001 -0.048 0.042 
29 L9 L10 -0.011 -0.025 0.003 59 L3 L6 0.000 -0.021 0.019 
30 L9 L15 -0.010 -0.026 0.006 60 L11 L14 0.000 -0.038 0.037 
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Table 10 (continued). Sorted shape difference matrix for the 20-day samples (low dose and 
high dose), with difference estimate, lower bound (LB), and upper bound (UB). 
No. Landmarks Estimate LB UB No. Landmarks Estimate LB UB 
61 L12 L15 0.000 -0.034 0.034 91 L9 L12 0.010 -0.019 0.038 
62 L4 L9 0.000 -0.031 0.030 92 L9 L11 0.010 -0.011 0.030 
63 L4 L8 0.000 -0.027 0.027 93 L9 L14 0.010 -0.036 0.054 
64 L10 L12 0.000 -0.031 0.030 94 L5 L12 0.011 -0.031 0.053 
65 L10 L14 0.000 -0.053 0.051 95 L2 L4 0.011 -0.013 0.036 
66 L10 L11 0.001 -0.024 0.025 96 L3 L5 0.011 -0.011 0.032 
67 L4 L15 0.001 -0.021 0.021 97 L2 L15 0.013 -0.021 0.044 
68 L7 L11 0.002 -0.029 0.032 98 L2 L8 0.013 -0.028 0.051 
69 L4 L7 0.002 -0.019 0.022 99 L2 L7 0.013 -0.025 0.048 
70 L5 L15 0.002 -0.019 0.023 100 L4 L5 0.014 -0.004 0.031 
71 L12 L14 0.002 -0.026 0.029 101 L2 L6 0.014 -0.024 0.045 
72 L4 L6 0.002 -0.013 0.017 102 L2 L9 0.017 -0.018 0.051 
73 L8 L15 0.002 -0.011 0.016 103 L5 L14 0.018 -0.025 0.062 
74 L5 L11 0.002 -0.034 0.035 104 L5 L6 0.020 0.009 0.030 
75 L7 L12 0.003 -0.038 0.043 105 L2 L5 0.027 -0.003 0.055 
76 L8 L12 0.003 -0.034 0.043 106 L1 L13 0.223 -0.003 0.467 
77 L8 L11 0.003 -0.026 0.033 107 L1 L12 0.230 0.005 0.477 
78 L4 L14 0.004 -0.031 0.038 108 L1 L14 0.234 0.011 0.473 
79 L2 L12 0.004 -0.025 0.031 109 L1 L10 0.244 0.008 0.479 
80 L14 L15 0.005 -0.040 0.047 110 L1 L11 0.250 0.029 0.490 
81 L2 L11 0.005 -0.028 0.037 111 L1 L2 0.257 0.043 0.493 
82 L8 L14 0.005 -0.048 0.054 112 L1 L9 0.270 0.044 0.500 
83 L7 L15 0.005 -0.010 0.020 113 L1 L3 0.282 0.071 0.514 
84 L7 L14 0.005 -0.040 0.050 114 L1 L15 0.297 0.081 0.522 
85 L2 L10 0.006 -0.038 0.048 115 L1 L16 0.299 0.085 0.532 
86 L13 L14 0.006 -0.022 0.032 116 L1 L4 0.300 0.092 0.525 
87 L2 L3 0.006 -0.012 0.026 117 L1 L8 0.317 0.097 0.541 
88 L5 L13 0.007 -0.047 0.058 118 L1 L7 0.327 0.116 0.550 
89 L6 L14 0.007 -0.034 0.050 119 L1 L5 0.333 0.123 0.556 
90 L3 L14 0.007 -0.008 0.035 120 L1 L6 0.337 0.128 0.561 
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Figure 21. High and low subsets of scaled linear distances for 20-day low and high dose samples. 
The 20 lowest (left half of the diagram) and 20 highest (right half of the diagram) represent the 40 
tails of scaled linear distances between landmarks with associated 90% confidence interval 
(bootstrapping with 1,000 resampled). Significantly different landmarks between the two samples 
(CI’s do not include zero) are shown in red. 
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Figure 22. Significant shape changes in the EDMA results between the 20-day low dosage 
and 20-day high dosage samples. Red lines indicate a significant (p< 0.10) increase in size, 
and blue lines indicate a significant (p< 0.10) decrease in size. 
 
3.1.1.3 25-Day EDMA Results 
Due to high variance within the population likely tied to AMIRA filters and rendering 
outputs of the micro-CT scans, EDMA was not possible on the 25-day low dosage group. In lieu 
of these data, the 25day control sample was compared to the 25-day high dosage group to 
determine and shape differences between the untreated sample and the population with the highest 
dosage. A total of 58 individuals were evaluated within the 25-day old sample (23 control 
specimens and 35 high dosage individuals). Similar to the 20-day samples, linear distance for each 
subset was averaged across all individuals within the group to create form matrices for the 25-day 
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control group (Table 11) and for the 25-day high dosage group (Table 12). Each matrix was again 
divided by the geometric mean of each sample (112.88 for the control group, 112.18 for the high 
dosage group) to produce two new shape matrices: one for the 25-day control group (Table 13) 
and one for the 25-day high dosage group (Table 14). The omnibus test for the 25-day old sample 
produced a Z-statistic of 0.43995 and associated 90% confidence interval (0.2029 to 0.66977), so 
the null hypotheses that the two sample shapes are the same was rejected. The shape matrices were 
then subjected to Monte Carlo resampling (1,000 resamples) to produce a shape-difference matrix 
between each landmark. This new shape-difference matrix (SDM) was sorted, lowest to highest, 
based on the arithmetic difference between each landmark (Table 15), and the 20 lowest and 20 
highest of the group were plotted (Figure 23).  
 Within the 25-day sample, nearly one third of the entire set of linear distances (n=120) was 
significantly different between the control group and the high dosage group, with 35 linear 
measurements having confidence intervals not containing zero (Table 15). Landmarks 2, 10, and 
11 (anterior edge of mental foramen, posterior tip of mandibular angle, and most superior point of 
the inferior border of the mandibular angle) were represented the most in the sorted linear distance 
estimate table, suggesting shape changes in these regions. Landmark 10 has 10 significantly 
different linear metrics between the two samples, while Landmarks 2 and 11 both have seven 
(Figure 23). Other shape changes are seen in nearly every other aspect of the mandible, including 
the coronoid process, condyle, inferior margin, and alveolus (Figure 24). Interestingly, Landmark 
1 did not have any significant shape differences between the control and high dose samples; this 
can be explained either by issues arising from the EDMA complications and data compilation, or 
from shape changes appearing at different ages within the sample. These arguments are explored 
further in the discussion section of this dissertation. 
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Table 11. Mean form matrix for the 25-day control sample. 
 L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12 L13 L14 L15 L16 
L1 0                
L2 578.04 0               
L3 559.46 22.10 0              
L4 547.44 69.44 51.12 0             
L5 511.50 139.89 119.91 71.51 0            
L6 526.18 123.42 104.27 54.06 20.48 0           
L7 532.00 161.35 143.43 92.43 38.86 41.75 0          
L8 553.03 188.29 172.22 121.71 74.56 75.95 36.00 0         
L9 592.22 143.61 132.87 89.87 88.35 74.23 66.10 64.57 0        
L10 620.92 170.97 162.89 123.48 121.07 108.68 93.01 78.06 35.36 0       
L11 603.86 93.82 89.10 65.63 109.41 89.31 106.39 118.49 58.50 78.93 0      
L12 612.25 54.82 61.95 74.26 140.45 120.51 148.76 166.99 110.14 129.94 52.19 0     
L13 609.43 44.04 63.07 104.42 175.70 157.44 191.64 214.47 162.10 183.63 105.17 54.58 0    
L14 592.44 44.54 62.87 113.21 182.78 166.94 205.26 232.21 185.68 210.90 132.18 84.36 38.15 0   
L15 566.79 132.60 118.54 70.63 61.39 46.79 45.12 57.94 27.52 62.14 62.63 109.22 157.14 176.21 0  
L16 562.01 88.60 75.04 39.06 79.82 59.84 84.71 106.30 65.41 96.27 42.35 69.94 110.22 129.85 52.50 0 
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Table 12. Mean form matrix for the 25-day high dose sample. 
 L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12 L13 L14 L15 L16 
L1 0                
L2 575.07 0               
L3 556.56 22.22 0              
L4 540.70 71.94 52.77 0             
L5 505.25 140.63 120.15 69.64 0            
L6 519.38 123.32 103.56 51.44 20.98 0           
L7 522.10 160.73 142.06 89.41 37.51 41.11 0          
L8 539.56 187.63 170.64 118.75 72.69 74.95 35.48 0         
L9 578.99 141.20 129.29 85.99 86.11 71.78 64.87 65.01 0        
L10 602.59 167.07 157.52 117.72 115.80 103.46 88.54 75.37 32.89 0       
L11 592.03 96.02 89.43 65.19 106.42 86.05 102.19 114.29 53.02 72.43 0      
L12 603.79 54.76 60.36 74.69 139.11 118.53 146.39 164.82 106.67 125.53 54.18 0     
L13 603.81 42.30 61.35 104.99 174.44 155.39 189.11 211.95 158.02 178.45 106.50 53.76 0    
L14 589.99 42.70 61.64 113.87 181.77 165.05 202.81 229.71 181.58 205.56 133.27 83.63 37.71 0   
L15 554.43 132.45 117.15 67.97 58.67 44.27 42.81 56.89 27.75 59.29 60.23 108.29 155.53 174.33 0  
L16 551.82 88.63 73.89 37.03 78.02 57.47 82.44 104.23 61.71 90.72 40.65 68.77 109.35 128.54 50.74 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
88 
 
Table 13. Mean shape matrix for the 25-day control sample. 
 L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12 L13 L14 L15 L16 
L1 0                
L2 5.121 0               
L3 4.956 0.196 0              
L4 4.850 0.615 0.453 0             
L5 4.531 1.239 1.062 0.634 0            
L6 4.661 1.093 0.924 0.479 0.181 0           
L7 4.713 1.429 1.271 0.819 0.344 0.370 0          
L8 4.899 1.668 1.526 1.078 0.661 0.673 0.319 0         
L9 5.246 1.272 1.177 0.796 0.783 0.658 0.586 0.572 0        
L10 5.501 1.515 1.443 1.094 1.073 0.963 0.824 0.691 0.313 0       
L11 5.349 0.831 0.789 0.581 0.969 0.791 0.943 1.050 0.518 0.699 0      
L12 5.424 0.486 0.549 0.658 1.244 1.068 1.318 1.479 0.976 1.151 0.462 0     
L13 5.399 0.390 0.559 0.925 1.556 1.395 1.698 1.900 1.436 1.627 0.932 0.484 0    
L14 5.248 0.395 0.557 1.003 1.619 1.479 1.818 2.057 1.645 1.868 1.171 0.747 0.338 0.000   
L15 5.021 1.175 1.050 0.626 0.544 0.415 0.400 0.513 0.244 0.550 0.555 0.968 1.392 1.561 0  
L16 4.979 0.785 0.665 0.346 0.707 0.530 0.750 0.942 0.579 0.853 0.375 0.620 0.976 1.150 0.465 0 
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Table 14. Mean shape matrix for the 25-day high dose sample. 
 L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12 L13 L14 L15 L16 
L1 0                
L2 5.197 0               
L3 5.029 0.201 0              
L4 4.886 0.650 0.477 0             
L5 4.566 1.271 1.086 0.629 0            
L6 4.693 1.114 0.936 0.465 0.190 0           
L7 4.718 1.452 1.284 0.808 0.339 0.371 0          
L8 4.876 1.695 1.542 1.073 0.657 0.677 0.321 0         
L9 5.232 1.276 1.168 0.777 0.778 0.649 0.586 0.587 0        
L10 5.445 1.510 1.423 1.064 1.046 0.935 0.800 0.681 0.297 0       
L11 5.350 0.868 0.808 0.589 0.962 0.778 0.923 1.033 0.479 0.655 0      
L12 5.456 0.495 0.545 0.675 1.257 1.071 1.323 1.489 0.964 1.134 0.490 0     
L13 5.456 0.382 0.554 0.949 1.576 1.404 1.709 1.915 1.428 1.613 0.962 0.486 0    
L14 5.331 0.386 0.557 1.029 1.643 1.491 1.833 2.076 1.641 1.858 1.204 0.756 0.341 0   
L15 5.010 1.197 1.059 0.614 0.530 0.400 0.387 0.514 0.251 0.536 0.544 0.979 1.405 1.575 0  
L16 4.986 0.801 0.668 0.335 0.705 0.519 0.745 0.942 0.558 0.820 0.367 0.621 0.988 1.162 0.458 0 
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Table 15. Sorted shape difference matrix for the 25-day samples (control and high dose), with 
difference estimate, lower bound (LB), and upper bound (UB). 
No. Landmarks Estimate LB UB No. Landmarks Estimate LB UB 
1 L1 L14 -0.083 -0.265 0.101 31 L8 L13 -0.015 -0.032 0.002 
2 L1 L2 -0.076 -0.254 0.104 32 L7 L14 -0.014 -0.036 0.009 
3 L1 L3 -0.073 -0.251 0.109 33 L14 L15 -0.014 -0.030 0.002 
4 L1 L13 -0.057 -0.235 0.115 34 L13 L15 -0.013 -0.028 0.001 
5 L2 L11 -0.037 -0.051 -0.022 35 L3 L7 -0.013 -0.031 0.005 
6 L1 L4 -0.036 -0.215 0.145 36 L5 L12 -0.013 -0.032 0.007 
7 L2 L4 -0.035 -0.046 -0.024 37 L6 L14 -0.013 -0.029 0.006 
8 L1 L5 -0.034 -0.219 0.152 38 L3 L6 -0.012 -0.024 0.002 
9 L11 L14 -0.033 -0.053 -0.014 39 L13 L16 -0.012 -0.029 0.004 
10 L1 L12 -0.032 -0.210 0.147 40 L14 L16 -0.011 -0.037 0.014 
11 L1 L6 -0.032 -0.217 0.149 41 L7 L13 -0.011 -0.031 0.009 
12 L2 L5 -0.032 -0.048 -0.015 42 L12 L15 -0.011 -0.023 0.001 
13 L11 L13 -0.031 -0.047 -0.014 43 L8 L12 -0.010 -0.027 0.008 
14 L2 L8 -0.027 -0.045 -0.010 44 L6 L13 -0.009 -0.027 0.010 
15 L11 L12 -0.027 -0.039 -0.016 45 L2 L12 -0.009 -0.022 0.004 
16 L4 L14 -0.026 -0.038 -0.014 46 L3 L15 -0.008 -0.020 0.002 
17 L3 L4 -0.024 -0.033 -0.015 47 L12 L14 -0.008 -0.026 0.009 
18 L4 L13 -0.024 -0.038 -0.010 48 L5 L6 -0.008 -0.017 0.000 
19 L3 L5 -0.023 -0.037 -0.008 49 L1 L16 -0.008 -0.182 0.172 
20 L5 L14 -0.023 -0.042 -0.004 50 L4 L11 -0.008 -0.021 0.006 
21 L2 L7 -0.023 -0.042 -0.004 51 L9 L15 -0.007 -0.017 0.003 
22 L2 L15 -0.022 -0.035 -0.009 52 L7 L12 -0.005 -0.024 0.013 
23 L2 L6 -0.021 -0.035 -0.006 53 L1 L7 -0.005 -0.187 0.173 
24 L5 L13 -0.020 -0.040 0.001 54 L2 L3 -0.005 -0.013 0.003 
25 L3 L11 -0.019 -0.032 -0.005 55 L6 L8 -0.004 -0.019 0.009 
26 L8 L14 -0.019 -0.038 0.001 56 L2 L9 -0.004 -0.018 0.010 
27 L4 L12 -0.017 -0.032 -0.001 57 L6 L12 -0.003 -0.020 0.014 
28 L3 L8 -0.016 -0.033 0.000 58 L3 L16 -0.003 -0.022 0.016 
29 L2 L16 -0.016 -0.039 0.007 59 L13 L14 -0.003 -0.019 0.012 
30 L8 L9 -0.015 -0.030 -0.001 60 L12 L13 -0.002 -0.014 0.009 
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Table 15 (continued). Sorted shape difference matrix for the 25-day samples (control and 
high dose), with difference estimate, lower bound (LB), and upper bound (UB). 
No. Landmarks Estimate LB UB No. Landmarks Estimate LB UB 
61 L12 L16 -0.002 -0.023 0.018 91 L10 L14 0.011 -0.011 0.031 
62 L7 L8 -0.002 -0.013 0.011 92 L4 L7 0.011 -0.008 0.029 
63 L6 L7 -0.002 -0.015 0.012 93 L1 L15 0.011 -0.168 0.188 
64 L8 L15 -0.001 -0.012 0.010 94 L4 L16 0.011 -0.009 0.032 
65 L7 L9 -0.001 -0.017 0.017 95 L4 L15 0.011 -0.001 0.023 
66 L1 L11 0.000 -0.179 0.176 96 L9 L12 0.012 0.002 0.023 
67 L8 L16 0.000 -0.021 0.021 97 L7 L15 0.013 0.001 0.026 
68 L3 L14 0.000 -0.010 0.011 98 L6 L11 0.014 -0.003 0.031 
69 L5 L16 0.002 -0.020 0.027 99 L5 L15 0.014 -0.001 0.028 
70 L3 L12 0.003 -0.010 0.016 100 L4 L6 0.014 0.001 0.028 
71 L5 L8 0.004 -0.013 0.019 101 L10 L13 0.014 -0.005 0.033 
72 L9 L14 0.004 -0.015 0.022 102 L1 L9 0.014 -0.163 0.189 
73 L4 L5 0.004 -0.012 0.021 103 L6 L15 0.015 0.002 0.026 
74 L3 L13 0.004 -0.006 0.015 104 L10 L15 0.015 0.000 0.029 
75 L5 L9 0.005 -0.016 0.024 105 L9 L10 0.016 0.004 0.027 
76 L2 L10 0.005 -0.014 0.023 106 L10 L12 0.017 0.001 0.032 
77 L4 L8 0.005 -0.012 0.021 107 L8 L11 0.017 -0.002 0.035 
78 L5 L7 0.005 -0.009 0.018 108 L4 L9 0.019 0.002 0.035 
79 L7 L16 0.005 -0.014 0.026 109 L7 L11 0.019 -0.001 0.037 
80 L15 L16 0.007 -0.014 0.026 110 L3 L10 0.020 0.001 0.038 
81 L5 L11 0.007 -0.012 0.027 111 L9 L16 0.022 0.000 0.040 
82 L2 L13 0.008 -0.004 0.020 112 L1 L8 0.023 -0.162 0.202 
83 L11 L16 0.008 -0.015 0.029 113 L7 L10 0.024 0.002 0.044 
84 L9 L13 0.008 -0.006 0.022 114 L5 L10 0.026 0.001 0.049 
85 L2 L14 0.009 -0.002 0.020 115 L6 L10 0.028 0.005 0.049 
86 L3 L9 0.009 -0.005 0.023 116 L4 L10 0.030 0.009 0.050 
87 L6 L9 0.009 -0.009 0.026 117 L10 L16 0.033 0.006 0.057 
88 L8 L10 0.010 -0.006 0.027 118 L9 L11 0.039 0.026 0.053 
89 L11 L15 0.011 -0.002 0.024 119 L10 L11 0.045 0.026 0.062 
90 L6 L16 0.011 -0.009 0.032 120 L1 L10 0.055 -0.118 0.227 
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Figure 23. High and low subsets of scaled linear distances for 25-day control and high dose 
samples. The 20 lowest (left half of the diagram) and 20 highest (right half of the diagram) 
represent the 40 tails of scaled linear distances between landmarks with associated 90% 
confidence interval (bootstrapping with 1,000 resampled). Significantly different 
landmarks between the two samples (CI’s do not include zero) are shown in red. 
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Figure 24. Significant shape changes in the EDMA results between the 25-day control and 
25-day high dosage samples. Red lines indicate a significant (p< 0.10) increase in size, and 
blue lines indicate a significant (p< 0.10) decrease in size. 
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3.1.2  EDMA Results Summary 
Overall, the EDMA results show marked shape changes between dosage groups for both 
age groups within the sample. These results suggest shape changes in the 20-day sample occur 
primarily in the anterior aspect of the mandible, primarily the position of the incisor. The 25-day 
results, albeit using control rather than low dose samples due to complications and errors that could 
not be reconciled with WINEDMA, demonstrate marked shape changes in the posterior aspect of 
the mandible, namely the coronoid process, mandibular condyle, and the angle of the mandible. 
The cause of these differences across age groups is not readily apparent, and is explored further in 
the Discussion chapter of this dissertation. The high variance seen in many of the landmarks could 
be indicative or EDMA errors, though it was evident in test runs utilizing even high numbers of 
resamples (2,000 to 10,000 runs). 
3.2 GEOMETRIC MORPHOMETRIC RESULTS 
Geometric morphometric analysis revealed many interesting aspects of offspring 
mandibular shape change as both age and treatment level increased. The analyses were conducted 
on the entire group, allowing for estimation of shape changes between the three age groups. The 
offspring sample was also evaluated within each age group to determine any mandibular shape 
changes within the varying dosage groups. Principle component analysis (PCA) was conducted 
across all three age groups and on the overall sample combined. Due to the loss of medium dose 
data and overall smaller sample sizes within each group, canonical variate analysis (CVA) was 
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only conducted using the entire sample, corrected for the effects of sex, to better describe shape 
changes between treatment groups. 
 
3.2.1  ANOVA 
All specimens were evaluated using PCA to determine any shape changes that occurred as 
a result of thyroxine dosage. All mandible landmark data were subjected to a Procrustes ANOVA, 
comparing both treatment groups and ages, to determine if significant differences exist between 
the samples. Within MorphoJ, ANOVA tests were conducted comparing both centroid size and 
Procrustes coordinates; significant differences (p< 0.05) between centroid sizes suggest size 
differences between populations, whereas significant differences (p< 0.05) between Procrustes 
coordinates suggest shape differences between the groups.  
ANOVA tests found significant size (p= 0.0051) and shape (p< 0.001) differences between 
treatment groups within the combined mandibular landmark data (Table 16). This result suggests 
that dosage does, in fact, have a significant effect on mandibular shape. Further ANOVA tests 
found significant centroid size (p< 0.001) and Procrustes coordinate (p< 0.001) differences 
between age groups within the combined mandibular sample (Table 16). These results do not 
necessarily suggest that dosage is the prime cause of size and shape differences between the age 
groups, as confounding factors (e.g., sex) may also play primary roles in the ontogeny of offspring 
mandible. 
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Table 16. ANOVA results for treatment for both size (centroid) and shape (Procrustes 
coordinates) for the combined landmark data. 
  SS MS df F p 
T
re
at
m
en
t 
Centroid Size      
Individual 3463.3 1154.4 3 4.37 0.005** 
Residuals 62641.7 264.3 237   
Procrustes Coordinates      
Individual 0.012 <0.0001 123 2.64 <0.001** 
Residuals 0.351 <0.0001 9717   
A
ge
 
Centroid Size      
Individual 34448.8 17224.4 2 129.5 <0.001** 
Residuals 31656.2 133.0 238   
Procrustes Coordinates      
Individual 0.065 0.0008 82 26.23 <0.001** 
Residuals 0.297 <0.0001 9758   
**indicates significant (p<0.05) differences within the group 
 
Overall, PC analysis of the sample demonstrated shape differences across all three age 
groups. These changes can be explained as differences arising from thyroxine dosage as age of the 
sample increased, but could also be explained as sex differences within the sample. To ensure that 
the shape changes seen in the GM analyses of the samples were not a direct result of either 
sampling bias in sex or size differences between the sexes, ANOVA tests were again run using the 
Procrustes distances of the control groups for each age. Significant results (p< 0.05) between sexes 
in the Procrustes distances within the untreated control groups suggest that sex may explain the 
shape differences more than thyroxine dosage. Due to the loss of sex data in the 15-day control 
group, the tests could only be run on the 20- and 25-day samples. Within each of these two age 
groups, the control samples were imported in to MorphoJ and given a Procrustes fit. ANOVA tests 
between males and females were then run on both the centroid sizes and Procrustes coordinates; 
significant differences (p< 0.05) in the centroid size in a group suggests that there are size 
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differences between the sexes, while significant differences (p< 0.05) between the Procrustes 
coordinates suggests that there are shape differences between females.  
Using sex as the individual classifier with both samples, the ANOVA tests did not show 
any significant differences in centroid size or Procrustes coordinate differences between males and 
females in either the 20-day or 25-day samples (Table 17). These results within the control groups 
demonstrate that sexual dimorphism does not result in either size or shape differences within the 
sample mandibular sample. Therefore, any resulting size or shape differences seen in the sample 
are best explained by differences in thyroxine dosage. 
 
Table 17. ANOVA results comparing sex for both size (centroid) and shape (Procrustes 
coordinates) within the 20-day and 25-day samples. 
  SS MS df F p 
20
-d
ay
 
Sa
m
pl
e 
Centroid Size      
Individual 74.32 74.32 1 0.42 0.5235 
Residuals 977.81 175.17 17   
Procrustes Coordinates      
Individual 0.001 <0.001 95 0.95 0.6133 
Residuals 0.021 <0.001 1615   
25
-d
ay
 
Sa
m
pl
e 
Centroid Size      
Individual 54.81 54.81 1 0.29 0.5932 
Residuals 3912.14 186.29 21   
Procrustes Coordinates      
Individual 0.001 <0.001 95 1.02 0.4234 
Residuals 0.022 <0.001 1995   
**indicates significant (p<0.05) differences within the group 
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3.2.2  Principle Component Analysis Results 
Within each age group, principal component scores were exported from MorphoJ and 
imported in to SPSS for ANOVA tests to identify significant differences between principle 
components (PC’s) within each age group. Significant (p <0.05) results for a PC indicate that that 
particular PC explains shape differences between samples and should be further evaluated. Further 
Bonferroni corrections were applied within SPSS to evaluate p-values for each PC to determine 
the interaction of each PC with each treatment group. The relevant PC’s are described within each 
age group below, and results of the ANOVA are presented in Appendix C.  
 
3.2.1.1 15-Day Sample 
Due to loss of medium dose data, only control, low, and high dosage offspring were 
evaluated for the 15-day old sample (n= 49 individuals). A total of 41 PC’s were extracted to 
explain 100% of the overall shape variation seen within the 15-day sample (Figure 25), with more 
than 90% of all shape variation was explained by the first 15 PC’s (Table 18). Only one principle 
component within the 15-day old sample, PC 9 (3.5% of all variation within the sample), 
demonstrated significant differences (p=0.013) between the low- and high dosage groups in 
preliminary ANOVA tests. This PC also demonstrated a distinct separation of treatment groups 
(Figure 26). PC9 is associated with pronounced shape changes in the high dose group in nearly all 
aspects of the mandible most notably an anterior movement in the coronoid process and superior 
movement of the mandibular angle; both of these shape changes appear as reduction in both 
regions (Figure 27). There is also an anterior movement of Landmark 2 (mental foramen) and a 
posterior and lingual displacement of Landmark 16 (mandibular foramen). Shape changes 
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described by PC9 also demonstrate a marked rotation of the mandibular condyle as dosage 
increases (Figure 27). 
 
Table 18. PCA results accounting for over 90% of all shape 
variation within the 15-day old sample. 
PC Eigenvalues % Variance Cumulative Variance 
1. 0.00025826 18.288 18.288 
2. 0.00022402 15.863 34.151 
3. 0.00015834 11.212 45.363 
4. 0.00011954 8.465 53.828 
5. 0.00009445 6.688 60.516 
6. 0.00008003 5.667 66.183 
7. 0.00006953 4.923 71.106 
8. 0.00006227 4.409 75.515 
9. 0.00004930 3.491 79.007 
10. 0.00004214 2.984 81.990 
11. 0.00003031 2.146 84.137 
12. 0.00002594 1.837 85.973 
13. 0.00002201 1.558 87.532 
14. 0.00002050 1.451 88.983 
15. 0.00001897 1.343 90.326 
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Figure 25. Eigenvalues for the 15-day old sample displaying the % of 
shape variation explained by each principle component.   
 
 
Figure 26. Scatterplot demonstrating separation of treatment groups 
along PC9 axis.  Ellipses represent 90% confidence for sample means. 
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Figure 27. Wireframe deformations for PC9 within the 15-day old sample (scaling 
factor = 0.1). The light blue wireframe represents the mean shape of the 15-day old 
sample, and the dark blue represents the shape changes towards the high dosage 
group described by the PC. 
  
Overall, GM analysis of the 15-day old sample showed shape changes throughout the 
mandible. PCA demonstrates that these shape changes occur primarily in the anterior-posterior 
dimensions, with minor changes appearing in the mediolateral plane. The most apparent of the 
shape changes occurred in the coronoid process and angle of the mandible, with mediolateral 
rotation of the mandibular condyle.  
 
 
 
102 
 
3.2.1.2 20-Day Sample 
A total of 41 PC’s were calculated for the 20-day old sample (n= 74 individuals), and 
included all dosage groups. The first 15 PC’s accounted for 90% of all variation within the sample 
(Table 19), with the first four PC’s explaining roughly 50% of all variation (Figure 28). Within the 
20-day sample, preliminary ANOVA results suggest PC3 demonstrated significant difference (p= 
0.035) between treatment groups. These results are corroborated by a clear distinction between 
treatment groups in a scatterplot of PC scores, particularly between the control group and treatment 
groups (Figure 29). The shape changes associated with PC3 (11.5% of all variation within the 
sample) are seen a reduction of the coronoid process and mandibular angle in the high dosage 
group, a posterior movement of the mandibular condyles, and slight anterior movement of the 
mental foramen (Figure 30). A distinct narrowing of the mandible can be seen in the mandibular 
condyle, with all landmarks in this region demonstrating a marking change in location towards the 
midline of the mandible as thyroxine dose increases (Figure 30). 
Table 19. PCA results accounting for over 90% of all shape 
variation within the 20-day old sample. 
PC Eigenvalues % Variance Cumulative Variance 
1. 0.00020160 15.706 15.706 
2. 0.00016911 13.176 28.882 
3. 0.00014799 11.530 40.412 
4. 0.00011177 8.708 49.120 
5. 0.00009384 7.311 56.431 
6. 0.00008296 6.464 62.894 
7. 0.00006438 5.016 67.910 
8. 0.00005346 4.165 72.075 
9. 0.00004964 3.867 75.943 
10. 0.00003753 2.924 78.867 
11. 0.00003412 2.658 81.525 
12. 0.00002999 2.337 83.862 
13. 0.00002567 2.000 85.862 
14. 0.00002454 1.912 87.774 
15. 0.00001957 1.525 89.299 
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Figure 28. Eigenvalues for the 20-day old sample displaying the % of 
shape variation explained by each principle component.   
 
 
Figure 29. Scatterplot demonstrating separation of treatment groups 
along PC3 axis.  Ellipses represent 90% confidence for sample means. 
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Figure 30. Wireframe deformations for PC3 (scaling factor = 0.1). The light blue 
wireframe represents the mean shape of the 20-day old sample, and the dark blue 
represents the shape changes described by the PC. 
 
Overall shape changes seen in the 20-day sample are more apparent than those seen in the 
15-day sample, though the regions are the same: coronoid process, mandibular angle, and 
mandibular condyles. Shape changes are also seen in the inferior aspect of the mandible in the 
mediolateral dimension as dose increases. 
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3.2.1.3 25-Day Sample 
Forty-one PC’s were calculated for the 25-day offspring (n= 118 individuals) across all 
dosage groups, with the first 18 accounting over 90% of all variation within the sample (Table 20 
and Figure 31). Preliminary ANOVA results show eight PC’s with significant differences (p< 0.05) 
in shape (Appendix C). These eight PC’s also demonstrate substantial separation between the 
control group and treatment groups (Figure 32). Of the eight significant PC’s, only five account 
for more than 3% of total variation: PC1, PC3, PC5, PC6, and PC7 (Table 20). 
  
Table 20. PCA results accounting for over 90% of all shape 
variation within the 25-day old sample. 
PC Eigenvalues % Variance Cumulative Variance 
1. 0.00020352 16.724 16.724 
2. 0.00016926 13.908 30.631 
3. 0.00011288 9.275 39.907 
4. 0.00009083 7.464 47.370 
5. 0.00007700 6.327 53.698 
6. 0.00006842 5.622 59.320 
7. 0.00006427 5.281 64.601 
8. 0.00005320 4.371 68.972 
9. 0.00004156 3.415 72.387 
10. 0.00003596 2.954 75.341 
11. 0.00003181 2.614 77.955 
12. 0.00002813 2.311 80.266 
13. 0.00002458 2.020 82.286 
14. 0.00002357 1.936 84.222 
15. 0.00002207 1.814 86.036 
16. 0.00001630 1.340 87.376 
17. 0.00001571 1.291 88.667 
18. 0.00001465 1.204 89.871 
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Figure 31. Eigenvalues for the 25-day old sample displaying the % of 
shape variation explained by each principle component. 
 
  
  
Figure 32. Scatterplot demonstrating separation of treatment groups by PC’s along 
both axes.  Ellipses represent 90% confidence for sample means. 
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Shape changes associated with PC1 (16.7% of overall variation) are primarily associated 
with the angle of the mandible in the high dosage group, with minor changes with the alveolus 
near the incisor and near the mandibular condyles; these changes are also associated with a medial 
movement of the condyles (Figure 33). The shape changes explained by PC3 (9.3% of overall 
variation) also involve the angle of the mandible and alveolus near the incisor, but are much more 
marked in the coronoid process and mandibular condyles, as well as minor shape changes along 
the alveolus of the molar as dose increases (Figure 33). PC5 and PC6, accounting for a combined 
12% of overall variation, are associated with shape changes throughout the mandible, most notably 
in the mandibular condyles and coronoid process, though there is very little medial-lateral shape 
change in either PC (Figure 34). The shape changes explained by PC7 (5.3% of overall variation) 
are also located in the posterior aspect of the mandible, though the changes in the anterior mandible 
are drastically reduced (Figure 35). 
Overall, the shape changes seen in the 25-day sample involve nearly all aspects of the 
mandible as thyroxine dose increases, with the most marked changes seen in the posterior portion: 
mandibular condyle, mandibular angle, and coronoid process. These changes are also more marked 
than those seen in either the 15- or 20-day samples, especially in regards to the condyle and 
coronoid process.  
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Figure 33. Wireframe deformations for PC1 and PC3 (scaling factor = 0.1). The light blue 
wireframe represents the mean shape of the 25-day old sample, and the dark blue 
represents the shape changes described by the PC. 
 
 
 
  
  
Figure 34. Wireframe deformations for PC5 and PC6 (scaling factor = 0.1). The light blue 
wireframe represents the mean shape of the 25-day old sample, and the dark blue 
represents the shape changes described by the PC. 
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Figure 35. Wireframe deformations for PC7 (scaling factor = 0.1). The light blue 
wireframe represents the mean shape of the 25-day old sample, and the dark blue 
represents the shape changes described by the PC. 
 
3.2.3  Canonical Variate Analysis Results 
Due to the smaller samples size and missing data for some subgroups, canonical variance 
analysis was conducted on the Procrustes transformation of the combined data using the MorphoJ 
software. Canonical variate analysis allows comparison between dosage groups after potential 
confounding factors have been regressed out of the sample. Furthermore, this method allows 
comparison between dosage groups in some of smaller sample sizes present in groups within the 
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present sample. Age and centroid size were set as covariates and regressed out within the program, 
and a new covariation matrix was created on the residuals of the regression for CVA analysis. This 
was done regressing age out of the sample and performing CVA on the residuals. 
 
3.3.2.1 Combined Mandibular Sample 
For the 241 specimens within the combined sample, CVA using 5,000 permutations 
produces significant differences (p< 0.001) between the four treatment groups in both Procrustes 
distance and Mahalanobis distances (Table 21), which are more clearly demonstrated in the group 
clustering of differences between treatment groups (Figure 36). Canonical variate 1 (CV1) 
accounts for 54.7% of the overall variance related to the high dose group, with CV2 accounting 
for 27.7% and CV3 the remaining 17.7% of variation. The mandibular shape changes associated 
with each CV are depicted as wireframe deformations demonstrating the variation related to 
increased dosage explained by the permutations (Figure 37-Figure 39). 
 
Table 21. Between group distance statistics (p-values) from CVA for 
all mandibles, with Procrustes distance above the diagonal and 
Mahalanobis distance below the diagonal. 
 Control Low Medium High 
Control - 0.0008* 0.0026 0.0002* 
Low <0.0001* - 0.0008* 0.1616 
Medium <0.0001* <0.0001* - 0.0078 
High <0.0001* 0.0010* <0.0001* - 
*P<0.001 based on 5,000 permutations 
 
Canonical variate analysis demonstrates marked shape changes between treatment groups 
once corrected for age. CV1, which accounts for more than half of all variation seen in the 
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combined sample, is associated with shape changes throughout the mandible, and more 
pronounced changes in the coronoid process, mandibular angle, and alveolus near the incisor 
(Figure 37). This CV is also linked to mediolateral shape changes of the inferior margin of the 
mandible (Landmark 13) and the anterior positioning of the mental foramen (Landmark 2; Figure 
37). 
  
Figure 36. Canonical variance analysis of the combined sample based on Procrustes 
coordinates demonstrating grouping produced by the three CV’s (90% confidence for 
sample means).  
 
 Accounting for almost one-third of all shape variation within the combined sample, CV2 
also displays prominent shape changes in the coronoid process, mandibular angle, and alveolus of 
the incisor, with added variation in the position and orientation of the mandibular condyle (Figure 
38). Mediolateral shape changes associated with CV2 are minor in comparison to CV1, with 
minimal shape changes near the alveolus of the incisor (Landmarks 1 and 14). As with the first 
two CV’s, CV3 encapsulates shape changes primarily in the posterior mandible (coronoid process, 
112 
 
mandibular condyle, and mandibular angle), with only minor shape changes in the anterior 
mandible (Figure 39). 
 
 
 
Figure 37. Canonical variance analysis of the combined sample demonstrating wireframe 
deformations of shape variation explained by CV1 (54.7% of all variation within the sample. 
The light blue represents the non-deformed shape, and the dark blue the deformed shape of 
CV1 related to the high dose group (scaling factor = 10.0).  
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Figure 38. Canonical variance analysis of the combined sample demonstrating 
wireframe deformations of shape variation explained by CV2 (27.7% of all variation 
within the sample. The light blue represents the non-deformed shape, and the dark 
blue the deformed shape of CV2 (scaling factor = 10.0).  
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Figure 39. Canonical variance analysis of the combined sample demonstrating 
wireframe deformations of shape variation explained by CV3 (17.7% of all variation 
within the sample. The light blue represents the non-deformed shape, and the dark 
blue the deformed shape of CV3 (scaling factor = 10.0). 
 
Overall, CVA on the combined data once corrected for age demonstrated noticeable shape 
changes in the mandible in regards to dosage. The grouping of the different treatment groups 
(Figure 36) corroborates the notable variation explained seen in the wireframe reconstructions 
(Figure 37-Figure 39). As previously stated, ANOVA tests on the Procrustes distances and centroid 
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sizes demonstrates no statistical difference between male and females in control groups, precluding 
sex as an explanatory factor in these shape changes. The shape changes seen in CVA also mirror 
those seen in PCA, suggesting an overall shape change within the sample associated with thyroxine 
dosage. 
3.2.4  GM RESULTS SUMMARY 
Shape changes seen in the GM results demonstrate marked shape changes in the mandible 
across both age and dosage groups. These shape changes could be linked to thyroxine dosage, or 
could be explained by other biomechanical factors as a result of maternal thyrotoxicosis. Across 
all three age groups, shape changes were particular apparent in the coronoid process, mandibular 
condyle, angle of the mandible, and the alveolus of the incisor. These changes are similar to those 
seen in the EDMA analyses, but it should be restated that EDMA and GM results are not effective 
under direct comparison, and should be treated as compliments to one another (Lele and 
Richtsmeier 1991). The shape changes seen in the GM results and relevant discussion regarding 
similarities and differences to the EDMA results are discussed in the Discussion chapter of this 
dissertation.  
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4.0  DISCUSSION 
This study compared the micro-CT images of the offspring of pregnant dams given control, 
low, medium, and high doses of thyroxine during pregnancy in an attempt to quantify and explain 
shape changes in the offspring mandible. As discussed in Chapter 1 of this dissertation, thyroxine 
has an effect on bone growth and development, specifically in the cranial base and other areas of 
endochondral ossification. What is not entirely clear is the role of maternal thyroxine in the growth 
and development of the offspring mandible, and bone with complex formation process involving 
aspects of intramembranous and endochondral ossification, and formation and development of 
secondary cartilage in the condyles. This research utilized two separate methods of evaluating and 
conceptualizing shape changes in biological samples: Euclidean Distance Matrix Analysis 
(EDMA) and geometric morphometric (GM) analysis. These two methodologies were not included 
to test, prove, or disprove one another, but rather to complement each other and better describe the 
shape changes, if any, that occur in both age and dosage ranges. These variations could result from 
embryological changes in the mandible itself, biomechanical changes either pre- or postnatal 
associated with shape changes in the cranial base, muscles of mastication, or behavioral changes 
related to chewing, or as a result of unanticipated changes as a result of the administration of 
levothyroxine.  
One overarching hypothesis was proposed at the outset of this study: 
Mice exposed to exogenous thyroxine during fetal development will demonstrate altered 
mandibular shape compared to unexposed mice. 
Three secondary hypotheses were also proposed: 
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(1) The regions of shape change in the mandible will be in areas associated with muscle
attachment (e.g., gonial angle, coronoid process).
(2) The shape changes in exposed mice will be more pronounced as age increases.
(3) The shape changes in exposed mice will be more pronounced as dosage increases.
The results of both the EDMA and GM analyses paint a complicated picture of shape 
changes across both age and dosage groups within the present sample. Both methods demonstrate 
marked shape changes between treated and untreated group, suggesting that the overarching 
hypothesis set forth is supported: offspring exposed to exogenous thyroxine during embryological 
development demonstrate shape changes in the mandible. The results related to the secondary 
hypotheses, however, provide a more complex picture, with each method displaying varying shape 
changes in different regions of the mandible. These differences can be explained by multiple 
causes, ranging from cellular, biomechanical, behavioral, or even issues related to data collection 
and differences between the evaluation methods. To better conceptualize what is happening with 
the present data, the separate results from each method will be further discussed below. 
4.1.1 EDMA Shape Changes 
At first glance, EDMA results demonstrate marked shape changes in mandible shape.  The 
data were separated in to age groups (15-, 20-, and 25-day samples) to test both the overall 
hypotheses and the three secondary hypotheses. Unfortunately, due to unresolvable errors with 
both the data and software, the 15-day sample had to be removed from analysis. In looking for 
significant differences between the treated and untreated samples, only the 20-day sample could 
support or disprove the overall hypotheses. However, the three secondary hypotheses could all be 
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questioned using high dosage samples. The secondary hypotheses assume that the high dosage 
samples in both age groups should show increased shape changes when compared to the low 
dosage groups. Furthermore, the high dosage groups in the 25-day sample should exhibit more 
marked shape changes than those seen in the 20-day sample. Finally, the shape changes seen, 
particularly those in the high dosage group, should be seen in areas of muscle attachment, such as 
the coronoid process or mandibular angle. 
To better visualize the shape changes presented in the EDMA results, the significant shape 
changes between landmarks (those with 90% confidence intervals not containing zero after 1,000 
resamples) can be mapped on to mandible images to better conceptualize shape changes. Within 
the 20-day sample, 15 linear distances were significantly different between the low and high 
dosage groups (see Table 10). All of the significant shape changes in the 20-day sample involve 
an increase in size, primarily in the overall length of the anterior mandible (Figure 22). In fact, the 
location of the incisor (Landmark 1) is significantly more anterior in every linear distance in the 
mandible with the exception of Landmark 13, strongly indicating an overall increase in mandibular 
size in the anterior direction. There is no reduction in size seen anywhere in the 20-day mandibular 
sample. 
The overall lengthening of the mandible in the 20-day sample supports the overarching 
hypotheses of this dissertation, as well as the secondary hypotheses regarding dose dependence. 
The first secondary hypotheses regarding areas of change at sites of muscle attachment is also 
supported by this sample, at least to a small degree, as there are shape changes associated with the 
attachment site of the temporalis muscle at the coronoid process. The overall increase in size, as 
well as increase in linear measurements increasing in size, supports the other secondary hypothesis 
that shape changes will increase with age. These shape changes can be explained as compensatory 
119 
 
growth in regards to changing cranial base shape. The 20-day sample does show a lack of width 
change anywhere in the mandible, suggesting that there is little to no mediolateral shape change 
within the sample.  
The 25-day low dosage sample was removed from EDMA analysis due to a large number 
of software errors when attempting shape analyses. These errors, suggesting either large variance 
within one particular landmark, could be related to scaling and rendering issues with the original 
micro-CT scans. As such, the 25-control sample was used in comparison to the 25-day high dosage 
sample. Based on the 20-day sample results, one would expect the shape differences to be much 
more pronounced; this is demonstrated clearly by the 35 linear distances that were statistically 
significant (p< 0.10) between the control and high dosage group (see Table 15). Many linear 
distances within the 25-day sample displayed very large confidence intervals, further suggesting 
that EDMA may have difficulty dealing with the scaling of the present dataset. According to the 
EDMA results, increases in size of the mandibular angle were seen with nearly all other aspects of 
the mandibular body (Figure 24). The shape changes in this region of the mandible were also 
apparent in the mediolateral dimension, with significant (p <0.10) widening of the posterior 
mandible. Concurrent with these size increases were decreases associated with the anterior 
mandible, namely the mental foramen and aspects of the mandibular body not associated with the 
alveolus (Figure 24). These changes between the superior and inferior margins of the mandibular 
body are also mirror in a reduction in height of the coronoid process and reduction in size between 
the posterior aspect of the condyle and the body of the mandible.  
The size changes seen in the 25-day sample once again support the overall hypotheses that 
exogenous thyroxine will alter the overall shape of the offspring mandible. The 25-day EDMA 
comparison also supports the first and third secondary hypotheses, suggesting that increased 
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dosage is associated with an increase in shape changes. Finally, the 25-day sample demonstrates 
marked changes in the areas associated with muscle attachments, specifically the attachment of 
the masseter and medial pterygoid at the mandibular angle (Figure 24). The observed shape 
changes are suggestive of a number of possible explanatory factors. The mandible could be 
compensating for overall cranial base growth, where the high dosage individuals exhibit significant 
growth changes affecting both condyle location and occlusion. According to Enlow and Moss, this 
manner of shape change could explain the mandible lengthening to meet both occlusal demands 
and accommodate condylar change (Moss and Rankow 1968; Enlow 1982; Enlow 1990; Enlow 
and Hans 1996).  
The increase in size of the mandibular angle is particularly interesting, as no shape 
increases were seen in this region in either of the earlier age groups. Existing literature suggests 
that this is a result of increased biomechanical demands by the muscles of the region (masseter, 
medial pterygoid), though no soft tissue was preserved for this study to determine if this is the 
case. The reduction in size related to the location of the mental foramen could be cause by two 
potential shape changes: a posterior movement of the foramen itself, or an overall flexion of the 
entire mandible (seen as a clockwise increase in growth in the images in this project). The later 
theory is supported by the 20-day sample, as it exhibits an increase in size in the anterior aspect of 
the mandible (Figure 22). However, caution must be place in such a straight-forward explanation 
of the size changes in the 25-day sample, as it assumes that the thyroxine is affecting only the bone 
and cartilage of the mandible and not the musculature, teeth, mastication process, or occlusion.  
Overall, the shape changes seen between the 25-day control and high dosage groups 
suggest that all proposed hypotheses be supported. With nearly one third of all linear distances 
exhibiting shape changes in the 25-day sample, far more than that seen in the 20-day sample, it is 
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possible that increased age is directly linked to increase shape changes; however, the comparisons 
allowed by EDMA between the 20- and 25-day sample are limited to dosage, and age changes 
between the two samples cannot be ruled out as contributing factor to the observed shape changes. 
It is also apparent that the increased dosage is causing increased shape changes, as demonstrated 
by the low and high dose comparisons in the youngest sample. The areas of change are seen 
throughout the mandible, and not all are associated with muscle attachments, suggesting this topic 
be addressed with increased scrutiny in the future. 
Overall, the EDMA analyses demonstrate marked shape changes in both tested age groups 
and dosages, and all of the proposed hypotheses are supported. Both of the age groups demonstrate 
shape changes between either the control or low dosage groups and the high dosage groups. The 
shape changes seen in the EDMA results also increase with age and with dosage. The one 
questionable result involved the secondary hypotheses concerning shape changes occurring at 
areas of muscle attachment. While this was certainly true of the 25-day sample, it is only associated 
with changes of the coronoid process in the 20-day sample. This could be the result of the thyroxine 
causing shape changes in different regions of the mandible at different times, or these changes not 
becoming apparent until a later age. To better answer these questions, daily samples would be 
necessary. Furthermore, the loss of EDMA data of the 15-day controls and 25-day low dosage 
further hindered this question, and finer smoothing and more control within the data may be 
necessary to definitively tease out the answer to the question of timing of these shape changes. 
This study demonstrated marked shape changes between the dosage groups, particularly 
within the high dose sample. The causes of these changes, however, require further evaluation. 
The shape changes as a result of exogenous thyroxine could be linked to compensatory growth of 
the anterior mandible in response to cranial base changes. However, thyroxine can affect muscle 
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tissues, so shape changes of the mandibular angle could be a result of thyroxine acting on those 
tissues rather than the bone itself (Kemp and Hoyt 1969b; Hall 1973). If the cranial base narrows, 
or if the glenoid fossa shift in position, the mandible follows suit (Moss and Rankow 1968; Enlow 
1968). The anterior aspect of the mandible in this sample appears to follow this principle of 
craniofacial growth and development (Figure 40). The shape changes in the posterior aspect of the 
mandible, namely the coronoid process, the condyles, and the mandibular angle, also appear to 
move in relation to cranial base changes seen in other studies (discussed in detail below; Parsons 
et al. 2015; Cray, unpublished). To further understand the shape changes occurring across the 
different age groups, GM analyses must also be evaluated. 
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Figure 40. Schematic interpretation of overall mandibular shape changes seen in 
EDMA results as both age and thyroxine dosage increase. Red arrows indicate 
areas of growth and blue lines indicate areas of reduction. 
 
4.1.2  GM Shape Changes 
4.1.2.1 Principle Component Analysis 
All available samples within the three age and four dosage groups were evaluated using 
GM techniques. Once fitted to Procrustes coordinates, the sample was evaluated using ANOVA 
to determine if significant differences (p< 0.05) existed between age groups treatment groups 
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within the population (Table 16). When comparing treatment groups (control, low, medium, and 
high dosage), ANOVA tests indicate significant differences in both size (p = 0.0051) and shape 
(p< 0.001), demonstrating that dosage does, in fact, alter the overall shape of the offspring 
mandible. Age groups were also compared, and both size (p< 0.001) and shape (p< 0.001) exhibit 
significant differences; this later result is not surprising, as one would expect older individuals to 
have larger mandibles, and that shape changes would exist between age groups as biomechanical 
loads and mastication demands changes as an individual ages. Unfortunately, sex was not recorded 
for the 15-day sample, so ANOVA tests were run using the 20- and 25-day samples to determine 
if sex played a role in the observed shape changes (Table 17). No significant size (p= 0.534) or 
shape (p= 0.613) differences existed between males or females in the 20-day control sample. 
Furthermore, no significant size (p=0.593) or shape (p= 0.423) differences existed between the 
sexes in the 25-day control sample. By demonstrating that sex does not play a significant role in 
shape differences of the mandibles across age groups, the argument can then be made that any 
observed shape differences are more likely a result of thyroxine dosage.  
Once sex was eliminated as a possible explanation for the demonstrable shape differences, 
the sample was evaluated using PCA to determine where any dose-dependent shape changes are 
occurring in the mandible in each of the three age groups. With over 40 PC’s created to explain all 
shape variation for each sample, ANOVA and Bonferroni tests were used to determine which PC’s 
should be reviewed first to best explain variation. Only one PC in the 15-day sample (PC9, 3.5% 
of all variation) demonstrated a significant difference between dosage groups. Since the medium 
dosage data for the 15-day animals were lost, only control, low, and high could be compared. The 
shape changes seen in the 15-day sample are localized in the posterior and anterior mandible 
(Figure 27). The shape changes seen between dosage groups along PC9 are seen in the anterior 
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aspect of the mandible, namely the position of the incisor, and more markedly in the posterior 
mandible at the coronoid process and mandibular angle. Since the functional matrix of the anterior 
mandible results from occlusion, these shape changes suggest a slight alteration in form of the 
mandible towards the incisors, which may be indicative of compensatory changes to maintain 
occlusion (Moss and Rankow 1968; Enlow 1990).  
The changes seen in the coronoid process and mandibular angle suggest a reduction in 
biomechanical loading caused by the temporalis and masseter/pterygoid muscles, respectively. 
Whether these changes are caused by an overall reduction in function of these muscles, or if these 
changes are due to different functional demands due to fluctuations in shape of the cranial base 
cannot be determined by the present study. Mediolaterally, shape changes explained by PC9 are 
observable in the movement towards the midline of the mandibular angle and the lateral flaring of 
the condyle, and to a lesser extent the medial movement of both the anterior aspect of the mandible 
around the incisor. Overall, the 15-day sample GM results support the overarching hypothesis that 
thyroxine will alter mandibular shape, as well as the secondary hypotheses regarding the shape 
changes occurring at sites of muscle attachment. 
As with the 20-day sample, only one PC was determined to be significantly different by 
the ANOVA and Bonferroni tests: PC3. This PC, which explains 11.5% of all variation within the 
sample, is particularly useful in separating the control group and high dosage group from the rest 
of the sample (Figure 27). These shape changes are localized in the posterior aspect of the 
mandible, primarily a reduction of the mandibular angle and slight reduction in the coronoid 
process. There is also a posterior movement of the condyle and alveolus, both of which could be a 
result of compensatory growth to maintain occlusion. The mediolateral shape changes are more 
pronounced than those seen in the younger sample, with a distinct narrowing of the alveolus near 
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the incisor, and again a lateral flaring of the condyle and medial movement of the mandibular 
angle. These medial and lateral movements represent magnifications of the shape changes seen in 
the 15-day sample, suggesting an increase in shape changes as age increases.  
Shape changes seen in the GM results of the 25-day sample are more difficult to 
conceptualize, as five PC’s successfully discriminated between treatment groups and accounted 
for more than 3% of overall variation individually (Figure 31). The shape changes explained by 
PC1 (16.7% of overall variation) are localized in the condyle, mandibular angle, and the alveolus 
of the incisor, as well as lateral flaring of the condyle. Contrary to this, PC3 (9.4% of all shape 
variation) is associated with a medial movement of the condyle and anterior reduction in the 
condyle; PC3 is also associated with a more marked superior movement of the coronoid process. 
As with PC1, shape changes along PC3 decrease as dosage increases. PC5 and PC6 accounted for 
12% of all variation within the 25-day sample, and are associated with significant rotation of the 
anterior aspect of the mandible, posterior displacement of the mandibular condyle resulting in a 
shorter span between incisor and coronoid process, increased dimensions of the mandibular angle, 
and little to no shape changes in the mediolateral direction. PC7 accounted for just 5.3% of overall 
shape variation, but is associated with shape changes throughout the mandible: superior rotation 
of the anterior aspect of the mandible, drastic changes in both coronoid process and condyle 
location, and posterior flaring of the mandibular angle. In sum, the shape changes of the 25-sample 
demonstrated an increased effect of thyroxine of with both age and dosage, and these changes are 
primarily associated with areas of muscle attachment.  
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4.1.2.2 Canonical Variate Analysis 
 To further corroborate the shape changes seen from PCA, canonical variate analysis (5,000 
permutations) was conducted across the entire sample to test for significant (p< 0.001) differences 
between the four dosage groups. Prior to conducting CVA, regression was used to correct for age, 
allowing for effective comparison of dosage alone. Significant differences in Mahalanobis distance 
exist between each of the four dosage groups (all p< 0.0001), which demonstrate a distinct 
difference in shape as a result of thyroxine dosage. Furthermore, Procrustes distances were 
significantly different between control  low, control  high, and low  medium comparisons 
(see Table 21). Accounting for more than half of all variation in the population, CV1 is linked with 
a superior rotation of the anterior mandible, reduction of the mandibular angle, and a less 
pronounced reduction in coronoid process (Figure 41). CV2, which accounts for roughly 28% of 
all variance, is also associated with a superior rotation of the anterior mandible, as well as a 
reduction in coronoid process resulting in a more flexed mandible, and a marked increase in 
mandibular angle (Figure 41). CV3 (18% of all variance) is linked primarily to shape changes in 
the coronoid process and mandibular angle, with slight reduction in anterior mandible length 
(Figure 41). These CVA results corroborate those seen in PCA, linking increased dosage with a 
superior displacement of the incisor and an increase in mandibular angle and movement of the 
condyles. These changes are best explained by compensatory growth of the mandible to maintain 
occlusion and deal with changes of the cranial base, though the effect of the thyroxine on the 
muscles themselves leading to altered biomechanical loads may be a contributing factor. 
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Figure 41. CVA results across all dosage groups, corrected for age. Red arrows 
indicate areas of growth and blue lines indicate areas of reduction. 
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4.1.3  Comparison of EDMA and GM Results 
4.1.3.1 15-day Sample Comparison 
Due to the errors associated with the collection and analysis of the 15-day EDMA, 
evaluation of the two methods for the 15-day sample is not possible. It should be noted that EDMA 
and GM are not directly comparable methods, and should instead be seen as separate paths towards 
answering the same questions (Lele and Richtsmeier 2001). The 15-day GM sample displays a 
slight rotation of the anterior mandible, a slight reduction of the mandibular angle and both a 
marked reduction of the coronoid process and rotation of the mandibular condyle.  
 
4.1.3.2 20-day Sample Comparison 
The EDMA results comparing the 20-day low dosage group and high dosage groups 
resulted in significant shape changes in the anterior mandible, specifically an increase in size and 
superior rotation of the alveolus towards the cranial base. There was also a slight increase of the 
coronoid process in the vertical dimension. The GM results also display a similar change in shape 
of the anterior mandible, and shape changes in the 20-day sample using this method were much 
more marked in a reduction of the mandibular angle and a rotation of the mandibular condyle. The 
shape changes seen in the mandibular angle between the two methods are also very similar as GM 
results suggest an anterior movement of Landmark 9 (most anterior point of subcondylar incisive) 
with little vertical change in the position of Landmark 10 (posterior tip of mandibular angle. The 
GM analysis also demonstrates that the superior margin of the mandible moves towards the cranial 
base, potentially in relation to mandibular rotation, which is also seen in the EDMA results. The 
only shape changes not corroborated by the two methods are in the position of the mandibular 
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condyle. The EDMA results show only an increase in distance between the posterior margin of the 
mandibular condyle and the incisor, whereas the GM results show a vertical change in position of 
the anterior margin of the condyle that is not seen in the EDMA results. Why these two methods 
disagree at this landmark is uncertain, though it may be tied to the far reduced sample size used in 
EDMA (32 individuals in two groups) compared to those used in the GM analysis (74 individuals 
in four groups). 
 Overall, both methods suggest an increase in size of the mandible in the anterior-posterior 
dimensions. Coupled with vertical changes in shape towards the anterior aspect of the mandible, 
these shape changes strongly suggest a superior rotation of the incisor. Previous orthodontic and 
animal model research predicts this sort of shape change in response to alterations in shape of the 
cranial base (Moss and Rankow 1968; Petrovich 1974) 
 
4.1.3.3 25-day Sample Comparison 
 The shape changes seen in both the EDMA and GM analyses coincide with one another. 
Although not directly comparable, both methods demonstrate marked shape changes along the 
superior margin of the mandible and coronoid process, with a superior rotation of the incisor; this 
is particularly evident when comparing the EDMA results to those of PC1, PC3, PC5, and PC6 of 
the GM analyses. The changes seen in both methods in the mandibular angle, where the high 
dosage groups exhibit a more pronounced angle both posteriorly and inferiorly, are also mirrored. 
These results further demonstrate an overall change in shape in the 25-day sample that supports 
the overarching and secondary hypotheses: individuals exposed to maternal thyroxine demonstrate 
shape changes of the mandible in both an age- and dose-dependent manner, and these changes do 
affect the areas of muscle attachment.  
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Furthermore, the CVA analysis with GM can be compared to the overall shape changes 
seen with both EDMA and the PCA. The CVA results show a pronounced superior rotation of the 
anterior mandible in all three CV’s (Figure 41). These results mirror those of the EDMA and PCA 
results, and are again suggestive of compensatory growth of the mandible in relation to shape 
changes of the cranial base. The CVA results regarding the mandibular angle also support those 
seen in the other methods, indicating that maternal thyroxine affects this area of the mandible, 
either through increased action of the masseter, changes in the bone itself, or a combination of 
both. 
4.1.4 Overall Shape Changes and Existing Literature 
Unfortunately, very little is known regarding shape changes of the craniofacial complex in 
regards to maternal thyroid levels; in light of this shortfall, orthodontic and dental research can be 
used as a predictive model for changes in mandibular shape as a result of shape changes elsewhere 
in the cranial base. The results described above demonstrate that thyroxine affects change on the 
mandible in both an age- and dose-dependent manner. As such, the 25-day high dose sample is a 
prime model for the overall effect of maternal thyroxine on the offspring mandible, as it displayed 
the most marked shape changes of any tested group. Preliminary studies of cranial base shape 
variation in the same samples 20-specimens suggest altered shape, especially in regard to the 
anterior aspect of the skull and maxilla (Cray, unpublished). These findings, particularly with 
individuals receiving higher doses of levothyroxine, should lead to a compensatory rotation of the 
anterior mandible to maintain occlusion (Moss and Rankow 1968; Enlow 1982).  
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The high dosage of thyroxine results in a pronounced superior rotation of the anterior 
aspect of the mandible, particularly the root of the incisor, towards the cranial base. Prior studies 
in orthodontics and dentistry have shown that rotation of this sort is primarily the result of response 
growth to maintain occlusion (Lavergne and Gasson 1976; Baumrind, Korn, and West 1984). The 
chin of the mouse is an area known to respond to changes elsewhere in the mandible (Atchley, 
Plummer, and Riska 1985). This rotation therefore suggests that the anterior aspect of the mandible 
is responding to growth elsewhere. The primary area of growth in the mandible is at the condyle 
and along the margin of the ramus (Petrovich 1974; Enlow 1982), so one would expect these areas 
to be changing as well. Indeed, there are demonstrable changes in the mediolateral position of the 
condyles, particularly in PC3 and PC7 of the 25-day sample; these two PC’s showed a marked 
movement of the condyle towards the midline. Within the 20-day group, the location of the glenoid 
fossae narrowed, moving towards the midline of the cranial base, which would also affect the 
location of the mandibular condyles within the present study (Cray, unpublished). 
Since no data exist regarding the role of thyroxine on areas of muscle attachment of the 
mandible, biomechanical research provides the only parallel with which to compare the present 
sample. The mandibular angle is formed in response to biomechanical stress placed upon it by the 
masseter and medial pterygoid muscles (Moss and Rankow 1968). As such, any alteration to this 
musculature would result in shape changes in this area. Reduced masseter function results in 
reduced mandibular angle, though it is also tied to reduced condylar formation and reduction of 
the posterior aspect of the ramus (Yonemitsu, Muramoto, and Soma 2007). Both the EDMA and 
GM results of the present study show an increase in size of the mandibular angle with increased 
dosage in younger ages, followed by a reduction in the 25-day sample (analogous to the early adult 
period in humans). The reduction in size of mandibular angle in the younger populations could be 
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tied to changes in masticatory habits or changes in biomechanical load, as these have been shown 
to reduce masseter size in animal models (Maeda et al. 1987; Widmer, Morris-Wiman, and Nekula 
2002). The calvarial sample of the 20-day population of this group showed a narrowing of the 
zygomatic arch (Parsons et al. 2015), which may not necessarily alter the function of the masseter. 
The shape changes in the mandibular angle in this study thus remain an enigma, as little is known 
concerning alteration of zygomatic orientation on the function of the masseter muscle.  
The final area of shape change seen in the mandibular sample is of the coronoid process. 
Both the EDMA and GM results demonstrated an overall reduction in size of the coronoid process 
as a function of dosage and age. This is assumed to be associated with a reduction in biomechanical 
load exerted by the temporalis (Moss 1997a; Enlow 1990). The cause of this reduction is not 
readily apparent, though the same sample (20-day, high dosage) exhibited a reduced vault height 
(Cray, unpublished). Should it be shown that the thyroxine is targeting calvarial bone growth, thus 
reducing either the attachment area of the temporalis or the area of the zygomatic arch, it would 
alter the size of the temporalis muscle, leading to corresponding reduction in the coronoid process. 
Further study on both the muscle attachment sites of the skull and muscle mass of the temporalis 
is needed to better describe the effect of maternal thyroxine, though an overall reduction in muscle 
area caused by a reduced cranial vault height remains a plausible explanation. 
The shape changes observed in the present study, most pronounced in the 25-day high 
dosage sample, are suggestive of growth in response to shape changes in the cranial vault. Excess 
maternal thyroxine has been linked to changes in endochondral bone formation, including the 
cranial base (Hall 1973; Hanken and Summers 1988; Allan et al. 2000; Cray et al. 2013). The 
movement of the mandible towards the midline and superior rotation of the anterior mandible 
towards the cranial base are expected in light of mirror changes in the cranial base within the same 
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sample (Cray, unpublished). The shape changes in the mandibular angle are more difficult to 
explain, as the region is larger in size in the 15- and 20-day samples, and smaller in the 25-day 
sample. These changes could be tied to masticatory habits, shape changes of the zygomatic arch, 
or another unanticipated change in the sample, but cannot be easily explained in the thyroxine-
exposed sample.  
4.1.5 Strengths and Limitations 
There are a number of strengths with the present study. First and foremost the overarching 
question of the role of maternal thyroxine levels on offspring craniofacial development. Despite a 
number of promising new studies, there is a paucity of literature regarding the role of maternal 
environment of mandibular development. Along these lines, this study also paves the way for 
future research further examining the nature of mandibular changes in direct response to cranial 
base shape changes, the role of thyroxine on masticatory muscles and the concomitant changes to 
occlusion and mastication, and other potential confounding factors affecting shape changes in the 
mandible. Finally, this research adds to existing literature regarding normal variation; with such a 
high prevalence of maternal thyroid issues, the resulting shape changes in the craniofacial complex 
of offspring (both mice and human) stands to account for part of the overall variation seen within 
a population. 
This study was faced with multiple limitations commonly associated with biological and 
statistical projects. The primary limitation of this study is that of sample size. Large sample sizes 
in the 25-day sample allowed for adequate power to evaluate the proposed hypotheses. However, 
due to both data loss and sample damage amongst some groups, the sample sizes of the 15- and 20 
135 
 
day samples were smaller than anticipated. Limitations to the present study also exist regarding 
the nature of the sample images and the software used to evaluate landmark data. While Amira is 
designed to work with high-resolution micro-CT scans, both MorphoJ and EDMA require only 
landmark data in different formats. This requires careful manipulation of micro-CT images and 
their respective scaling, and second-hand review of these data can introduce errors to the software 
programs. This is the likeliest explanation of the EDMA errors encountered during this research; 
had these errors been systemic throughout the dataset, both the EDMA and GM samples would 
demonstrate extreme variance within the sample. However, the GM data did not show the same 
errors in the 15-day control group that precluded EDMA analysis of the sample.  
The basic nature of geometric morphometrics, which scales data using Procrustes 
superimposition, means that it is capable of dealing with a number of different shapes and 
configurations of landmark data. However, GM does not adequately deal with nuisance factors, or 
variables in the sample that are not of interest yet still alter the overall shape of the sample (e.g., 
behavioral changes, environmental differences). Simply put, GM does not eliminate all nuisance 
factors within a dataset; rather, the fitting of data to a single coordinate system simply forces any 
nuisance parameters within the dataset in to a single shape (Lele and Richtsmeier 2001). This 
means that many factors that could be affecting the population may be omitted from analysis.  
4.1.6 Future Directions 
Geometric morphometric studies are on the rise in both the anthropological and clinical 
literature. The ability to evaluate shape changes are especially appealing for those interested in 
evolutionary comparisons both between and within species, both past and present (Viòarsdóttir, 
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O’Higgins, Paul, and Stringer 2002; Viòarsdóttir and O’Higgins 2003). In particular, studies of 
mandibular form shed light on form and functional changes in the past (Thayer and Dobson 2010; 
Pampush and Daegling 2016). Shape studies add a powerful lens with which to evaluate studies 
of paleoanthropological populations that have traditionally been analyzed using linear 
measurements alone (see Kesterke and Ahern 2007). The added tool of GM studies will no doubt 
continue to add to the understanding of past hominin population, and the added linear measurement 
methodology afforded by EDMA will help temper the shape-only results of the GM process. 
Contemporary mandibular research still exists primarily in the dental and orthodontic 
literature, but its applicability to broader fields is readily apparent. Many studies have evaluated 
some of the proposed hypotheses regarding mandibular and chin formation in primate populations 
(Hylander 1979; Hylander 1984; Lieberman 2011), but the fact that the human chin is still a 
popular topic of both academic and popular debate highlights the enigma of its formation and 
function (Pampush and Daegling 2016). This project utilizes methods that may be used as a model 
for shape differences existing between different populations, be they extant primate or 
paleoanthropological, that have been proposed over the last decade (Schwartz and Tattersall 2000; 
Ichim, Swain, and Kieser 2006; Thayer and Dobson 2010; Garvin and Ruff 2012). A better 
understanding of both normal and abnormal mandibular development facilitates a fuller 
understanding of evolutionary and medical implications of craniofacial growth and development. 
Future studies should continue to look at the role of maternal thyroid and its impact on 
osteoblasts, osteoclasts, and overall bone maintenance in offspring. With the high prevalence in 
thyroid dysfunction both in the U.S. and abroad, a better understanding of these hormones and 
their role on bone growth is certainly an avenue of research in need of further study; these studies 
need not apply solely to bone and/or craniofacial development, and continued research on all 
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aspects of thyroid function are needed. Research on the maternal environment, the only 
environment of a human for their first nine months post-conception, are in dire need of scientific 
scrutiny. Studies of teratogens are common, but the role of maternal environment on the offspring 
in regards to normal human variation carries implications beyond the realm of biomedicine and in 
to anthropology and elsewhere. 
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APPENDIX A: AMIRA PROTOCOL 
Appendix A includes the entire landmarking protocol for Amira. This protocol was utilized 
for each skull to visualize the mandible, landmark the mandible, and export these landmarks for 
further analysis. 
A.1 LANDMARKING
The following protocol manual was used for the above dissertation to evaluate the shape changes 
of mouse mandibles exposed to heightened maternal thyroxine during pregnancy. The processes described 
herein will be updated throughout the dissertation project as needed. 
A.1.1 FILE LOCATIONS AND NAMING CONVENTIONS
All micro-CT scan files are stored on the shared research servers at the University of Pittsburgh’s 
Craniofacial and Dental Genetics Laboratory.  
/Volumes/ResearchStudies/Twist Mouse/Thyrox/Amira 
Each individual has three associated files: 
-one AmiraMesh file that has been cleaned and filtered (.am file)
-one Gaussian smoothing filter script file (.hx)
-one landmark file for cranial vault script studies (.hx)
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The cleaned and filtered AmiraMesh files (.am files) will be used for the mandibular shape analyses. Prior 
to the start of this project, the files were named according to their specimen number and are indicated as 
filtered files due to their names and are all ~45Mb is size (examples below): 
759-filtered.am 
177_female-filtered.am 
There is no indication in the file name as to the age or treatment group of the specimen. 
A.1.2 IMPORT AND VISUALIZING AMIRAMESH FILES
The .am files for this project have already been trimmed and filtered, so very little additional filtering is 
necessary. To begin visualization of the file, use the ‘Open Data…” button in the Pool Window and select 
the desired AmiraMesh file. This will place a green object with the file name within the Pool Window. 
Clicking on this object will populate the Properties Window, displaying the file size and voxel size for the 
skull. To visualize the skull, select the object with the Pool Window and click the “IsoSurface” button. This 
will add a yellow object to the Pool Window, and click on this object will populate the Properties Window 
allowing for various visualization options.  The objects for this project will be compactified (default 
selection), and threshold will be adjusted to best visualize the mandibles. Ideally, a threshold of 42.0 will 
be used for this project. Thresholds below this introduce a lot of noise to the visualization, particularly 
around the alveolar border of the incisors, and thresholds above this introduce opacity in the rendering, 
particularly in the thinner aspects of the posterior ramus (Figure A1). Thresholds will be adjusted if needed 
for each file, though it is not expected. 
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Figure A1. Setting a threshold and visualizing the AmiraMesh file. 
  
Once a threshold has been entered, click on the green ‘Apply’ button in the Properties Window. The selected 
threshold for each mandible will be recorded on the master Excel file under the tab “Thresholds”. If the 
thresholds are variable (e.g., one threshold for the alveolar landmarks and a different threshold for the 
condylar landmarks), it will be noted. The master Excel file for the thresholds is located in the directory: 
/Volumes/ResearchStudies/Twist Mouse/Thyrox/Mandible Shape/Landmarking.xls 
 
 
A.1.3 LANDMARKING THE MANDIBLE 
Once the AmiraMesh file is loaded and an isosurface has been applied, landmarking can begin. To better 
visualize the location of each landmark, switch to ‘Two Viewers’ by clicking on the view change options 
above the rendering (Figure A2). 
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Figure A2. Views to Better Visualize the Data. 
To begin landmarking, add a Landmarks object by right clicking in the Pool Window, highlighting ‘Create’, 
then ‘Data’, then click on ‘Landmarks’. This will add a green object called ‘Landmarks’ to the Pool 
Window. Within the Properties Window, click ‘Landmark Editor’ to create ’Landmark View’ object 
(Figure A3). 
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Figure A3. Creating a Landmark Object. 
Within the Properties Window, be sure that Edit Mode is set to ‘Add’ and that the Interact cursor 
is selected in the Viewer. You can then begin to add landmarks to the mandible (Figure A4). You 
will need to alternate between the two viewers, the Interact cursor, and the Trackball cursor to 
accurately place the necessary landmarks. It may also be necessary to reduce the size of the 
landmarks in order to better visualize their placement; this can be done my clicking on the 
‘Landmark View’ object and reducing the Size down to 0.5 within the Properties Window. 
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Figure A4. Placing Landmarks on the Mandible. 
The order in which the landmarks are place is very important, and must be the same for each 
mandible. Placing the landmarks in the incorrect order will result in errors for both the EDMA and 
geometric morphometric analyses. For the purpose of this study, the left mandible will be 
landmarked first, and landmarks on the right mandible will be placed second (Table A1). Multiple 
foramina: in the event of multiple foramina, the anterior most foramen will be landmarked.  
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Table A1. Order of Mandibular Landmarks. 
Side 
Landmark 
Number Landmark 
Left 
1 Anterior superior incisor alveolar rim (midline) 
2 Anterior edge of mental foramen 
3 Anterior edge molar alveolar rim (midline) 
4 Intersection molar alveolar rim and coronoid process 
5 Apex of coronoid process  
6 Posterior base of coronoid process (midline) 
7 Anterior edge of mandibular condyle (midline) 
8 Posterior edge mandibular condyle (midline) 
9 Most anterior point of subcondylar incisive 
10 Posterior tip of mandibular angle 
11 Most superior point of inferior border of mandibular angle 
12 Anterior edge of inferior border of masseteric ridge 
13 Most inferior point on mandibular symphysis 
14 Anterior inferior incisor alveolar rim (midline) 
15 Anterior edge of mandibular foramen 
16 Anterior edge ramal fossa foramen 
17 Most posterior point along molar alveolar border 
Right 
18 Anterior superior incisor alveolar rim (midline) 
19 Anterior edge of mental foramen 
20 Anterior edge molar alveolar rim (midline) 
21 Intersection molar alveolar rim and coronoid process 
22 Apex of coronoid process  
23 Posterior base of coronoid process (midline) 
24 Anterior edge of mandibular condyle (midline) 
25 Posterior edge mandibular condyle (midline) 
26 Most anterior point of subcondylar incisive 
27 Posterior tip of mandibular angle 
28 Most superior point of inferior border of mandibular angle 
29 Anterior edge of inferior border of masseteric ridge 
30 Most inferior point on mandibular symphysis 
31 Anterior inferior incisor alveolar rim (midline) 
32 Anterior edge of mandibular foramen 
33 Anterior edge ramal fossa foramen 
34 Most posterior point along molar alveolar border 
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A.1.4 EXPORTING LANDMARK DATA
Once the 34 landmarks are placed, they must be exported as an ASCII file for later import in to 
other software programs. To do so, right-click on the ‘Landmarks’, select ‘Save Data As…” and 
save the landmark file in the following folder: 
/Volumes/ResearchStudies/Twist Mouse/Thyrox/Mandible Shape/Mandible 
Landmarks 
Files will be named according to their sample number, with underscores between identifiers: 
511_mand_landmarks.ascii 
This produces an Ascii file with coordinates that can be read by any text reader (Figure A5). 
Figure A5. Example Ascii File. 
The Amira network files (.hx files) will be saved in the same folder: 
/Volumes/ResearchStudies/Twist Mouse/Thyrox/Mandible Shape/Mandible Landmarks 
Files will be saved with the same filename as the associated landmark files (.ascii files): 
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511_mand_landmarks.hx 
A.1.5 DEALING WITH MISSING DATA
In some instances, it may be necessary to omit a landmark from analysis. However, the exported 
landmarks in the Ascii file are only recorded in the order in which they are placed. Careful note 
must be taken when choosing to omit a landmark, and the output Ascii file must be updated 
accordingly. To do so, open the export file in a text editing program and insert ‘m m m’ in the 
place of the appropriate landmark (Figure A6). A space is necessary between each letter. 
Figure A6. Dealing With Missing Data. 
Any missing landmarks should also be noted on the master Excel file: 
/Volumes/ResearchStudies/Twist Mouse/Thyrox/Mandible Shape/Landmarking.xls 
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Landmarks should only be omitted in cases where landmarks cannot be placed due to imaging 
issues due to threshold resolutions (e.g., alveolar border). In the event of damage to the mandible 
that alters overall shape in any way (e.g., fractures), or if imaging is unavailable, the entire 
mandible will be omitted from the study, though it will be noted in the master Excel file. 
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APPENDIX B: EDMA OUTPUTS 
Appendix B consists of the complete EDMA output files. The following are the raw outputs 
used for the above dissertation to evaluate the shape changes of mouse mandibles exposed to 
heightened maternal thyroxine during pregnancy. The processes described herein will be updated 
throughout the dissertation project as needed. These results are discussed in detail in Chapter 3, 
Section 1. 
Due to errors with the WINEDMA software, some of these files are incomplete, 
specifically many of the image outputs. 
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 15-DAY SAMPLE
Mean shape-difference matrix for the 15-day samples: 15-day low dosage and 15-day high dosage. 
L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12 L13 L14 L15 L16 
L1 0 
L2 0.3397 0 
L3 0.2517 0.0091 0 
L4 0.1028 -0.0051 -0.0210 0 
L5 -0.1120 0.0076 -0.0125 0.0070 0 
L6 -0.0628 0.0003 -0.0174 0.0029 0.0071 0 
L7 -0.1305 0.0375 0.0159 0.0349 0.0267 0.0269 0 
L8 -0.1628 0.0148 -0.0073 0.0102 0.0079 0.0013 -0.0181 0 
L9 0.0102 0.0213 -0.0011 0.0020 -0.0212 -0.0297 -0.0147 -0.0242 0 
L10 0.0164 0.0142 -0.0069 -0.0030 -0.0161 -0.0257 -0.0183 -0.0237 0.0001 0 
L11 0.1754 0.0393 0.0184 0.0066 -0.0133 -0.0252 -0.0055 -0.0280 -0.0072 -0.0238 0 
L12 0.3598 0.0183 -0.0047 -0.0307 -0.0205 -0.0346 0.0003 -0.0205 -0.0035 -0.0125 0.0071 0 
L13 0.4505 0.0099 0.0053 -0.0223 -0.0126 -0.0226 0.0091 -0.0139 0.0033 -0.0065 0.0163 0.0058 0 
L14 0.4150 -0.0281 -0.0122 -0.0331 -0.0213 -0.0284 0.0056 -0.0175 -0.0079 -0.0145 0.0101 -0.0023 0.0089 0 
L15 -0.0340 0.0208 0.0002 0.0135 -0.0109 -0.0164 0.0004 -0.0139 -0.0117 -0.0094 -0.0088 -0.0111 -0.0023 -0.0105 0 
L16 0.0833 0.0384 0.0230 0.0274 -0.0226 -0.0253 -0.0171 -0.0399 -0.0154 -0.0251 -0.0045 -0.0144 0.0011 0.0038 -0.0129 0 
150 
Z statistic:  0.45048 
Confidence interval for Z with alpha = 0.100 
 Upper bound:  0.74987       Lower bound: -0.44808 
Distribution of bootstrapped Z statistics 
  0.450  |Z******************************************************************************
  0.485  |*******************************************************************
  0.519  |****************************************************************** 
  0.553  |**********************************************************
  0.588   |*******************************************************
  0.622  |********************************************
  0.656     |**********************************
  0.691 |*********************************
  0.725  |*************** 
  0.759  |******************
  0.793  |************ 
  0.828  |*************
  0.862  |******* 
  0.896  |****** 
  0.931  |** 
  0.965  |**** 
  0.999    | 
  1.033    | 
  1.068    | 
  1.102    |* 
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Confidence interval for scale difference with alpha = 0.100 
      Upper bound:  0.51477       Lower bound: -7.64195 
Distribution of bootstrapped scale differences 
-9.301    |*****
-8.494    |*******************
-7.686    |****************************
-6.879    |***************************************************
-6.072    |***********************************************************
-5.264    |*********************************************************************************************************
-4.457    |************************************************************************************************************************
-3.650    |********************************************************************************************************************************
-2.842    |D******************************************************************************************************************************
-2.035   |*************************************************************************************************************
-1.228    |***************************************************************************************
-0.420    |****************************************************************
0.387    |**************************************
1.194    |***********************
2.002    |*********
2.809    |*****
3.616    |** 
4.424    |
5.231    |*
6.038    |* 
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20-DAY SAMPLE
Mean shape-difference matrix for the 20-day samples: 20-day low dosage and 20-day high dosage. 
L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12 L13 L14 L15 L16 
L1 0 
L2 0.2570 0 
L3 0.2819 0.0065 0 
L4 0.3003 0.0112 -0.0053 0 
L5 0.3335 0.0267 0.0113 0.0138 0 
L6 0.3365 0.0143 -0.0004 0.0020 0.0199 0 
L7 0.3270 0.0134 -0.0038 0.0016 -0.0162 -0.0129 0 
L8 0.3169 0.0128 -0.0056 0.0003 -0.0167 -0.0170 -0.0010 0 
L9 0.2704 0.0174 -0.0047 0.0003 -0.0082 -0.0273 -0.0074 -0.0084 0 
L10 0.2436 0.0059 -0.0167 -0.0115 -0.0188 -0.0369 -0.0137 -0.0117 -0.0105 0 
L11 0.2501 0.0047 -0.0157 -0.0067 0.0025 -0.0197 0.0015 0.0031 0.0105 0.0006 0 
L12 0.2298 0.0039 -0.0116 -0.0015 0.0111 -0.0077 0.0027 0.0027 0.0099 0.0003 -0.0019 0 
L13 0.2229 -0.0171 -0.0056 -0.0060 0.0068 -0.0080 -0.0039 -0.0048 -0.0009 -0.0110 -0.0119 -0.0142 0 
L14 0.2344 -0.0097 0.0073 0.0036 0.0182 0.0070 0.0054 0.0050 0.0105 0.0004 -0.0002 0.0019 0.0061 0 
L15 0.2974 0.0125 -0.0066 0.0012 0.0017 -0.0190 0.0053 0.0022 -0.0104 -0.0180 -0.0026 0.0000 -0.0075 0.0046 0 
L16 0.2991 -0.0036 -0.0169 -0.0229 -0.0071 -0.0285 -0.0065 -0.0066 -0.0251 -0.0319 -0.0369 -0.0221 -0.0095 -0.0018 -0.0237 0 
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Z statistic:  0.33652 
Confidence interval for Z with alpha = 0.100 
 Upper bound:  0.56476       Lower bound:  0.14439 
Distribution of bootstrapped Z statistics 
-0.197    |****
-0.148    |*****
-0.099    |**********
-0.050    |**
-0.001    | 
0.048    |* 
0.097    |************** 
0.146    |*************************************** 
0.195    |******************************************************************************************** 
0.243    |************************************************************************************************************ 
0.292    |*************************************************************************************************************************************** 
0.341    |Z****************************************************************************************************************************************************************
0.390    |*************************************************************************************************************************** 
0.439    |******************************************************************************************************************************** 
0.488    |************************************************************************* 
0.537    |************************************************* 
0.586    |******************************** 
0.635    |*************** 
0.684    |******* 
0.733    |* 
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Confidence interval for scale difference with alpha = 0.100 
      Upper bound:  2.23920       Lower bound: -4.37549 
Distribution of bootstrapped scale differences 
-7.357    |**
-6.703    |*****
-6.048    |****
-5.394    |***************
-4.739    |**********************
-4.085    |************************************
-3.430    |***************************************************
-2.775    |********************************************************************************
-2.121    |**************************************************************************************************
-1.466    |*********************************************************************************************************************************************
-0.812    |D***************************************************************************************************************************************************
-0.157    |****************************************************************************************************************
0.497    |*************************************************************************************************** 
1.152    |************************************************************** 
1.806    |***************************************************************** 
2.461    |***************************** 
3.116    |**************** 
3.770    |******* 
4.425    |***** 
5.079    |** 
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25-DAY SAMPLE
Mean shape-difference matrix for the 25-day samples: 25-day controls and 25-day high dosage. 
L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12 L13 L14 L15 L16 
L1 0 
L2 0.1393 0 
L3 0.1514 -0.0079 0 
L4 0.2463 -0.0559 -0.0384 0 
L5 0.2631 -0.0575 -0.0466 0.0005 0 
L6 0.2768 -0.0469 -0.0334 0.0087 0.0004 0 
L7 0.3283 -0.0477 -0.0336 0.0049 0.0044 -0.0091 0 
L8 0.3896 -0.0502 -0.0341 -0.0021 0.0003 -0.0155 -0.0033 0 
L9 0.3612 -0.0085 0.0100 0.0178 -0.0040 -0.0100 -0.0129 -0.0305 0 
L10 0.4400 0.0058 0.0280 0.0363 0.0316 0.0222 0.0278 0.0102 0.0261 0 
L11 0.3287 -0.0600 -0.0316 -0.0239 0.0014 -0.0040 0.0179 0.0206 0.0602 0.0692 0 
L12 0.2418 -0.0198 0.0019 -0.0355 -0.0293 -0.0263 -0.0190 -0.0205 0.0202 0.0289 -0.0410 0 
L13 0.1730 0.0089 0.0078 -0.0407 -0.0406 -0.0329 -0.0305 -0.0312 0.0115 0.0217 -0.0474 -0.0069 0 
L14 0.1105 0.0122 0.0012 -0.0417 -0.0446 -0.0336 -0.0358 -0.0388 0.0006 0.0114 -0.0578 -0.0231 -0.0149 0 
L15 0.3624 -0.0366 -0.0148 0.0142 0.0227 0.0116 0.0177 -0.0040 -0.0250 0.0115 0.0089 -0.0203 -0.0237 -0.0265 0 
L16 0.3164 -0.0430 -0.0204 -0.0035 -0.0063 -0.0082 -0.0007 -0.0018 0.0303 0.0502 0.0043 -0.0191 -0.0313 -0.0352 0.0122 0 
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Z statistic:  0.43995 
Confidence interval for Z with alpha = 0.100 
 Upper bound:  0.66977       Lower bound:  0.20294 
Distribution of bootstrapped Z statistics 
-0.349    |**
-0.287    | 
-0.224    |**************
-0.162    |**********
-0.099    | 
-0.037    | 
0.026    | 
0.088    | 
0.151    |************** 
0.213    |************************************************** 
0.276    |********************************************************************************************** 
0.338    |**************************************************************************************************************************************** 
0.401    |************************************************************************************************************************************************************ 
0.464    |Z*********************************************************************************************************************************************************************************************
0.526    |******************************************************************************************************************************************************* 
0.589    |********************************************************************************************* 
0.651    |************************************************** 
0.714    |************************ 
0.776    |************* 
0.839  |**** 
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Confidence interval for scale difference with alpha = 0.100 
      Upper bound:  3.29279       Lower bound: -2.14588 
Distribution of bootstrapped scale differences 
-5.638    |*
-4.997    |*
-4.357    |***
-3.717    |*****
-3.076    |**************
-2.436    |***************************
-1.796    |************************************************************
-1.155    |**************************************************************************************************
-0.515    |**************************************************************************************************************************** 
0.125    |**************************************************************************************************************************************************************
0.766    |D******************************************************************************************************************************** 
1.406    |************************************************************************************************************************************ 
2.046    |******************************************************************************************************** 
2.687    |************************************************************************** 
3.327    |**************************************** 
3.967    |*********************** 
4.608    |*** 
5.248    |*** 
5.889    |* 
6.529
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APPENDIX C: GM OUTPUTS 
Appendix C consists of the complete GM output files. These results are discussed in detail 
in Chapter 3, Section 2.  
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 15-DAY SAMPLE
16 landmarks in 3 dimensions. 
 The dataset contains 49 observations, of which 49 are included for analyses. 
Average shape: 
Lmk.  Axis 1 (x)  Axis 2 (y)  Axis 3 (z) 
 1 -0.39043345  -0.00690972  -0.11172318
 2 -0.23168044   0.02555497  -0.00866892
 3 -0.18312336   0.00677576  -0.04896145
 4 -0.02061470   0.00535360  -0.07405625
 5  0.17362234  0.01130879 -0.16503202
 6  0.13261984  0.00446730 -0.11688368
 7  0.26664866 -0.00590003  -0.08863012
 8  0.34874882 -0.00566006  -0.02559787
 9  0.18525102  0.01546282  0.08613556 
 10  0.24061486  0.01065218  0.17256918 
 11  0.04976878  0.00375153  0.12953130 
 12 -0.13257365   0.01157993   0.13259618
 13 -0.29533547  -0.02298626   0.09827937
 14 -0.36023206   0.00859040  -0.00339237
 15  0.17570233  0.00250008  0.00795654 
 16  0.04101648 -0.06454128   0.01587775
Procrustes sums of squares: 0.06789081012623971 
Tangent sums of squares: 0.06778606133309208 
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PC Eigenvalues % Variance Cumulative % 
1. 0.00025826 18.288 18.288 
2. 0.00022402 15.863 34.151 
3. 0.00015834 11.212 45.363 
4. 0.00011954 8.465 53.828 
5. 0.00009445 6.688 60.516 
6. 0.00008003 5.667 66.183 
7. 0.00006953 4.923 71.106 
8. 0.00006227 4.409 75.515 
9. 0.00004930 3.491 79.007 
10. 0.00004214 2.984 81.990 
11. 0.00003031 2.146 84.137 
12. 0.00002594 1.837 85.973 
13. 0.00002201 1.558 87.532 
14. 0.00002050 1.451 88.983 
15. 0.00001897 1.343 90.326 
16. 0.00001804 1.277 91.603 
17. 0.00001508 1.068 92.671 
18. 0.00001412 1.000 93.671 
19. 0.00001254 0.888 94.559 
20. 0.00001027 0.727 95.286 
21. 0.00000903 0.640 95.925 
22. 0.00000809 0.573 96.498 
23. 0.00000774 0.548 97.046 
24. 0.00000694 0.492 97.538 
25. 0.00000593 0.420 97.957 
26. 0.00000537 0.380 98.337 
27. 0.00000427 0.303 98.640 
28. 0.00000362 0.256 98.896 
29. 0.00000308 0.218 99.115 
30. 0.00000256 0.182 99.296 
31. 0.00000201 0.142 99.438 
32. 0.00000161 0.114 99.553 
33. 0.00000147 0.104 99.656 
34. 0.00000134 0.095 99.752 
35. 0.00000119 0.085 99.836 
36. 0.00000079 0.056 99.892 
37. 0.00000065 0.046 99.938 
38. 0.00000033 0.024 99.962 
39. 0.00000030 0.021 99.983 
40. 0.00000014 0.010 99.992 
41. 0.00000011 0.008 100 
Total variance:  0.00141221 
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 20-DAY SAMPLE
16 landmarks in 3 dimensions. 
 The dataset contains 51 observations, of which 51 are included for analyses. 
Average shape: 
Lmk.  Axis 1 (x)  Axis 2 (y)  Axis 3 (z) 
 1 -0.38787621   0.10851161  -0.00379904
 2 -0.22879119   0.00914619   0.02304849
 3 -0.17667239   0.05116873   0.00500855
 4 -0.01860061   0.07055633   0.00814633
 5  0.17155322  0.16532403  0.01221474 
 6  0.13541255  0.11967449  0.00603246 
 7  0.26225086  0.08953251 -0.00740131
 8  0.34953654  0.03319813 -0.00941033
 9  0.19110534 -0.08984341   0.01411713
 10  0.24538655 -0.18327864   0.01083837
 11  0.03385534 -0.12832190   0.00502419
 12 -0.13449114  -0.12829122   0.01072983
 13 -0.29684765  -0.09230650  -0.02343650
 14 -0.35990084   0.00105169   0.00691657
 15  0.18081634 -0.01380278   0.00360562
 16  0.03326328 -0.01231927  -0.06163512
Procrustes sums of squares: 0.06427403471189583 
Tangent sums of squares: 0.06417702455186614 
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PC Eigenvalues % Variance Cumulative % 
1 0.0002016 15.706 15.706 
2 0.00016911 13.176 28.882 
3 0.00014799 11.53 40.412 
4 0.00011177 8.708 49.12 
5 0.00009384 7.311 56.431 
6 0.00008296 6.464 62.894 
7 0.00006438 5.016 67.91 
8 0.00005346 4.165 72.075 
9 0.00004964 3.867 75.943 
10 0.00003753 2.924 78.867 
11 0.00003412 2.658 81.525 
12 0.00002999 2.337 83.862 
13 0.00002567 2 85.862 
14 0.00002454 1.912 87.774 
15 0.00001957 1.525 89.299 
16 0.00001932 1.505 90.804 
17 0.00001586 1.236 92.039 
18 0.00001309 1.02 93.059 
19 0.00001165 0.908 93.967 
20 0.00001126 0.877 94.844 
21 0.0000087 0.678 95.522 
22 0.00000827 0.644 96.167 
23 0.00000765 0.596 96.763 
24 0.000007 0.545 97.308 
25 0.00000539 0.42 97.728 
26 0.00000524 0.408 98.136 
27 0.00000439 0.342 98.478 
28 0.0000037 0.288 98.766 
29 0.00000301 0.235 99.001 
30 0.00000243 0.189 99.19 
31 0.00000209 0.163 99.353 
32 0.00000174 0.135 99.488 
33 0.00000138 0.108 99.596 
34 0.00000118 0.092 99.688 
35 0.00000113 0.088 99.775 
36 0.00000091 0.071 99.846 
37 0.00000071 0.055 99.902 
38 0.00000052 0.041 99.942 
39 0.00000042 0.032 99.975 
40 0.00000021 0.016 99.991 
41 0.00000011 0.009 100 
Total variance:  0.00128354 
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 25-DAY SAMPLE
16 landmarks in 3 dimensions. 
 The dataset contains 118 observations, of which 118 are included for analyses. 
Average shape: 
Lmk.  Axis 1 (x)  Axis 2 (y)  Axis 3 (z) 
 1 -0.38248254   0.10649700  -0.00166561
 2 -0.22857047   0.01141904   0.02182663
 3 -0.17772298   0.05463452   0.00449788
 4 -0.01881461   0.06839945   0.00791435
 5  0.17330237  0.17174151  0.01200489 
 6  0.13515389  0.12191013  0.00505780 
 7  0.25836397  0.09364936 -0.00808090
 8  0.34759856  0.02916161 -0.00928708
 9  0.19534065 -0.09570148   0.01107281
 10  0.25218099 -0.18499150   0.01364858
 11  0.02760078 -0.12666285   0.00412673
 12 -0.13514867  -0.12815150   0.01090576
 13 -0.29477268  -0.09384553  -0.02445665
 14 -0.36040843  -0.00129879   0.00717077
 15  0.17739835 -0.01374064   0.00463199
 16  0.03098081 -0.01302032  -0.05936795
Procrustes sums of squares: 0.1426041554143566 
Tangent sums of squares: 0.14238834520171426 
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PC Eigenvalues % Variance Cumulative % 
1 0.00020352 16.724 16.724 
2 0.00016926 13.908 30.631 
3 0.00011288 9.275 39.907 
4 0.00009083 7.464 47.37 
5 0.000077 6.327 53.698 
6 0.00006842 5.622 59.32 
7 0.00006427 5.281 64.601 
8 0.0000532 4.371 68.972 
9 0.00004156 3.415 72.387 
10 0.00003596 2.954 75.341 
11 0.00003181 2.614 77.955 
12 0.00002813 2.311 80.266 
13 0.00002458 2.02 82.286 
14 0.00002357 1.936 84.222 
15 0.00002207 1.814 86.036 
16 0.0000163 1.34 87.376 
17 0.00001571 1.291 88.667 
18 0.00001465 1.204 89.871 
19 0.00001337 1.099 90.97 
20 0.00001176 0.966 91.936 
21 0.00001078 0.885 92.821 
22 0.00000981 0.806 93.628 
23 0.00000886 0.728 94.356 
24 0.00000811 0.666 95.022 
25 0.00000678 0.557 95.579 
26 0.00000643 0.528 96.107 
27 0.00000596 0.489 96.597 
28 0.00000506 0.416 97.013 
29 0.00000459 0.377 97.39 
30 0.00000432 0.355 97.745 
31 0.00000422 0.347 98.092 
32 0.00000366 0.301 98.392 
33 0.00000349 0.287 98.679 
34 0.00000286 0.235 98.914 
35 0.0000028 0.23 99.145 
36 0.00000225 0.185 99.33 
37 0.00000211 0.173 99.503 
38 0.00000189 0.155 99.658 
39 0.00000164 0.135 99.793 
40 0.00000151 0.124 99.917 
41 0.00000101 0.083 100 
Total variance:  0.00121699 
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